<?xml version="1.0" encoding="utf-8"?>
<iati-activities version="2.03" generated-datetime="2026-11-09T09:21:46+00:00">
  <iati-activity last-updated-datetime="2026-11-07T09:53:07+00:00" xml:lang="en" default-currency="USD" humanitarian="0" hierarchy="1">
    <iati-identifier>47045-PHL-T-PBSP-1</iati-identifier>
    <reporting-org ref="47045" type="30">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </reporting-org>
    <title>
      <narrative>Intensifying and mainstreaming integrated DOTS in the Philippines project - Philippines (01-Jan-2014-31-Dec-2017)</narrative>
    </title>
    <description type="1">
      <narrative>Philippines, Tuberculosis, Philippine Business for Social Progress, Inc.</narrative>
    </description>
    <description type="2">
      <narrative>Goal: To reduce TB prevalence and mortality beyond 55% by 2016 from the 1990 baseline in support of the Millenium Development Goals for poverty alleviation. Objectives: Increase case detection rate for TB all forms from 82% in 2012 to 90% in 2016; Increase MDR TB case detection rate from 22% in 2012 to 40% of estimated MDR TB cases among the notified TB cases in 2016; Increase Treatment Success Rate for MDR TB from 56% in 2009 to 75% in 2016; Sustain Treatment Success Rate for TB all forms at &gt;=90% in 2016.</narrative>
    </description>
    <participating-org ref="47045" type="30" role="1" crs-channel-code="47045">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </participating-org>
    <participating-org type="24" role="2" crs-channel-code="23000">
      <narrative>Philippine Business for Social Progress, Inc.</narrative>
    </participating-org>
    <participating-org type="24" role="4" crs-channel-code="23000">
      <narrative>Philippine Business for Social Progress, Inc.</narrative>
    </participating-org>
    <other-identifier ref="PHL-T-PBSPP01" type="A1">
      <owner-org ref="47045">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </owner-org>
    </other-identifier>
    <activity-status code="4" />
    <activity-date type="1" iso-date="2014-01-01" />
    <activity-date type="2" iso-date="2014-01-01" />
    <activity-date type="3" iso-date="2017-12-31" />
    <activity-date type="4" iso-date="2017-12-31" />
    <contact-info type="1">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Communications</narrative>
      </department>
      <telephone>+41 58 791 1700</telephone>
      <email>website@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <contact-info type="2">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Grant Management Division</narrative>
      </department>
      <person-name>
        <narrative>xxxx xxxx</narrative>
      </person-name>
      <job-title>
        <narrative>Fund Portfolio Manager</narrative>
      </job-title>
      <telephone>+41 58 791 1700</telephone>
      <email>xxxx</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <activity-scope code="4" />
    <recipient-country code="PH" percentage="100">
      <narrative>Philippines</narrative>
    </recipient-country>
    <sector vocabulary="1" code="12263" percentage="100">
      <narrative>Tuberculosis</narrative>
    </sector>
    <tag vocabulary="2" code="3">
      <narrative>Ensure healthy lives and promote well-being for all at all ages</narrative>
    </tag>
    <tag vocabulary="3" code="3.3">
      <narrative>End the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases, and combat hepatitis, water-borne diseases and other communicable diseases</narrative>
    </tag>
    <collaboration-type code="1" />
    <default-flow-type code="10" />
    <default-finance-type code="110" />
    <default-aid-type code="C01" vocabulary="1" />
    <default-tied-status code="5" />
    <transaction ref="249be4c6-1d80-43b4-b861-cadcf22badd8">
      <transaction-type code="2" />
      <transaction-date iso-date="2014-04-12" />
      <value currency="USD" value-date="2014-04-12">23477845.00</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="20ecb3c9-4f5b-4666-b14d-9fb8e91939f5">
      <transaction-type code="3" />
      <transaction-date iso-date="2014-04-16" />
      <value currency="USD" value-date="2014-04-16">5087971.00</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="0e650f98-d6e8-4fd6-b639-0495a75e749a">
      <transaction-type code="3" />
      <transaction-date iso-date="2014-08-29" />
      <value currency="USD" value-date="2014-08-29">3151337.00</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="a5d99730-3bc4-4225-bde1-ecc472c46560">
      <transaction-type code="3" />
      <transaction-date iso-date="2014-08-29" />
      <value currency="USD" value-date="2014-08-29">50000.00</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="5790c147-e1cd-44e5-8a3b-966b6dfbdd19">
      <transaction-type code="3" />
      <transaction-date iso-date="2014-11-27" />
      <value currency="USD" value-date="2014-11-27">7016315.00</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="f08d0242-157d-4ff8-bd42-45748d213111">
      <transaction-type code="3" />
      <transaction-date iso-date="2014-12-19" />
      <value currency="USD" value-date="2014-12-19">3232315.00</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="7158158a-7c71-4460-8030-e5d1490bbe41">
      <transaction-type code="3" />
      <transaction-date iso-date="2015-04-02" />
      <value currency="USD" value-date="2015-04-02">4724812.12</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="1b57a682-8d61-4096-91de-1eb9bd437442">
      <transaction-type code="2" />
      <transaction-date iso-date="2015-04-27" />
      <value currency="USD" value-date="2015-04-27">26051353.00</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="72711535-5f5e-4429-8ee6-9136cbb5fc80">
      <transaction-type code="2" />
      <transaction-date iso-date="2015-04-27" />
      <value currency="USD" value-date="2015-04-27">-215094.88</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="1203f125-48c5-42ad-b40b-b6239bc98f5f">
      <transaction-type code="3" />
      <transaction-date iso-date="2015-04-30" />
      <value currency="USD" value-date="2015-04-30">7186625.00</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="5e50b1b1-bf16-44ac-9439-8187ecf1b529">
      <transaction-type code="3" />
      <transaction-date iso-date="2015-06-26" />
      <value currency="USD" value-date="2015-06-26">8530129.00</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="7be1d9ae-183b-4709-9189-b7d53633146e">
      <transaction-type code="3" />
      <transaction-date iso-date="2015-07-24" />
      <value currency="USD" value-date="2015-07-24">30000.00</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="e4ae5ae7-179d-4350-a43d-a1e062b7e16e">
      <transaction-type code="3" />
      <transaction-date iso-date="2015-12-03" />
      <value currency="USD" value-date="2015-12-03">7580616.00</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="132c88c4-e9ca-4e94-b175-a2280694bac6">
      <transaction-type code="3" />
      <transaction-date iso-date="2015-12-11" />
      <value currency="USD" value-date="2015-12-11">1895272.00</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="06a2dd23-beed-4c99-a06c-a836bd3bb63a">
      <transaction-type code="2" />
      <transaction-date iso-date="2016-02-10" />
      <value currency="USD" value-date="2016-02-10">-828711.00</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="22485d19-76ae-4424-ae75-0ec0b1fb38f3">
      <transaction-type code="2" />
      <transaction-date iso-date="2016-02-10" />
      <value currency="USD" value-date="2016-02-10">5891603.00</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="311fbf86-545a-4463-b4ea-1350769e3173">
      <transaction-type code="3" />
      <transaction-date iso-date="2016-02-12" />
      <value currency="USD" value-date="2016-02-12">5891603.00</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="e58407c2-2150-460f-bc03-244d2ed7caf0">
      <transaction-type code="2" />
      <transaction-date iso-date="2016-05-30" />
      <value currency="USD" value-date="2016-05-30">22972801.00</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="dad1e32f-99c8-4976-9fcb-de1add8e9d5d">
      <transaction-type code="3" />
      <transaction-date iso-date="2016-05-31" />
      <value currency="USD" value-date="2016-05-31">3370177.00</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="10bc27ab-c91e-45d7-b722-3a678eb5fd55">
      <transaction-type code="3" />
      <transaction-date iso-date="2016-07-21" />
      <value currency="USD" value-date="2016-07-21">30000.00</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="6c7fc6bd-f8d1-4fb5-ba15-0aa7d303f281">
      <transaction-type code="3" />
      <transaction-date iso-date="2016-07-21" />
      <value currency="USD" value-date="2016-07-21">8936405.00</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="93ded7c2-a7a6-4d95-8256-26cc887a5dad">
      <transaction-type code="3" />
      <transaction-date iso-date="2016-10-13" />
      <value currency="USD" value-date="2016-10-13">674944.74</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="05be0a9e-fb40-4864-82f5-89db6433402a">
      <transaction-type code="2" />
      <transaction-date iso-date="2016-10-28" />
      <value currency="USD" value-date="2016-10-28">17803798.00</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="9c528478-5b36-4111-8bf7-82fab6bebe9f">
      <transaction-type code="2" />
      <transaction-date iso-date="2016-10-28" />
      <value currency="USD" value-date="2016-10-28">-9961274.26</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="7bcbce80-5ea7-4637-9c6e-d85f127782db">
      <transaction-type code="3" />
      <transaction-date iso-date="2016-11-01" />
      <value currency="USD" value-date="2016-11-01">11982595.00</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="5cc8f55a-683a-409a-8952-4126ca8aa4e2">
      <transaction-type code="3" />
      <transaction-date iso-date="2016-12-02" />
      <value currency="USD" value-date="2016-12-02">1418206.15</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="1311a60d-7940-45f9-a1d7-b2aca436c1fd">
      <transaction-type code="2" />
      <transaction-date iso-date="2016-12-15" />
      <value currency="USD" value-date="2016-12-15">5821203.00</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="71979396-be63-4c42-86c9-5f8972d8e18c">
      <transaction-type code="2" />
      <transaction-date iso-date="2016-12-15" />
      <value currency="USD" value-date="2016-12-15">-4402996.85</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="8cbfee2f-0b80-48ba-92c3-894c35b314d5">
      <transaction-type code="3" />
      <transaction-date iso-date="2017-01-06" />
      <value currency="USD" value-date="2017-01-06">20000.00</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="fde22ae5-6bf7-45d3-9c2d-35e2e2245988">
      <transaction-type code="3" />
      <transaction-date iso-date="2017-01-06" />
      <value currency="USD" value-date="2017-01-06">5801203.00</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="1fa4919f-4931-4c8d-8c02-21ce7425a01e">
      <transaction-type code="2" />
      <transaction-date iso-date="2017-02-15" />
      <value currency="USD" value-date="2017-02-15">1209978.83</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="884d20ee-1751-46ab-a6b7-602ec6e2ef7d">
      <transaction-type code="3" />
      <transaction-date iso-date="2017-02-23" />
      <value currency="USD" value-date="2017-02-23">1209978.83</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="8cee52ba-6d3a-4536-9e4e-9a3200fe0750">
      <transaction-type code="2" />
      <transaction-date iso-date="2017-05-01" />
      <value currency="USD" value-date="2017-05-01">13950030.84</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="7c64cbf0-2016-4009-9dcb-178d10c6fd04">
      <transaction-type code="3" />
      <transaction-date iso-date="2017-05-02" />
      <value currency="USD" value-date="2017-05-02">7127344.99</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="9207826d-d24b-46b5-8e18-cf20cb2bed4f">
      <transaction-type code="3" />
      <transaction-date iso-date="2017-05-18" />
      <value currency="USD" value-date="2017-05-18">2457470.39</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="0e0a528d-008c-4094-9e92-024cd585a9f1">
      <transaction-type code="2" />
      <transaction-date iso-date="2017-07-27" />
      <value currency="USD" value-date="2017-07-27">16276303.00</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="6ba9c576-b7d2-4a85-8f4a-2440d77bde0a">
      <transaction-type code="2" />
      <transaction-date iso-date="2017-07-27" />
      <value currency="USD" value-date="2017-07-27">-4365215.46</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="a25936e4-662b-4010-8828-b4bc98d0ba16">
      <transaction-type code="3" />
      <transaction-date iso-date="2017-07-28" />
      <value currency="USD" value-date="2017-07-28">6844840.00</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="d326c659-30aa-4ba6-9797-39dffaa7041c">
      <transaction-type code="3" />
      <transaction-date iso-date="2017-07-28" />
      <value currency="USD" value-date="2017-07-28">4689864.33</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="4e79bbd5-220f-4df9-a47d-470f2199dffe">
      <transaction-type code="3" />
      <transaction-date iso-date="2017-11-28" />
      <value currency="USD" value-date="2017-11-28">4741598.67</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="e0e24c1c-a48b-46ae-9d7e-41fb21069c7a">
      <transaction-type code="2" />
      <transaction-date iso-date="2017-12-15" />
      <value currency="USD" value-date="2017-12-15">50000.00</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="8ff8676e-c0c3-4bff-b7c7-1e996559ccac">
      <transaction-type code="3" />
      <transaction-date iso-date="2017-12-15" />
      <value currency="USD" value-date="2017-12-15">50000.00</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="9a0f243b-1a08-4bb7-9004-073cb6cc946c">
      <transaction-type code="7" />
      <transaction-date iso-date="2018-04-17" />
      <value currency="USD" value-date="2018-04-17">347628.62</value>
      <description>
        <narrative>Funds returned to the Global Fund from PHL-T-PBSPP01.</narrative>
      </description>
      <provider-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="30f5fc02-9f57-4448-b707-5dfdea34bd58">
      <transaction-type code="2" />
      <transaction-date iso-date="2018-04-27" />
      <value currency="USD" value-date="2018-04-27">-347628.62</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="4cc92435-1897-43f4-8494-ea46a59900f5">
      <transaction-type code="2" />
      <transaction-date iso-date="2018-05-31" />
      <value currency="USD" value-date="2018-05-31">347629.40</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="2a0e3481-a712-4d34-b951-35a53cb716b1">
      <transaction-type code="3" />
      <transaction-date iso-date="2018-06-05" />
      <value currency="USD" value-date="2018-06-05">347629.40</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <document-link url="https://data.theglobalfund.org/grant/PHL-T-PBSP" format="text/html">
      <title>
        <narrative>Grant page on the data explorer of the Global Fund.</narrative>
      </title>
      <description>
        <narrative>An overview of a grant over its lifetime.</narrative>
      </description>
      <category code="A12" />
      <category code="A01" />
      <category code="A02" />
      <category code="A05" />
      <category code="A07" />
      <category code="A08" />
      <language code="en" />
      <document-date iso-date="2026-11-09" />
    </document-link>
    <document-link url="https://www.theglobalfund.org/media/13342/core_grantregulationsversiontwo_regulations_en.pdf" format="application/pdf">
      <title>
        <narrative>Grant terms and conditions.</narrative>
      </title>
      <description>
        <narrative>General terms and conditions which apply to Global Fund grants.</narrative>
      </description>
      <category code="A04" />
      <language code="en" />
    </document-link>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>MDR TB-other 1: Number and percentage of laboratories showing at least 95% proficiency for isoniazid and rifampicin drug susceptibility testing among the total number of laboratories that undertake drug susceptibility testing during the reporting period</narrative>
      </title>
      <description>
        <narrative>Module: MDR-TB.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>MDR TB-other 1: Number and percentage of laboratories showing at least 95% proficiency for isoniazid and rifampicin drug susceptibility testing among the total number of laboratories that undertake drug susceptibility testing during the reporting period</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2012" iso-date="2012-12-31">
          <comment>
            <narrative>Numerator: 3; Denominator: 7; Percentage: 42.9%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2014-07-01" />
          <period-end iso-date="2014-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 4; Denominator: 4; Percentage: 100%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 3; Denominator: 4; Percentage: 75%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2015-07-01" />
          <period-end iso-date="2015-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 5; Denominator: 5; Percentage: 100%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 4; Denominator: 5; Percentage: 80%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2016-01-01" />
          <period-end iso-date="2016-06-30" />
          <actual>
            <comment>
              <narrative>Numerator: 0; Denominator: 0.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2016-07-01" />
          <period-end iso-date="2016-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 7; Denominator: 7; Percentage: 100%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 7; Denominator: 7; Percentage: 100%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2017-07-01" />
          <period-end iso-date="2017-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 7; Denominator: 7; Percentage: 100%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 8; Denominator: 9; Percentage: 88.9%.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of TB cases with RR-TB and/or MDR-TB notified</narrative>
      </title>
      <description>
        <narrative>Module: MDR-TB.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Number of TB cases with RR-TB and/or MDR-TB notified</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Cumulative annually.</narrative>
        </description>
        <baseline year="2012" iso-date="2012-12-31">
          <comment>
            <narrative>Numerator: 1994; Denominator: 11469; Percentage: 17.4%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2014-01-01" />
          <period-end iso-date="2014-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 1425.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1409.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2014-07-01" />
          <period-end iso-date="2014-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 2850.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 3032.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2015-01-01" />
          <period-end iso-date="2015-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 2183.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 2412.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2015-07-01" />
          <period-end iso-date="2015-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 4365.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 4788.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2016-01-01" />
          <period-end iso-date="2016-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 2589.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 2784.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2016-07-01" />
          <period-end iso-date="2016-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 5600.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 5771; Denominator: 5600; Percentage: 103%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2017-01-01" />
          <period-end iso-date="2017-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 3850.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 3211.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2017-07-01" />
          <period-end iso-date="2017-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 7700.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 6417.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of cases with RR-TB and/or MDR-TB that began second-line treatment</narrative>
      </title>
      <description>
        <narrative>Module: MDR-TB.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Number of cases with RR-TB and/or MDR-TB that began second-line treatment</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Cumulative annually.</narrative>
        </description>
        <baseline year="2012" iso-date="2012-12-31">
          <comment>
            <narrative>Numerator: 1807; Denominator: 11469; Percentage: 15.8%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2014-01-01" />
          <period-end iso-date="2014-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 1425.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1210.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2014-07-01" />
          <period-end iso-date="2014-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 2850.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 2567.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2015-01-01" />
          <period-end iso-date="2015-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 2183.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1864.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2015-07-01" />
          <period-end iso-date="2015-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 4365.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 4035.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2016-01-01" />
          <period-end iso-date="2016-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 2589.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 2561.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2016-07-01" />
          <period-end iso-date="2016-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 5600.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 5336; Denominator: 5600; Percentage: 95.3%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2017-01-01" />
          <period-end iso-date="2017-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 3850.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 2913.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2017-07-01" />
          <period-end iso-date="2017-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 7700.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 5684.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of cases with RR-TB and/or MDR-TB started on treatment for MDR-TB who were lost to follow up during the first six months of treatment</narrative>
      </title>
      <description>
        <narrative>Module: MDR-TB.</narrative>
      </description>
      <indicator measure="2" ascending="0" aggregation-status="0">
        <title>
          <narrative>Percentage of cases with RR-TB and/or MDR-TB started on treatment for MDR-TB who were lost to follow up during the first six months of treatment</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2012" iso-date="2012-12-31" value="17" />
        <period>
          <period-start iso-date="2014-01-01" />
          <period-end iso-date="2014-06-30" />
          <target value="15" />
          <actual value="13" />
        </period>
        <period>
          <period-start iso-date="2014-07-01" />
          <period-end iso-date="2014-12-31" />
          <target value="15" />
          <actual value="14" />
        </period>
        <period>
          <period-start iso-date="2015-01-01" />
          <period-end iso-date="2015-06-30" />
          <target value="10" />
          <actual value="16" />
        </period>
        <period>
          <period-start iso-date="2015-07-01" />
          <period-end iso-date="2015-12-31" />
          <target value="10" />
          <actual value="15.4" />
        </period>
        <period>
          <period-start iso-date="2016-01-01" />
          <period-end iso-date="2016-06-30" />
          <target value="10" />
          <actual value="14.48">
            <comment>
              <narrative>Numerator: 270; Denominator: 1864.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2016-07-01" />
          <period-end iso-date="2016-12-31" />
          <target value="10" />
          <actual value="14.7">
            <comment>
              <narrative>Numerator: 591; Denominator: 4027.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2017-01-01" />
          <period-end iso-date="2017-06-30" />
          <target value="6" />
          <actual value="10.7">
            <comment>
              <narrative>Numerator: 273; Denominator: 2552.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2017-07-01" />
          <period-end iso-date="2017-12-31" />
          <target value="6" />
          <actual value="11.2">
            <comment>
              <narrative>Numerator: 310; Denominator: 2758.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>DOTS-other 1: Number and percentage of notified TB cases (all forms) contributed by non-NTP providers- private/ public sector</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>DOTS-other 1: Number and percentage of notified TB cases (all forms) contributed by non-NTP providers- private/ public sector</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Cumulative annually.</narrative>
        </description>
        <baseline year="2012" iso-date="2012-12-31" value="17.6">
          <comment>
            <narrative>Numerator: 39574; Denominator: 225361.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2014-07-01" />
          <period-end iso-date="2014-12-31" />
          <target value="1.4">
            <comment>
              <narrative>Numerator: 1560; Denominator: 108791.</narrative>
            </comment>
          </target>
          <actual value="0.9">
            <comment>
              <narrative>Numerator: 1033; Denominator: 108791.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2015-01-01" />
          <period-end iso-date="2015-06-30" />
          <target value="1.4">
            <comment>
              <narrative>Numerator: 3120; Denominator: 217581.</narrative>
            </comment>
          </target>
          <actual value="2.4">
            <comment>
              <narrative>Numerator: 5315; Denominator: 217581.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2015-07-01" />
          <period-end iso-date="2015-12-31" />
          <target value="4.6">
            <comment>
              <narrative>Numerator: 5160; Denominator: 111166.</narrative>
            </comment>
          </target>
          <actual value="6.3">
            <comment>
              <narrative>Numerator: 9334; Denominator: 147500.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2016-01-01" />
          <period-end iso-date="2016-06-30" />
          <target value="3.2">
            <comment>
              <narrative>Numerator: 7200; Denominator: 222331.</narrative>
            </comment>
          </target>
          <actual value="15">
            <comment>
              <narrative>Numerator: 12730; Denominator: 84867.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2016-07-01" />
          <period-end iso-date="2016-12-31" />
          <target value="6.4">
            <comment>
              <narrative>Numerator: 7200; Denominator: 112766.</narrative>
            </comment>
          </target>
          <actual value="9">
            <comment>
              <narrative>Numerator: 14254; Denominator: 158054.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2017-01-01" />
          <period-end iso-date="2017-06-30" />
          <target value="7">
            <comment>
              <narrative>Numerator: 8640; Denominator: 122659.</narrative>
            </comment>
          </target>
          <actual value="9.5">
            <comment>
              <narrative>Numerator: 14319; Denominator: 150239.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2017-07-01" />
          <period-end iso-date="2017-12-31" />
          <target value="7">
            <comment>
              <narrative>Numerator: 17280; Denominator: 245318.</narrative>
            </comment>
          </target>
          <actual value="9">
            <comment>
              <narrative>Numerator: 27450; Denominator: 304153.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Cumulative annually.</narrative>
        </description>
        <baseline year="2012" iso-date="2012-12-31" value="217354" />
        <period>
          <period-start iso-date="2014-07-01" />
          <period-end iso-date="2014-12-31" />
          <target value="108791" />
          <actual value="112106" />
        </period>
        <period>
          <period-start iso-date="2015-01-01" />
          <period-end iso-date="2015-06-30" />
          <target value="217581" />
          <actual value="243379" />
        </period>
        <period>
          <period-start iso-date="2015-07-01" />
          <period-end iso-date="2015-12-31" />
          <target value="111166" />
          <actual value="147500" />
        </period>
        <period>
          <period-start iso-date="2016-01-01" />
          <period-end iso-date="2016-06-30" />
          <target value="222331" />
          <actual value="299207" />
        </period>
        <period>
          <period-start iso-date="2016-07-01" />
          <period-end iso-date="2016-12-31" />
          <target value="112766" />
          <actual value="158054" />
        </period>
        <period>
          <period-start iso-date="2017-01-01" />
          <period-end iso-date="2017-06-30" />
          <target value="122659" />
          <actual value="150239" />
        </period>
        <period>
          <period-start iso-date="2017-07-01" />
          <period-end iso-date="2017-12-31" />
          <target value="245318" />
          <actual value="304153" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of notified cases of bacteriologically confirmed TB, new and relapses</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of notified cases of bacteriologically confirmed TB, new and relapses</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Cumulative annually.</narrative>
        </description>
        <baseline year="2012" iso-date="2012-12-31" value="99011" />
        <period>
          <period-start iso-date="2014-07-01" />
          <period-end iso-date="2014-12-31" />
          <target value="48955" />
          <actual value="46375" />
        </period>
        <period>
          <period-start iso-date="2015-01-01" />
          <period-end iso-date="2015-06-30" />
          <target value="97911" />
          <actual value="99268" />
        </period>
        <period>
          <period-start iso-date="2015-07-01" />
          <period-end iso-date="2015-12-31" />
          <target value="50025" />
          <actual value="50180" />
        </period>
        <period>
          <period-start iso-date="2016-01-01" />
          <period-end iso-date="2016-06-30" />
          <target value="100049" />
          <actual value="101648" />
        </period>
        <period>
          <period-start iso-date="2016-07-01" />
          <period-end iso-date="2016-12-31" />
          <target value="50744" />
          <actual value="55624" />
        </period>
        <period>
          <period-start iso-date="2017-01-01" />
          <period-end iso-date="2017-06-30" />
          <target value="41704" />
          <actual value="55405" />
        </period>
        <period>
          <period-start iso-date="2017-07-01" />
          <period-end iso-date="2017-12-31" />
          <target value="83408" />
          <actual value="113884" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of bacteriologically confirmed TB cases successfully treated (cured plus completed treatment) among the bacteriologically confirmed TB cases registered during a specified period</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of bacteriologically confirmed TB cases successfully treated (cured plus completed treatment) among the bacteriologically confirmed TB cases registered during a specified period</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Cumulative annually.</narrative>
        </description>
        <baseline year="2012" iso-date="2012-12-31" value="90">
          <comment>
            <narrative>Numerator: 75387; Denominator: 83413.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2014-01-01" />
          <period-end iso-date="2014-06-30" />
          <target value="90">
            <comment>
              <narrative>Numerator: 42966; Denominator: 47740.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2014-07-01" />
          <period-end iso-date="2014-12-31" />
          <target value="90">
            <comment>
              <narrative>Numerator: 85931; Denominator: 95479.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2015-01-01" />
          <period-end iso-date="2015-06-30" />
          <target value="90">
            <comment>
              <narrative>Numerator: 44060; Denominator: 48956.</narrative>
            </comment>
          </target>
          <actual value="89.9">
            <comment>
              <narrative>Numerator: 84522; Denominator: 93993.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2015-07-01" />
          <period-end iso-date="2015-12-31" />
          <target value="90">
            <comment>
              <narrative>Numerator: 88120; Denominator: 97911.</narrative>
            </comment>
          </target>
          <actual value="91.5">
            <comment>
              <narrative>Numerator: 74263; Denominator: 81130.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2016-01-01" />
          <period-end iso-date="2016-06-30" />
          <target value="90">
            <comment>
              <narrative>Numerator: 45023; Denominator: 50025.</narrative>
            </comment>
          </target>
          <actual value="90.78">
            <comment>
              <narrative>Numerator: 37619; Denominator: 41442.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2016-07-01" />
          <period-end iso-date="2016-12-31" />
          <target value="90">
            <comment>
              <narrative>Numerator: 90044; Denominator: 100049.</narrative>
            </comment>
          </target>
          <actual value="86.4">
            <comment>
              <narrative>Numerator: 77785; Denominator: 90044.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2017-01-01" />
          <period-end iso-date="2017-06-30" />
          <target value="90">
            <comment>
              <narrative>Numerator: 45670; Denominator: 50744.</narrative>
            </comment>
          </target>
          <actual value="88.9">
            <comment>
              <narrative>Numerator: 48864; Denominator: 54982.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2017-07-01" />
          <period-end iso-date="2017-12-31" />
          <target value="90">
            <comment>
              <narrative>Numerator: 91340; Denominator: 101488.</narrative>
            </comment>
          </target>
          <actual value="89.7">
            <comment>
              <narrative>Numerator: 99877; Denominator: 111373.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of notified TB cases, all forms, contributed by non-NTP providers - community referrals</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of notified TB cases, all forms, contributed by non-NTP providers - community referrals</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Cumulative annually.</narrative>
        </description>
        <baseline year="2011" iso-date="2011-12-31" value="0">
          <comment>
            <narrative>Numerator: 8500; Denominator: 214997.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2014-07-01" />
          <period-end iso-date="2014-12-31" />
          <target value="1.4">
            <comment>
              <narrative>Numerator: 3000; Denominator: 217581.</narrative>
            </comment>
          </target>
          <actual value="3.6">
            <comment>
              <narrative>Numerator: 7875; Denominator: 217581.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2015-01-01" />
          <period-end iso-date="2015-06-30" />
          <target value="1.9">
            <comment>
              <narrative>Numerator: 2130; Denominator: 111166.</narrative>
            </comment>
          </target>
          <actual value="7.9">
            <comment>
              <narrative>Numerator: 8768; Denominator: 111166.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2015-07-01" />
          <period-end iso-date="2015-12-31" />
          <target value="1.9">
            <comment>
              <narrative>Numerator: 4260; Denominator: 222331.</narrative>
            </comment>
          </target>
          <actual value="2.9">
            <comment>
              <narrative>Numerator: 6400; Denominator: 222331.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2016-01-01" />
          <period-end iso-date="2016-06-30" />
          <target value="7.8">
            <comment>
              <narrative>Numerator: 8760; Denominator: 112766.</narrative>
            </comment>
          </target>
          <actual value="11.02">
            <comment>
              <narrative>Numerator: 9356; Denominator: 84867.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2016-07-01" />
          <period-end iso-date="2016-12-31" />
          <target value="6.5">
            <comment>
              <narrative>Numerator: 14760; Denominator: 225531.</narrative>
            </comment>
          </target>
          <actual value="10.1">
            <comment>
              <narrative>Numerator: 15911; Denominator: 158054.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2017-01-01" />
          <period-end iso-date="2017-06-30" />
          <target value="5">
            <comment>
              <narrative>Numerator: 6000; Denominator: 122659.</narrative>
            </comment>
          </target>
          <actual value="4.3">
            <comment>
              <narrative>Numerator: 6427; Denominator: 150239.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2017-07-01" />
          <period-end iso-date="2017-12-31" />
          <target value="5">
            <comment>
              <narrative>Numerator: 12000; Denominator: 245318.</narrative>
            </comment>
          </target>
          <actual value="4.2">
            <comment>
              <narrative>Numerator: 12752; Denominator: 304150.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of HIV-positive patients who were screened for TB in HIV care or treatment settings</narrative>
      </title>
      <description>
        <narrative>Module: TB/HIV.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Percentage of HIV-positive patients who were screened for TB in HIV care or treatment settings</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Cumulative annually.</narrative>
        </description>
        <baseline year="2015" iso-date="2015-12-31">
          <comment>
            <narrative>Numerator: 11213; Denominator: 13386; Percentage: 83.8%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2014-07-01" />
          <period-end iso-date="2014-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 2218; Denominator: 2464; Percentage: 90%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 5296; Denominator: 7377; Percentage: 71.8%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2015-07-01" />
          <period-end iso-date="2015-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 2454; Denominator: 2727; Percentage: 90%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 11213; Denominator: 13386; Percentage: 83.8%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2016-01-01" />
          <period-end iso-date="2016-06-30" />
          <actual>
            <comment>
              <narrative>Numerator: 0; Denominator: 0.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2016-07-01" />
          <period-end iso-date="2016-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 2525; Denominator: 2805; Percentage: 90%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 19991; Denominator: 20656; Percentage: 96.8%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2017-07-01" />
          <period-end iso-date="2017-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 17693; Denominator: 19659; Percentage: 90%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 26067; Denominator: 26437; Percentage: 98.6%.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of HIV-positive registered TB patients given anti-retroviral therapy during TB treatment</narrative>
      </title>
      <description>
        <narrative>Module: TB/HIV.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of HIV-positive registered TB patients given anti-retroviral therapy during TB treatment</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Cumulative annually.</narrative>
        </description>
        <baseline year="2015" iso-date="2015-12-31" value="80.9">
          <comment>
            <narrative>Numerator: 182; Denominator: 225.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2014-01-01" />
          <period-end iso-date="2014-06-30" />
          <target value="100">
            <comment>
              <narrative>Numerator: 24; Denominator: 24.</narrative>
            </comment>
          </target>
          <actual value="45">
            <comment>
              <narrative>Numerator: 24; Denominator: 53.3.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2014-07-01" />
          <period-end iso-date="2014-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 47; Denominator: 47.</narrative>
            </comment>
          </target>
          <actual value="73.7">
            <comment>
              <narrative>Numerator: 28; Denominator: 38.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2015-01-01" />
          <period-end iso-date="2015-06-30" />
          <target value="100">
            <comment>
              <narrative>Numerator: 25; Denominator: 25.</narrative>
            </comment>
          </target>
          <actual value="90.6">
            <comment>
              <narrative>Numerator: 58; Denominator: 64.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2015-07-01" />
          <period-end iso-date="2015-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 50; Denominator: 50.</narrative>
            </comment>
          </target>
          <actual value="80.9">
            <comment>
              <narrative>Numerator: 182; Denominator: 225.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2016-01-01" />
          <period-end iso-date="2016-06-30" />
          <target value="100">
            <comment>
              <narrative>Numerator: 27; Denominator: 27.</narrative>
            </comment>
          </target>
          <actual value="87.98">
            <comment>
              <narrative>Numerator: 227; Denominator: 258.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2016-07-01" />
          <period-end iso-date="2016-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 53; Denominator: 53.</narrative>
            </comment>
          </target>
          <actual value="85.5">
            <comment>
              <narrative>Numerator: 565; Denominator: 661.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2017-01-01" />
          <period-end iso-date="2017-06-30" />
          <target value="100">
            <comment>
              <narrative>Numerator: 162; Denominator: 162.</narrative>
            </comment>
          </target>
          <actual value="92.5">
            <comment>
              <narrative>Numerator: 557; Denominator: 602.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2017-07-01" />
          <period-end iso-date="2017-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 323; Denominator: 323.</narrative>
            </comment>
          </target>
          <actual value="93.9">
            <comment>
              <narrative>Numerator: 1199; Denominator: 1277.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of TB patients who had an HIV test result recorded in the TB register</narrative>
      </title>
      <description>
        <narrative>Module: TB/HIV.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of TB patients who had an HIV test result recorded in the TB register</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Cumulative annually.</narrative>
        </description>
        <baseline year="2012" iso-date="2012-12-31" value="36.9">
          <comment>
            <narrative>Numerator: 3917; Denominator: 10618.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2014-01-01" />
          <period-end iso-date="2014-06-30" />
          <target value="80">
            <comment>
              <narrative>Numerator: 23330; Denominator: 29163.</narrative>
            </comment>
          </target>
          <actual value="37">
            <comment>
              <narrative>Numerator: 23330; Denominator: 63054.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2014-07-01" />
          <period-end iso-date="2014-12-31" />
          <target value="80">
            <comment>
              <narrative>Numerator: 46660; Denominator: 58325.</narrative>
            </comment>
          </target>
          <actual value="39.3">
            <comment>
              <narrative>Numerator: 4583; Denominator: 11664.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2015-01-01" />
          <period-end iso-date="2015-06-30" />
          <target value="80">
            <comment>
              <narrative>Numerator: 24459; Denominator: 30574.</narrative>
            </comment>
          </target>
          <actual value="51.7">
            <comment>
              <narrative>Numerator: 10917; Denominator: 21115.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2015-07-01" />
          <period-end iso-date="2015-12-31" />
          <target value="80">
            <comment>
              <narrative>Numerator: 48918; Denominator: 61148.</narrative>
            </comment>
          </target>
          <actual value="63.4">
            <comment>
              <narrative>Numerator: 37324; Denominator: 58887.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2016-01-01" />
          <period-end iso-date="2016-06-30" />
          <target value="80.1">
            <comment>
              <narrative>Numerator: 25644; Denominator: 32005.</narrative>
            </comment>
          </target>
          <actual value="79.5">
            <comment>
              <narrative>Numerator: 29864; Denominator: 37563.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2016-07-01" />
          <period-end iso-date="2016-12-31" />
          <target value="80">
            <comment>
              <narrative>Numerator: 51287; Denominator: 64109.</narrative>
            </comment>
          </target>
          <actual value="82.7">
            <comment>
              <narrative>Numerator: 66007; Denominator: 79821.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2017-01-01" />
          <period-end iso-date="2017-06-30" />
          <target value="80">
            <comment>
              <narrative>Numerator: 26926; Denominator: 33657.</narrative>
            </comment>
          </target>
          <actual value="85.4">
            <comment>
              <narrative>Numerator: 37503; Denominator: 43938.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2017-07-01" />
          <period-end iso-date="2017-12-31" />
          <target value="80">
            <comment>
              <narrative>Numerator: 53852; Denominator: 67314.</narrative>
            </comment>
          </target>
          <actual value="83.8">
            <comment>
              <narrative>Numerator: 76734; Denominator: 91586.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of new HIV-positive patients starting IPT during the reporting period</narrative>
      </title>
      <description>
        <narrative>Module: TB/HIV.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of new HIV-positive patients starting IPT during the reporting period</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Cumulative annually.</narrative>
        </description>
        <baseline year="2015" iso-date="2015-12-31" value="61.9">
          <comment>
            <narrative>Numerator: 1278; Denominator: 2064.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2014-01-01" />
          <period-end iso-date="2014-06-30" />
          <target value="60">
            <comment>
              <narrative>Numerator: 925; Denominator: 1542.</narrative>
            </comment>
          </target>
          <actual value="212.9">
            <comment>
              <narrative>Numerator: 711; Denominator: 334.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2014-07-01" />
          <period-end iso-date="2014-12-31" />
          <target value="60">
            <comment>
              <narrative>Numerator: 1850; Denominator: 3084.</narrative>
            </comment>
          </target>
          <actual value="66.4">
            <comment>
              <narrative>Numerator: 887; Denominator: 1336.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2015-01-01" />
          <period-end iso-date="2015-06-30" />
          <target value="60">
            <comment>
              <narrative>Numerator: 1081; Denominator: 1802.</narrative>
            </comment>
          </target>
          <actual value="59">
            <comment>
              <narrative>Numerator: 1063; Denominator: 1802.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2015-07-01" />
          <period-end iso-date="2015-12-31" />
          <target value="60">
            <comment>
              <narrative>Numerator: 2162; Denominator: 3604.</narrative>
            </comment>
          </target>
          <actual value="61.9">
            <comment>
              <narrative>Numerator: 1278; Denominator: 2064.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2016-01-01" />
          <period-end iso-date="2016-06-30" />
          <target value="70">
            <comment>
              <narrative>Numerator: 1512; Denominator: 2160.</narrative>
            </comment>
          </target>
          <actual value="47.74">
            <comment>
              <narrative>Numerator: 941; Denominator: 1971.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2016-07-01" />
          <period-end iso-date="2016-12-31" />
          <target value="70">
            <comment>
              <narrative>Numerator: 3024; Denominator: 4321.</narrative>
            </comment>
          </target>
          <actual value="68">
            <comment>
              <narrative>Numerator: 2938; Denominator: 4321.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2017-01-01" />
          <period-end iso-date="2017-06-30" />
          <target value="70">
            <comment>
              <narrative>Numerator: 1537; Denominator: 2195.</narrative>
            </comment>
          </target>
          <actual value="72.9">
            <comment>
              <narrative>Numerator: 1780; Denominator: 2442.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2017-07-01" />
          <period-end iso-date="2017-12-31" />
          <target value="70">
            <comment>
              <narrative>Numerator: 3073; Denominator: 4390.</narrative>
            </comment>
          </target>
          <actual value="78">
            <comment>
              <narrative>Numerator: 3817; Denominator: 4894.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
  </iati-activity>
  <iati-activity last-updated-datetime="2026-11-07T09:53:07+00:00" xml:lang="en" default-currency="USD" humanitarian="0" hierarchy="1">
    <iati-identifier>47045-PHL-T-PBSP-2</iati-identifier>
    <reporting-org ref="47045" type="30">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </reporting-org>
    <title>
      <narrative>Intensifying and Mainstreaming Integrated DOTS Project - Philippines (01-Jan-2018-31-Dec-2020)</narrative>
    </title>
    <description type="1">
      <narrative>Philippines, Tuberculosis, Philippine Business for Social Progress, Inc.</narrative>
    </description>
    <description type="2">
      <narrative>Goals: Reduce TB burden by decreasing the number of TB deaths by 50% from 14,000 to 7,000 by 2022; Reduce TB burden by decreasing incidence rate by 24% from 322/100,000 population to 243/100,000 by 2022; Achieve zero TB-affected families facing catastrophic costs by 2022. Objectives: By 2022, increase TB treatment coverage to from 92% to 95% for DSTB and from 32% to 90% for DRTB; By 2022, achieve treatment success rate of 92% for DSTB cases and 85% for DRTB cases; By 2022, reduce catastrophic cost of TB-affected households accessing DOTS facilities to zero.</narrative>
    </description>
    <participating-org ref="47045" type="30" role="1" crs-channel-code="47045">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </participating-org>
    <participating-org type="24" role="2" crs-channel-code="23000">
      <narrative>Philippine Business for Social Progress, Inc.</narrative>
    </participating-org>
    <participating-org type="24" role="4" crs-channel-code="23000">
      <narrative>Philippine Business for Social Progress, Inc.</narrative>
    </participating-org>
    <other-identifier ref="PHL-T-PBSPP02" type="A1">
      <owner-org ref="47045">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </owner-org>
    </other-identifier>
    <activity-status code="4" />
    <activity-date type="1" iso-date="2018-01-01" />
    <activity-date type="2" iso-date="2018-01-01" />
    <activity-date type="3" iso-date="2020-12-31" />
    <activity-date type="4" iso-date="2020-12-31" />
    <contact-info type="1">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Communications</narrative>
      </department>
      <telephone>+41 58 791 1700</telephone>
      <email>website@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <contact-info type="2">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Grant Management Division</narrative>
      </department>
      <person-name>
        <narrative>xxxx xxxx</narrative>
      </person-name>
      <job-title>
        <narrative>Fund Portfolio Manager</narrative>
      </job-title>
      <telephone>+41 58 791 1700</telephone>
      <email>xxxx</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <activity-scope code="4" />
    <recipient-country code="PH" percentage="100">
      <narrative>Philippines</narrative>
    </recipient-country>
    <sector vocabulary="1" code="12263" percentage="90.3">
      <narrative>Tuberculosis</narrative>
    </sector>
    <sector vocabulary="1" code="12110" percentage="9.7">
      <narrative>Multicomponent, RSSH</narrative>
    </sector>
    <tag vocabulary="2" code="3">
      <narrative>Ensure healthy lives and promote well-being for all at all ages</narrative>
    </tag>
    <tag vocabulary="3" code="3.3">
      <narrative>End the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases, and combat hepatitis, water-borne diseases and other communicable diseases</narrative>
    </tag>
    <tag vocabulary="3" code="3.8">
      <narrative>Achieve universal health coverage</narrative>
    </tag>
    <country-budget-items vocabulary="4">
      <budget-item code="e07bbbe4-54fa-4084-a6fe-7f1c9c3b77b6" percentage="7.43">
        <description>
          <narrative>Multicomponent -&gt; Program management -&gt; Grant management</narrative>
        </description>
      </budget-item>
      <budget-item code="c9a33ca8-7a81-4232-9a19-1315956af36c" percentage="2.1">
        <description>
          <narrative>RSSH -&gt; RSSH: Health management information systems and M&amp;E -&gt; Analysis, evaluations, reviews and transparency</narrative>
        </description>
      </budget-item>
      <budget-item code="41f514b1-2e70-4f77-98c1-68e6052dc6a9" percentage="0.16">
        <description>
          <narrative>RSSH -&gt; RSSH: Health management information systems and M&amp;E -&gt; Surveys</narrative>
        </description>
      </budget-item>
      <budget-item code="1c7b99cb-f18c-499f-a55d-f7a0d6b99b21" percentage="27.24">
        <description>
          <narrative>Tuberculosis -&gt; MDR-TB -&gt; Case detection and diagnosis (MDR-TB)</narrative>
        </description>
      </budget-item>
      <budget-item code="3637a37c-6acc-4a5b-b7e4-00640fd7e2ec" percentage="46.09">
        <description>
          <narrative>Tuberculosis -&gt; MDR-TB -&gt; Treatment (MDR-TB)</narrative>
        </description>
      </budget-item>
      <budget-item code="f7014493-22e9-4c03-96d0-144fbb3a254f" percentage="7.48">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Case detection and diagnosis (TB care and prevention)</narrative>
        </description>
      </budget-item>
      <budget-item code="a0ec8795-341f-4d7b-9bdd-618cfc782127" percentage="0.79">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Community TB care delivery</narrative>
        </description>
      </budget-item>
      <budget-item code="cbff055b-fbc0-468b-9604-e69b10cbd9dd" percentage="3.13">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Engaging all care providers (TB care and prevention)</narrative>
        </description>
      </budget-item>
      <budget-item code="1a563d22-2c21-4f9a-b142-805695850ac9" percentage="2.86">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Key populations (TB care and prevention) - Others</narrative>
        </description>
      </budget-item>
      <budget-item code="56afe3f2-1fa3-4fd3-b845-9ea07f4bfd51" percentage="0.48">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Key populations (TB care and prevention) - Prisoners</narrative>
        </description>
      </budget-item>
      <budget-item code="13c1e439-070b-4238-9903-7972703a027e" percentage="0.03">
        <description>
          <narrative>Tuberculosis -&gt; TB/HIV -&gt; Collaborative activities with other programs and sectors (TB/HIV)</narrative>
        </description>
      </budget-item>
      <budget-item code="755fd9d3-5219-420f-8cf5-d32af32e5180" percentage="0">
        <description>
          <narrative>Tuberculosis -&gt; TB/HIV -&gt; Community TB/HIV care delivery</narrative>
        </description>
      </budget-item>
      <budget-item code="03642497-8d31-43e6-9dc7-a1d83d6bad5e" percentage="0.72">
        <description>
          <narrative>Tuberculosis -&gt; TB/HIV -&gt; Engaging all care providers (TB/HIV)</narrative>
        </description>
      </budget-item>
      <budget-item code="92e11022-488c-4948-abb3-b61f3d9ca4f6" percentage="1.49">
        <description>
          <narrative>Tuberculosis -&gt; TB/HIV -&gt; TB/HIV - Collaborative interventions</narrative>
        </description>
      </budget-item>
    </country-budget-items>
    <collaboration-type code="1" />
    <default-flow-type code="10" />
    <default-finance-type code="110" />
    <default-aid-type code="C01" vocabulary="1" />
    <default-tied-status code="5" />
    <budget type="2" status="2">
      <period-start iso-date="2018-01-01" />
      <period-end iso-date="2018-12-31" />
      <value currency="USD" value-date="2018-01-01">36049635.13</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2019-01-01" />
      <period-end iso-date="2019-12-31" />
      <value currency="USD" value-date="2019-01-01">33607166.61</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2020-01-01" />
      <period-end iso-date="2020-12-31" />
      <value currency="USD" value-date="2020-01-01">48887085.63</value>
    </budget>
    <capital-spend percentage="24.06" />
    <transaction ref="ac1c2520-f3b7-4d29-aac1-2f82ef70aae4">
      <transaction-type code="2" />
      <transaction-date iso-date="2017-12-19" />
      <value currency="USD" value-date="2017-12-19">51293744.42</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="296af20c-3ea7-4ce8-a822-7b1ea61c2aea">
      <transaction-type code="3" />
      <transaction-date iso-date="2017-12-20" />
      <value currency="USD" value-date="2017-12-20">5315436.10</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP02 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="b205f4ed-dadc-4587-80a0-3e90c2cfbaed">
      <transaction-type code="3" />
      <transaction-date iso-date="2018-03-09" />
      <value currency="USD" value-date="2018-03-09">7048103.79</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="f129dd89-376f-4f0e-aee9-cea173a6cbe8">
      <transaction-type code="2" />
      <transaction-date iso-date="2018-03-27" />
      <value currency="USD" value-date="2018-03-27">50000.00</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="d48bae22-457d-46d1-b839-5667dfde57b0">
      <transaction-type code="3" />
      <transaction-date iso-date="2018-05-08" />
      <value currency="USD" value-date="2018-05-08">6948938.32</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP02 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="c1dfdeca-1df4-4745-bd07-2ed6e70b60e5">
      <transaction-type code="3" />
      <transaction-date iso-date="2018-08-14" />
      <value currency="USD" value-date="2018-08-14">9286757.48</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP02 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="5d3357df-8081-4af9-8e5e-fa2fe1ecc718">
      <transaction-type code="3" />
      <transaction-date iso-date="2018-10-30" />
      <value currency="USD" value-date="2018-10-30">4184815.73</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP02 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="c6041482-a9c3-4e48-8c1f-1371d15f9272">
      <transaction-type code="3" />
      <transaction-date iso-date="2018-12-19" />
      <value currency="USD" value-date="2018-12-19">4544904.41</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="d83a1e41-cd47-459b-8fe6-59d31e1a0e57">
      <transaction-type code="3" />
      <transaction-date iso-date="2018-12-31" />
      <value currency="USD" value-date="2018-12-31">50000.00</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="4bd15a2e-23f6-4ca0-ba49-5f6e92acd7fb">
      <transaction-type code="3" />
      <transaction-date iso-date="2019-01-15" />
      <value currency="USD" value-date="2019-01-15">1996000.00</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="1f3df9b3-dae3-4046-bf60-6c936e75b344">
      <transaction-type code="3" />
      <transaction-date iso-date="2019-02-07" />
      <value currency="USD" value-date="2019-02-07">9207714.72</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP02 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="8fc24ef9-b4cf-43b1-817a-dce9c953ac93">
      <transaction-type code="3" />
      <transaction-date iso-date="2019-03-26" />
      <value currency="USD" value-date="2019-03-26">84041.10</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="face8509-4532-4e77-98fc-43c9f5219364">
      <transaction-type code="3" />
      <transaction-date iso-date="2019-04-12" />
      <value currency="USD" value-date="2019-04-12">917751.19</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="228601e5-fd4d-4eba-9d4a-d3061f5efb85">
      <transaction-type code="2" />
      <transaction-date iso-date="2019-05-06" />
      <value currency="USD" value-date="2019-05-06">47118170.98</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="71e4673f-0597-48ac-bd63-3eac13bd5599">
      <transaction-type code="2" />
      <transaction-date iso-date="2019-05-06" />
      <value currency="USD" value-date="2019-05-06">-1759281.58</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="5656ac2c-b25d-4570-ae5f-0dc337b172ab">
      <transaction-type code="2" />
      <transaction-date iso-date="2019-05-07" />
      <value currency="USD" value-date="2019-05-07">50000.00</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="7defcb01-1fde-4d66-9d41-ab4091985eed">
      <transaction-type code="3" />
      <transaction-date iso-date="2019-05-09" />
      <value currency="USD" value-date="2019-05-09">6089787.42</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP02 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="b2506087-0244-4143-8672-7fa04d9c3bb7">
      <transaction-type code="3" />
      <transaction-date iso-date="2019-06-21" />
      <value currency="USD" value-date="2019-06-21">3862565.79</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="fee8483f-c5cd-4c31-b0f1-564eed1b9517">
      <transaction-type code="3" />
      <transaction-date iso-date="2019-07-19" />
      <value currency="USD" value-date="2019-07-19">5859514.00</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP02 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="257ed7fc-0e16-4a7e-bba9-5b01c47baf64">
      <transaction-type code="3" />
      <transaction-date iso-date="2019-10-17" />
      <value currency="USD" value-date="2019-10-17">9354015.62</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP02 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="0c967680-01db-4ce3-acc5-977eb64745db">
      <transaction-type code="3" />
      <transaction-date iso-date="2019-12-13" />
      <value currency="USD" value-date="2019-12-13">9406477.93</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP02 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="a9bdc18b-45c6-4ac8-b8fc-53a33a691034">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-01-16" />
      <value currency="USD" value-date="2020-01-16">2540155.49</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="39514b68-846d-47c9-b0da-dff45fb0bd00">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-01-23" />
      <value currency="USD" value-date="2020-01-23">598849.23</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="aee36e4c-c49d-41cc-8cbb-9e98624f05c4">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-01-30" />
      <value currency="USD" value-date="2020-01-30">35498.62</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="eec4d142-4d43-4ced-9d1f-0085a9731de4">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-02-13" />
      <value currency="USD" value-date="2020-02-13">2887828.86</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="40bf2fd8-988d-4446-97f3-bb6cf1106f62">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-02-18" />
      <value currency="USD" value-date="2020-02-18">50000.00</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="c8337422-d3b4-4bd8-ab95-af60e91173e7">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-04-02" />
      <value currency="USD" value-date="2020-04-02">6483478.02</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP02 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="939bdb51-2ed4-41b4-aec9-d4c2ff565b26">
      <transaction-type code="2" />
      <transaction-date iso-date="2020-04-09" />
      <value currency="USD" value-date="2020-04-09">20000000.00</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="bef53c3e-c47b-4c44-8a29-fae508224ae8">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-04-14" />
      <value currency="USD" value-date="2020-04-14">9403200.07</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP02 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="e74f8e6c-f02c-46e9-ad22-5d7bb72860db">
      <transaction-type code="2" />
      <transaction-date iso-date="2020-05-15" />
      <value currency="USD" value-date="2020-05-15">50000.00</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="38b61fab-81e6-4870-ab84-fa8098668731">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-06-16" />
      <value currency="USD" value-date="2020-06-16">4771036.68</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="a6390f04-70eb-4216-affd-ae875ee962d3">
      <transaction-type code="2" />
      <transaction-date iso-date="2020-06-30" />
      <value currency="USD" value-date="2020-06-30">7175472.20</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="b4e7bd95-035a-4fde-8655-e7045d0fc8e6">
      <transaction-type code="2" />
      <transaction-date iso-date="2020-06-30" />
      <value currency="USD" value-date="2020-06-30">-5825763.25</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="16aee6a6-0fe1-4dfd-b22d-6194cde589ef">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-07-08" />
      <value currency="USD" value-date="2020-07-08">5634309.87</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP02 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="11863417-c760-4ce4-a13c-e36141d08b6c">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-11-27" />
      <value currency="USD" value-date="2020-11-27">50000.00</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="69419b05-9eef-4228-9b13-94938f6b54c3">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-12-22" />
      <value currency="USD" value-date="2020-12-22">1515990.00</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP02 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="14adbd92-1fa1-4840-8e22-84255434f7cb">
      <transaction-type code="7" />
      <transaction-date iso-date="2021-10-01" />
      <value currency="USD" value-date="2021-10-01">17275.01</value>
      <description>
        <narrative>Funds returned to the Global Fund from PHL-T-PBSPP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="39d20650-43e3-45d5-9fea-783571c0e647">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-10-18" />
      <value currency="USD" value-date="2021-10-18">-17275.01</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="b149d180-e95b-4a10-8478-5c5c40c4f778">
      <transaction-type code="7" />
      <transaction-date iso-date="2022-01-20" />
      <value currency="USD" value-date="2022-01-20">7005.56</value>
      <description>
        <narrative>Funds returned to the Global Fund from PHL-T-PBSPP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="9968b815-f81c-4bf4-8fcb-2afdeadcd66e">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-01-25" />
      <value currency="USD" value-date="2022-01-25">-7005.56</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="d59bd518-9ceb-456d-8407-e109ddfc0ed0">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-07-26" />
      <value currency="USD" value-date="2022-07-26">-25172.33</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="PHL-T-PBSPP02-EXP-20181231">
      <transaction-type code="4" />
      <transaction-date iso-date="2018-12-31" />
      <value currency="USD" value-date="2018-12-31">36049635.16</value>
      <description>
        <narrative>Expenditure reported by Philippine Business for Social Progress, Inc. for PHL-T-PBSPP02, Jan 2018 to Dec 2018.</narrative>
      </description>
      <provider-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </provider-org>
    </transaction>
    <transaction ref="PHL-T-PBSPP02-EXP-20191231">
      <transaction-type code="4" />
      <transaction-date iso-date="2019-12-31" />
      <value currency="USD" value-date="2019-12-31">33607165.55</value>
      <description>
        <narrative>Expenditure reported by Philippine Business for Social Progress, Inc. for PHL-T-PBSPP02, Jan 2019 to Dec 2019.</narrative>
      </description>
      <provider-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </provider-org>
    </transaction>
    <transaction ref="PHL-T-PBSPP02-EXP-20201231">
      <transaction-type code="4" />
      <transaction-date iso-date="2020-12-31" />
      <value currency="USD" value-date="2020-12-31">48251360.25</value>
      <description>
        <narrative>Expenditure reported by Philippine Business for Social Progress, Inc. for PHL-T-PBSPP02, Jan 2020 to Dec 2020.</narrative>
      </description>
      <provider-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </provider-org>
    </transaction>
    <transaction ref="PHL-T-PBSPP02-EXP-20210630">
      <transaction-type code="4" />
      <transaction-date iso-date="2021-06-30" />
      <value currency="USD" value-date="2021-06-30">-6054568.36</value>
      <description>
        <narrative>Expenditure reported by Philippine Business for Social Progress, Inc. for PHL-T-PBSPP02, Jan 2021 to Jun 2021.</narrative>
      </description>
      <provider-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </provider-org>
    </transaction>
    <document-link url="https://data.theglobalfund.org/grant/PHL-T-PBSP" format="text/html">
      <title>
        <narrative>Grant page on the data explorer of the Global Fund.</narrative>
      </title>
      <description>
        <narrative>An overview of a grant over its lifetime.</narrative>
      </description>
      <category code="A12" />
      <category code="A01" />
      <category code="A02" />
      <category code="A05" />
      <category code="A07" />
      <category code="A08" />
      <language code="en" />
      <document-date iso-date="2026-11-09" />
    </document-link>
    <document-link url="https://www.theglobalfund.org/media/13342/core_grantregulationsversiontwo_regulations_en.pdf" format="application/pdf">
      <title>
        <narrative>Grant terms and conditions.</narrative>
      </title>
      <description>
        <narrative>General terms and conditions which apply to Global Fund grants.</narrative>
      </description>
      <category code="A04" />
      <language code="en" />
    </document-link>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of TB cases with RR-TB and/or MDR-TB notified</narrative>
      </title>
      <description>
        <narrative>Module: MDR-TB.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Number of TB cases with RR-TB and/or MDR-TB notified</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2017" iso-date="2017-12-31">
          <comment>
            <narrative>Numerator: 6417.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 5259.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 5259.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 5259.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 5259.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 5259.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 5259.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 58.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 58.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 58.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 58.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 58.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 58.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 1564.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 1564.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 1564.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 1564.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 1564.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 1564.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 3753.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 3753.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 3753.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 3753.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 3753.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 3753.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2018-01-01" />
          <period-end iso-date="2018-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 4568.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 3386; Percentage: 74%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 3217.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 31.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 956.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 2292.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2018-07-01" />
          <period-end iso-date="2018-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 4569.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 3295.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 3267; Denominator: 3295; Percentage: 99.2%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 28; Denominator: 3295; Percentage: 0.8%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 977; Denominator: 3295; Percentage: 29.7%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 2316; Denominator: 3295; Percentage: 70.3%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 5290.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 2594.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 2559; Denominator: 2594; Percentage: 98.7%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 35; Denominator: 2594; Percentage: 1.3%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 889; Denominator: 2594; Percentage: 34.3%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 1705; Denominator: 2594; Percentage: 65.7%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-07-01" />
          <period-end iso-date="2019-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 5291.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 3858.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 3827.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 31.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 1183.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 2675.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-01-01" />
          <period-end iso-date="2020-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 5195.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 2819.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 2796.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 23.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 882.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 1937.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-07-01" />
          <period-end iso-date="2020-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 5195.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 2524.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 2504.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 20.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 772.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 1752.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of cases with RR-TB and/or MDR-TB that began second-line treatment</narrative>
      </title>
      <description>
        <narrative>Module: MDR-TB.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Number of cases with RR-TB and/or MDR-TB that began second-line treatment</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2017" iso-date="2017-12-31">
          <comment>
            <narrative>Numerator: 5714.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 5259.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 5259.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 5259.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 5259.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 5259.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 5259.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 58.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 58.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 58.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 58.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 58.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 58.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 1564.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 1564.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 1564.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 1564.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 1564.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 1564.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 3753.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 3753.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 3753.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 3753.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 3753.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 3753.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="TB regimen" value="Short regimens" />
          <comment>
            <narrative>Numerator: 11.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="TB regimen" value="Short regimens" />
          <comment>
            <narrative>Numerator: 11.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="TB regimen" value="Short regimens" />
          <comment>
            <narrative>Numerator: 11.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="TB regimen" value="Short regimens" />
          <comment>
            <narrative>Numerator: 11.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="TB regimen" value="Short regimens" />
          <comment>
            <narrative>Numerator: 11.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="TB regimen" value="Short regimens" />
          <comment>
            <narrative>Numerator: 11.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2018-01-01" />
          <period-end iso-date="2018-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 4568.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 3126; Percentage: 68%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 3098.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 35.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 937.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 2196.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="TB regimen" value="Short regimens" />
            <comment>
              <narrative>Numerator: 2345.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2018-07-01" />
          <period-end iso-date="2018-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 4569.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 3158.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 3130; Denominator: 3158; Percentage: 99.1%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 28; Denominator: 3158; Percentage: 0.9%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 940; Denominator: 3158; Percentage: 29.8%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 2218; Denominator: 3158; Percentage: 70.2%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="TB regimen" value="Short regimens" />
            <comment>
              <narrative>Numerator: 2910; Denominator: 3158; Percentage: 92.1%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 5290.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 2674.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 2648; Denominator: 2674; Percentage: 99%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 26; Denominator: 2674; Percentage: 1%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 860; Denominator: 2674; Percentage: 32.2%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 1814; Denominator: 2674; Percentage: 67.8%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="TB regimen" value="Short regimens" />
            <comment>
              <narrative>Numerator: 2282; Denominator: 2674; Percentage: 85.3%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-07-01" />
          <period-end iso-date="2019-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 4233.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 3686.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 3648.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 38.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 1120.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 2566.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="TB regimen" value="Short regimens" />
            <comment>
              <narrative>Numerator: 2388.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-01-01" />
          <period-end iso-date="2020-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 4156.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 2665.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 2646.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 19.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 812.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 1853.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="TB regimen" value="Short regimens" />
            <comment>
              <narrative>Numerator: 1649.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-07-01" />
          <period-end iso-date="2020-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 4156.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 2391.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 2367.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 24.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 754.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 1637.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="TB regimen" value="Short regimens" />
            <comment>
              <narrative>Numerator: 58.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of cases with RR-TB and/or MDR-TB started on treatment for MDR-TB who were lost to follow up during the first six months of treatment</narrative>
      </title>
      <description>
        <narrative>Module: MDR-TB.</narrative>
      </description>
      <indicator measure="2" ascending="0" aggregation-status="0">
        <title>
          <narrative>Percentage of cases with RR-TB and/or MDR-TB started on treatment for MDR-TB who were lost to follow up during the first six months of treatment</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2017" iso-date="2017-12-31" value="16.18">
          <comment>
            <narrative>Numerator: 471; Denominator: 2911.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2018-01-01" />
          <period-end iso-date="2018-06-30" />
          <target value="12.99">
            <comment>
              <narrative>Numerator: 378; Denominator: 2911.</narrative>
            </comment>
          </target>
          <actual value="16.2">
            <comment>
              <narrative>Numerator: 471; Denominator: 2911.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2018-07-01" />
          <period-end iso-date="2018-12-31" />
          <target value="13">
            <comment>
              <narrative>Numerator: 594; Denominator: 4568.</narrative>
            </comment>
          </target>
          <actual value="16.4">
            <comment>
              <narrative>Numerator: 511; Denominator: 3110.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-06-30" />
          <target value="11.99">
            <comment>
              <narrative>Numerator: 548; Denominator: 4569.</narrative>
            </comment>
          </target>
          <actual value="16.5">
            <comment>
              <narrative>Numerator: 518; Denominator: 3140.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-07-01" />
          <period-end iso-date="2019-12-31" />
          <target value="12">
            <comment>
              <narrative>Numerator: 635; Denominator: 5290.</narrative>
            </comment>
          </target>
          <actual value="11.7">
            <comment>
              <narrative>Numerator: 310; Denominator: 2650.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-01-01" />
          <period-end iso-date="2020-06-30" />
          <target value="11">
            <comment>
              <narrative>Numerator: 582; Denominator: 5291.</narrative>
            </comment>
          </target>
          <actual value="9">
            <comment>
              <narrative>Numerator: 329; Denominator: 3664.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-07-01" />
          <period-end iso-date="2020-12-31" />
          <target value="11">
            <comment>
              <narrative>Numerator: 632; Denominator: 5745.</narrative>
            </comment>
          </target>
          <actual value="4.7">
            <comment>
              <narrative>Numerator: 124; Denominator: 2660.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of confirmed MDR-TB cases tested for susceptibility to any fluoroquinolone and any second-line injectable drug</narrative>
      </title>
      <description>
        <narrative>Module: MDR-TB.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of confirmed MDR-TB cases tested for susceptibility to any fluoroquinolone and any second-line injectable drug</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2017" iso-date="2017-12-31" value="42.68">
          <comment>
            <narrative>Numerator: 2439; Denominator: 5714.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2018-01-01" />
          <period-end iso-date="2018-06-30" />
          <target value="100">
            <comment>
              <narrative>Numerator: 4568; Denominator: 4568.</narrative>
            </comment>
          </target>
          <actual value="90.2">
            <comment>
              <narrative>Numerator: 2821; Denominator: 3126.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2018-07-01" />
          <period-end iso-date="2018-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 4569; Denominator: 4569.</narrative>
            </comment>
          </target>
          <actual value="95.2">
            <comment>
              <narrative>Numerator: 3005; Denominator: 3158.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-06-30" />
          <target value="100">
            <comment>
              <narrative>Numerator: 5290; Denominator: 5290.</narrative>
            </comment>
          </target>
          <actual value="97.9">
            <comment>
              <narrative>Numerator: 2618; Denominator: 2674.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-07-01" />
          <period-end iso-date="2019-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 5291; Denominator: 5291.</narrative>
            </comment>
          </target>
          <actual value="97.4">
            <comment>
              <narrative>Numerator: 3589; Denominator: 3686.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-01-01" />
          <period-end iso-date="2020-06-30" />
          <target value="100">
            <comment>
              <narrative>Numerator: 5745; Denominator: 5745.</narrative>
            </comment>
          </target>
          <actual value="88.3">
            <comment>
              <narrative>Numerator: 2354; Denominator: 2665.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-07-01" />
          <period-end iso-date="2020-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 5745; Denominator: 5745.</narrative>
            </comment>
          </target>
          <actual value="90.9">
            <comment>
              <narrative>Numerator: 2173; Denominator: 2391.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of HMIS or other routine reporting units submitting timely reports according to national guidelines</narrative>
      </title>
      <description>
        <narrative>Module: RSSH: Health management information systems and M&amp;E.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of HMIS or other routine reporting units submitting timely reports according to national guidelines</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2018" iso-date="2018-12-31" value="99.45">
          <comment>
            <narrative>Numerator: 3085; Denominator: 3102.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2018-01-01" />
          <period-end iso-date="2018-06-30" />
          <target value="93.91">
            <comment>
              <narrative>Numerator: 2913; Denominator: 3102.</narrative>
            </comment>
          </target>
          <actual value="99.1">
            <comment>
              <narrative>Numerator: 3065; Denominator: 3093.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2018-07-01" />
          <period-end iso-date="2018-12-31" />
          <target value="93.91">
            <comment>
              <narrative>Numerator: 2913; Denominator: 3102.</narrative>
            </comment>
          </target>
          <actual value="98.9">
            <comment>
              <narrative>Numerator: 3073; Denominator: 3108.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-06-30" />
          <target value="95.87">
            <comment>
              <narrative>Numerator: 2974; Denominator: 3102.</narrative>
            </comment>
          </target>
          <actual value="97.6">
            <comment>
              <narrative>Numerator: 3047; Denominator: 3122.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-07-01" />
          <period-end iso-date="2019-12-31" />
          <target value="95.87">
            <comment>
              <narrative>Numerator: 2974; Denominator: 3102.</narrative>
            </comment>
          </target>
          <actual value="95.7">
            <comment>
              <narrative>Numerator: 2996; Denominator: 3129.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-01-01" />
          <period-end iso-date="2020-06-30" />
          <target value="100">
            <comment>
              <narrative>Numerator: 3102; Denominator: 3102.</narrative>
            </comment>
          </target>
          <actual value="90.5">
            <comment>
              <narrative>Numerator: 2848; Denominator: 3147.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-07-01" />
          <period-end iso-date="2020-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 3102; Denominator: 3102.</narrative>
            </comment>
          </target>
          <actual value="92.9">
            <comment>
              <narrative>Numerator: 2911; Denominator: 3135.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of TB cases (all forms) notified among key affected populations/ high risk groups (other than prisoners)</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Number of TB cases (all forms) notified among key affected populations/ high risk groups (other than prisoners)</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2018" iso-date="2018-12-31">
          <comment>
            <narrative>Numerator: 686.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2018-01-01" />
          <period-end iso-date="2018-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 2422.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 713; Percentage: 29%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2018-07-01" />
          <period-end iso-date="2018-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 4042.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 4256.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 4922.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 2533.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-07-01" />
          <period-end iso-date="2019-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 4922.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 5452.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-01-01" />
          <period-end iso-date="2020-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 4922.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 5996.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-07-01" />
          <period-end iso-date="2020-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 4922.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 4497.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of TB cases (all forms) notified among prisoners</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Number of TB cases (all forms) notified among prisoners</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2018" iso-date="2018-12-31">
          <comment>
            <narrative>Numerator: 1802.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2018-01-01" />
          <period-end iso-date="2018-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 1000.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1802; Percentage: 120%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2018-07-01" />
          <period-end iso-date="2018-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 1000.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1874.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 2300.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1250.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-07-01" />
          <period-end iso-date="2019-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 2300.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 2166.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-01-01" />
          <period-end iso-date="2020-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 1928.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 846.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-07-01" />
          <period-end iso-date="2020-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 1928.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1131.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of notified TB cases (all forms) contributed by non-national TB program providers - community referrals</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of notified TB cases (all forms) contributed by non-national TB program providers - community referrals</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2016" iso-date="2016-12-31" value="40529" />
        <period>
          <period-start iso-date="2018-01-01" />
          <period-end iso-date="2018-06-30" />
          <target value="2500" />
          <actual value="84" />
        </period>
        <period>
          <period-start iso-date="2018-07-01" />
          <period-end iso-date="2018-12-31" />
          <target value="4120" />
          <actual value="5515" />
        </period>
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-06-30" />
          <target value="5000" />
          <actual value="5689" />
        </period>
        <period>
          <period-start iso-date="2019-07-01" />
          <period-end iso-date="2019-12-31" />
          <target value="5000" />
          <actual value="5141" />
        </period>
        <period>
          <period-start iso-date="2020-01-01" />
          <period-end iso-date="2020-06-30" />
          <target value="5000" />
          <actual value="3055" />
        </period>
        <period>
          <period-start iso-date="2020-07-01" />
          <period-end iso-date="2020-12-31" />
          <target value="5000" />
          <actual value="2509" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of notified TB cases (all forms) contributed by non-national TB program providers - private/non-governmental facilities</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Number of notified TB cases (all forms) contributed by non-national TB program providers - private/non-governmental facilities</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31">
          <comment>
            <narrative>Numerator: 31778; Denominator: 198445; Percentage: 16.01%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2018-01-01" />
          <period-end iso-date="2018-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 8000.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 6390; Percentage: 80%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2018-07-01" />
          <period-end iso-date="2018-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 8000.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 19471.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 9000.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 31778.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-07-01" />
          <period-end iso-date="2019-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 30000.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 33886.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-01-01" />
          <period-end iso-date="2020-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 30000.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 19232.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-07-01" />
          <period-end iso-date="2020-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 30000.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 14547.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2017" iso-date="2017-12-31">
          <comment>
            <narrative>Numerator: 332941.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 240705.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 240705.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 240705.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 240705.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 240705.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 240705.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 35967.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 35967.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 35967.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 35967.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 35967.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 35967.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Type of TB" value="Bacteriologically confirmed" />
          <comment>
            <narrative>Numerator: 96250.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Type of TB" value="Bacteriologically confirmed" />
          <comment>
            <narrative>Numerator: 96250.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Type of TB" value="Bacteriologically confirmed" />
          <comment>
            <narrative>Numerator: 96250.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Type of TB" value="Bacteriologically confirmed" />
          <comment>
            <narrative>Numerator: 96250.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Type of TB" value="Bacteriologically confirmed" />
          <comment>
            <narrative>Numerator: 96250.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Type of TB" value="Bacteriologically confirmed" />
          <comment>
            <narrative>Numerator: 96250.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 97541.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 97541.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 97541.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 97541.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 97541.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 97541.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 179131.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 179131.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 179131.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 179131.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 179131.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 179131.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="HIV test status" value="Negative" />
          <comment>
            <narrative>Numerator: 36863.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="HIV test status" value="Negative" />
          <comment>
            <narrative>Numerator: 36863.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="HIV test status" value="Negative" />
          <comment>
            <narrative>Numerator: 36863.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="HIV test status" value="Negative" />
          <comment>
            <narrative>Numerator: 36863.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="HIV test status" value="Negative" />
          <comment>
            <narrative>Numerator: 36863.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="HIV test status" value="Negative" />
          <comment>
            <narrative>Numerator: 36863.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="HIV test status" value="Not documented" />
          <comment>
            <narrative>Numerator: 239554.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="HIV test status" value="Not documented" />
          <comment>
            <narrative>Numerator: 239554.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="HIV test status" value="Not documented" />
          <comment>
            <narrative>Numerator: 239554.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="HIV test status" value="Not documented" />
          <comment>
            <narrative>Numerator: 239554.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="HIV test status" value="Not documented" />
          <comment>
            <narrative>Numerator: 239554.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="HIV test status" value="Not documented" />
          <comment>
            <narrative>Numerator: 239554.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Numerator: 255.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Numerator: 255.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Numerator: 255.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Numerator: 255.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Numerator: 255.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Numerator: 255.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2018-01-01" />
          <period-end iso-date="2018-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 150423.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 160917; Percentage: 107%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 152541.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 18618.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Type of TB" value="Bacteriologically confirmed" />
            <comment>
              <narrative>Numerator: 64146.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 59204.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 111955.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Negative" />
            <comment>
              <narrative>Numerator: 40113.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Not documented" />
            <comment>
              <narrative>Numerator: 119576.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 636.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2018-07-01" />
          <period-end iso-date="2018-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 193377.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 185540.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 162079; Denominator: 185432; Percentage: 87.4%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 23353; Denominator: 185432; Percentage: 12.6%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Type of TB" value="Bacteriologically confirmed" />
            <comment>
              <narrative>Numerator: 66089; Denominator: 185432; Percentage: 35.6%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 66547; Denominator: 185432; Percentage: 35.9%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 118885; Denominator: 185432; Percentage: 64.1%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Negative" />
            <comment>
              <narrative>Numerator: 40055; Denominator: 185432; Percentage: 21.6%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Not documented" />
            <comment>
              <narrative>Numerator: 99859; Denominator: 185432; Percentage: 53.9%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 598; Denominator: 185432; Percentage: 0.3%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 200550.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 198426.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 151261; Denominator: 198426; Percentage: 76.2%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 15255; Denominator: 198426; Percentage: 7.7%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Type of TB" value="Bacteriologically confirmed" />
            <comment>
              <narrative>Numerator: 57123; Denominator: 198426; Percentage: 28.8%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 57820; Denominator: 198426; Percentage: 29.1%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 108696; Denominator: 198426; Percentage: 54.8%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Negative" />
            <comment>
              <narrative>Numerator: 58972; Denominator: 198426; Percentage: 29.7%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Not documented" />
            <comment>
              <narrative>Numerator: 138763; Denominator: 198426; Percentage: 69.9%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 691; Denominator: 198426; Percentage: 0.4%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-07-01" />
          <period-end iso-date="2019-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 200550.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 198513.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 177419.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 20310.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Type of TB" value="Bacteriologically confirmed" />
            <comment>
              <narrative>Numerator: 72732.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 70625.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 127888.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Negative" />
            <comment>
              <narrative>Numerator: 63586.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Not documented" />
            <comment>
              <narrative>Numerator: 134306.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 621.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-01-01" />
          <period-end iso-date="2020-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 229200.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 147570.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 136131.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 11439.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Type of TB" value="Bacteriologically confirmed" />
            <comment>
              <narrative>Numerator: 59920.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 49710.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 97860.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Negative" />
            <comment>
              <narrative>Numerator: 45974.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Not documented" />
            <comment>
              <narrative>Numerator: 101178.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 418.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-07-01" />
          <period-end iso-date="2020-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 229200.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 106680.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 209167.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 14792.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Type of TB" value="Bacteriologically confirmed" />
            <comment>
              <narrative>Numerator: 107383.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 72101.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 151858.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Negative" />
            <comment>
              <narrative>Numerator: 84688.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Not documented" />
            <comment>
              <narrative>Numerator: 138372.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 899.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of new and relapse TB patients tested using WHO recommended rapid tests at the time of diagnosis</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of new and relapse TB patients tested using WHO recommended rapid tests at the time of diagnosis</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2017" iso-date="2017-12-31" value="16.23">
          <comment>
            <narrative>Numerator: 54030; Denominator: 332941.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2018-01-01" />
          <period-end iso-date="2018-06-30" />
          <target value="30">
            <comment>
              <narrative>Numerator: 55783; Denominator: 185944.</narrative>
            </comment>
          </target>
          <actual value="34">
            <comment>
              <narrative>Numerator: 55972; Denominator: 164463.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2018-07-01" />
          <period-end iso-date="2018-12-31" />
          <target value="30">
            <comment>
              <narrative>Numerator: 55783; Denominator: 185944.</narrative>
            </comment>
          </target>
          <actual value="46.8">
            <comment>
              <narrative>Numerator: 77542; Denominator: 165753.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-06-30" />
          <target value="50">
            <comment>
              <narrative>Numerator: 105795; Denominator: 211590.</narrative>
            </comment>
          </target>
          <actual value="29.4">
            <comment>
              <narrative>Numerator: 48593; Denominator: 165461.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-07-01" />
          <period-end iso-date="2019-12-31" />
          <target value="50">
            <comment>
              <narrative>Numerator: 105795; Denominator: 211590.</narrative>
            </comment>
          </target>
          <actual value="52">
            <comment>
              <narrative>Numerator: 103133; Denominator: 198513.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-01-01" />
          <period-end iso-date="2020-06-30" />
          <target value="80">
            <comment>
              <narrative>Numerator: 188549; Denominator: 235687.</narrative>
            </comment>
          </target>
          <actual value="70.6">
            <comment>
              <narrative>Numerator: 90725; Denominator: 128586.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-07-01" />
          <period-end iso-date="2020-12-31" />
          <target value="80">
            <comment>
              <narrative>Numerator: 188549; Denominator: 235687.</narrative>
            </comment>
          </target>
          <actual value="64.2">
            <comment>
              <narrative>Numerator: 71084; Denominator: 110677.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Treatment success rate- all forms: Percentage of TB cases, all forms, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB cases registered for treatment during a specified period, new and relapse cases</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Treatment success rate- all forms: Percentage of TB cases, all forms, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB cases registered for treatment during a specified period, new and relapse cases</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2016" iso-date="2016-12-31">
          <comment>
            <narrative>Numerator: 286811; Denominator: 315225; Percentage: 90.99%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 149614; Denominator: 280562; Percentage: 53.33%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 149614; Denominator: 280562; Percentage: 53.33%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 149614; Denominator: 280562; Percentage: 53.33%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 149614; Denominator: 280562; Percentage: 53.33%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 149614; Denominator: 280562; Percentage: 53.33%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 149614; Denominator: 280562; Percentage: 53.33%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 27501; Denominator: 48643; Percentage: 56.54%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 27501; Denominator: 48643; Percentage: 56.54%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 27501; Denominator: 48643; Percentage: 56.54%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 27501; Denominator: 48643; Percentage: 56.54%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 27501; Denominator: 48643; Percentage: 56.54%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 27501; Denominator: 48643; Percentage: 56.54%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2018-01-01" />
          <period-end iso-date="2018-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 112846; Denominator: 122659; Percentage: 92%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 139740; Denominator: 154623; Percentage: 90.4%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 36363.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 86.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2018-07-01" />
          <period-end iso-date="2018-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 112846; Denominator: 122659; Percentage: 92%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 137881; Denominator: 147035; Percentage: 93.8%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 122070; Denominator: 140375; Percentage: 87%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 18305; Denominator: 140375; Percentage: 13%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 139893; Denominator: 150423; Percentage: 93%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 146198; Denominator: 161740; Percentage: 90.4%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 132989; Denominator: 150143; Percentage: 88.6%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 17154; Denominator: 150143; Percentage: 11.4%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-07-01" />
          <period-end iso-date="2019-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 139893; Denominator: 150423; Percentage: 93%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 143326; Denominator: 158620; Percentage: 90.4%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 0.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 0.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-01-01" />
          <period-end iso-date="2020-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 138270; Denominator: 148678; Percentage: 93%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 151351; Denominator: 169076; Percentage: 89.5%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 189433.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 22516.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-07-01" />
          <period-end iso-date="2020-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 138270; Denominator: 148678; Percentage: 93%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 145610; Denominator: 198198; Percentage: 73.5%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 274820.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 29145.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of HIV-positive new and relapse TB patients on ART during TB treatment</narrative>
      </title>
      <description>
        <narrative>Module: TB/HIV.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of HIV-positive new and relapse TB patients on ART during TB treatment</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2017" iso-date="2017-12-31" value="92.95">
          <comment>
            <narrative>Numerator: 633; Denominator: 681.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2018-01-01" />
          <period-end iso-date="2018-06-30" />
          <target value="100">
            <comment>
              <narrative>Numerator: 568; Denominator: 568.</narrative>
            </comment>
          </target>
          <actual value="96.9">
            <comment>
              <narrative>Numerator: 620; Denominator: 640.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2018-07-01" />
          <period-end iso-date="2018-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 568; Denominator: 568.</narrative>
            </comment>
          </target>
          <actual value="95.4">
            <comment>
              <narrative>Numerator: 666; Denominator: 698.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-06-30" />
          <target value="100">
            <comment>
              <narrative>Numerator: 664; Denominator: 664.</narrative>
            </comment>
          </target>
          <actual value="98.2">
            <comment>
              <narrative>Numerator: 820; Denominator: 835.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-07-01" />
          <period-end iso-date="2019-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 664; Denominator: 664.</narrative>
            </comment>
          </target>
          <actual value="96.9">
            <comment>
              <narrative>Numerator: 869; Denominator: 897.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-01-01" />
          <period-end iso-date="2020-06-30" />
          <target value="100">
            <comment>
              <narrative>Numerator: 767; Denominator: 767.</narrative>
            </comment>
          </target>
          <actual value="97.1">
            <comment>
              <narrative>Numerator: 663; Denominator: 683.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-07-01" />
          <period-end iso-date="2020-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 767; Denominator: 767.</narrative>
            </comment>
          </target>
          <actual value="95.1">
            <comment>
              <narrative>Numerator: 329; Denominator: 346.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of people living with HIV initiated on ART who are screened for TB in HIV treatment settings</narrative>
      </title>
      <description>
        <narrative>Module: TB/HIV.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of people living with HIV initiated on ART who are screened for TB in HIV treatment settings</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2017" iso-date="2017-12-31" value="98.6">
          <comment>
            <narrative>Numerator: 26067; Denominator: 26437.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2018-01-01" />
          <period-end iso-date="2018-06-30" />
          <target value="90">
            <comment>
              <narrative>Numerator: 21519; Denominator: 23910.</narrative>
            </comment>
          </target>
          <actual value="95.9">
            <comment>
              <narrative>Numerator: 28153; Denominator: 29348.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2018-07-01" />
          <period-end iso-date="2018-12-31" />
          <target value="90">
            <comment>
              <narrative>Numerator: 21520; Denominator: 23911.</narrative>
            </comment>
          </target>
          <actual value="96.3">
            <comment>
              <narrative>Numerator: 33198; Denominator: 34464.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-06-30" />
          <target value="90">
            <comment>
              <narrative>Numerator: 29409; Denominator: 32677.</narrative>
            </comment>
          </target>
          <actual value="93.1">
            <comment>
              <narrative>Numerator: 34031; Denominator: 36565.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-07-01" />
          <period-end iso-date="2019-12-31" />
          <target value="90">
            <comment>
              <narrative>Numerator: 29409; Denominator: 32677.</narrative>
            </comment>
          </target>
          <actual value="96.6">
            <comment>
              <narrative>Numerator: 30468; Denominator: 31530.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-01-01" />
          <period-end iso-date="2020-06-30" />
          <target value="90">
            <comment>
              <narrative>Numerator: 39017; Denominator: 43352.</narrative>
            </comment>
          </target>
          <actual value="95.8">
            <comment>
              <narrative>Numerator: 42822; Denominator: 44681.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-07-01" />
          <period-end iso-date="2020-12-31" />
          <target value="90">
            <comment>
              <narrative>Numerator: 39017; Denominator: 43352.</narrative>
            </comment>
          </target>
          <actual value="96">
            <comment>
              <narrative>Numerator: 42767; Denominator: 44553.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of people living with HIV newly enrolled in HIV care started on TB preventive therapy</narrative>
      </title>
      <description>
        <narrative>Module: TB/HIV.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of people living with HIV newly enrolled in HIV care started on TB preventive therapy</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2017" iso-date="2017-12-31" value="67.99">
          <comment>
            <narrative>Numerator: 2938; Denominator: 4321.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2018-01-01" />
          <period-end iso-date="2018-06-30" />
          <target value="70">
            <comment>
              <narrative>Numerator: 3873; Denominator: 5533.</narrative>
            </comment>
          </target>
          <actual value="67.3">
            <comment>
              <narrative>Numerator: 1767; Denominator: 2624.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2018-07-01" />
          <period-end iso-date="2018-12-31" />
          <target value="70">
            <comment>
              <narrative>Numerator: 3873; Denominator: 5533.</narrative>
            </comment>
          </target>
          <actual value="63.7">
            <comment>
              <narrative>Numerator: 1944; Denominator: 3050.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-06-30" />
          <target value="70">
            <comment>
              <narrative>Numerator: 4191; Denominator: 5987.</narrative>
            </comment>
          </target>
          <actual value="65.9">
            <comment>
              <narrative>Numerator: 2106; Denominator: 3197.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-07-01" />
          <period-end iso-date="2019-12-31" />
          <target value="70">
            <comment>
              <narrative>Numerator: 4191; Denominator: 5987.</narrative>
            </comment>
          </target>
          <actual value="70">
            <comment>
              <narrative>Numerator: 3008; Denominator: 4300.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-01-01" />
          <period-end iso-date="2020-06-30" />
          <target value="70">
            <comment>
              <narrative>Numerator: 4594; Denominator: 6563.</narrative>
            </comment>
          </target>
          <actual value="60.9">
            <comment>
              <narrative>Numerator: 1463; Denominator: 2402.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-07-01" />
          <period-end iso-date="2020-12-31" />
          <target value="69.99">
            <comment>
              <narrative>Numerator: 4593; Denominator: 6562.</narrative>
            </comment>
          </target>
          <actual value="63.1">
            <comment>
              <narrative>Numerator: 2652; Denominator: 4200.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of registered new and relapse TB patients with documented HIV status</narrative>
      </title>
      <description>
        <narrative>Module: TB/HIV.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of registered new and relapse TB patients with documented HIV status</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2017" iso-date="2017-12-31" value="83.78">
          <comment>
            <narrative>Numerator: 76734; Denominator: 91586.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2018-01-01" />
          <period-end iso-date="2018-06-30" />
          <target value="83">
            <comment>
              <narrative>Numerator: 71017; Denominator: 85563.</narrative>
            </comment>
          </target>
          <actual value="85.2">
            <comment>
              <narrative>Numerator: 42175; Denominator: 49528.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2018-07-01" />
          <period-end iso-date="2018-12-31" />
          <target value="83">
            <comment>
              <narrative>Numerator: 71017; Denominator: 85563.</narrative>
            </comment>
          </target>
          <actual value="86.2">
            <comment>
              <narrative>Numerator: 46215; Denominator: 53625.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-06-30" />
          <target value="85">
            <comment>
              <narrative>Numerator: 82998; Denominator: 97645.</narrative>
            </comment>
          </target>
          <actual value="81.2">
            <comment>
              <narrative>Numerator: 66469; Denominator: 81820.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-07-01" />
          <period-end iso-date="2019-12-31" />
          <target value="85">
            <comment>
              <narrative>Numerator: 82998; Denominator: 97645.</narrative>
            </comment>
          </target>
          <actual value="89.5">
            <comment>
              <narrative>Numerator: 71685; Denominator: 80069.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-01-01" />
          <period-end iso-date="2020-06-30" />
          <target value="87">
            <comment>
              <narrative>Numerator: 95854; Denominator: 110177.</narrative>
            </comment>
          </target>
          <actual value="89">
            <comment>
              <narrative>Numerator: 73520; Denominator: 82644.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-07-01" />
          <period-end iso-date="2020-12-31" />
          <target value="87">
            <comment>
              <narrative>Numerator: 95854; Denominator: 110177.</narrative>
            </comment>
          </target>
          <actual value="70.9">
            <comment>
              <narrative>Numerator: 31718; Denominator: 44712.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
  </iati-activity>
  <iati-activity last-updated-datetime="2026-11-09T09:21:46+00:00" xml:lang="en" default-currency="USD" humanitarian="0" hierarchy="1">
    <iati-identifier>47045-PHL-T-PBSP-3</iati-identifier>
    <reporting-org ref="47045" type="30">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </reporting-org>
    <title>
      <narrative>Advancing Client-centered Care and Expanding Sustainable Services for TB - Philippines (01-Jan-2021-31-Dec-2023)</narrative>
    </title>
    <description type="1">
      <narrative>Philippines, Tuberculosis, Philippine Business for Social Progress, Inc.</narrative>
    </description>
    <description type="2">
      <narrative>Goals: Decrease TB deaths  from 26,000 in 2018 to 22,000 in 2023; Achieve zero TB-affected families facing catastrophic costs by 2023; Decrease TB Incidence by 12% from 554 per 100,000 population in 2018 to 488 per 100,000 population in 2023. Objectives: By 2023, achieve screening of at least 162 million people for TB either through symptom screening or chest x-ray; By 2023, test at least 14 million presumptive TB with WHO recommended rapid diagnostic tool; By 2023, initiate treatment for 2 million people with active TB, including 50,000 DRTB cases; By 2023, successfully treat 90% of DSTB patients and 85% of DRTB patients; By 2023, provide TB preventive therapy to 752,000 eligible patients.</narrative>
    </description>
    <participating-org ref="47045" type="30" role="1" crs-channel-code="47045">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </participating-org>
    <participating-org type="24" role="2" crs-channel-code="23000">
      <narrative>Philippine Business for Social Progress, Inc.</narrative>
    </participating-org>
    <participating-org type="24" role="4" crs-channel-code="23000">
      <narrative>Philippine Business for Social Progress, Inc.</narrative>
    </participating-org>
    <other-identifier ref="PHL-T-PBSPP03" type="A1">
      <owner-org ref="47045">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </owner-org>
    </other-identifier>
    <activity-status code="3" />
    <activity-date type="1" iso-date="2021-01-01" />
    <activity-date type="2" iso-date="2021-01-01" />
    <activity-date type="3" iso-date="2023-12-31" />
    <activity-date type="4" iso-date="2023-12-31" />
    <contact-info type="1">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Communications</narrative>
      </department>
      <telephone>+41 58 791 1700</telephone>
      <email>website@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <contact-info type="2">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Grant Management Division</narrative>
      </department>
      <person-name>
        <narrative>xxxx xxxx</narrative>
      </person-name>
      <job-title>
        <narrative>Fund Portfolio Manager</narrative>
      </job-title>
      <telephone>+41 58 791 1700</telephone>
      <email>xxxx</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <activity-scope code="4" />
    <recipient-country code="PH" percentage="100">
      <narrative>Philippines</narrative>
    </recipient-country>
    <sector vocabulary="1" code="12263" percentage="80.62">
      <narrative>Tuberculosis</narrative>
    </sector>
    <sector vocabulary="1" code="12110" percentage="19.38">
      <narrative>Multicomponent, RSSH</narrative>
    </sector>
    <tag vocabulary="2" code="3">
      <narrative>Ensure healthy lives and promote well-being for all at all ages</narrative>
    </tag>
    <tag vocabulary="3" code="3.3">
      <narrative>End the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases, and combat hepatitis, water-borne diseases and other communicable diseases</narrative>
    </tag>
    <tag vocabulary="3" code="3.8">
      <narrative>Achieve universal health coverage</narrative>
    </tag>
    <country-budget-items vocabulary="4">
      <budget-item code="6a7cb452-4c5d-49b6-aa43-8437d24fa1c5" percentage="0.38">
        <description>
          <narrative>Multicomponent -&gt; Program management -&gt; Coordination and management of national disease control programs</narrative>
        </description>
      </budget-item>
      <budget-item code="31a8e187-9648-42f5-a520-92e7e53d4ac6" percentage="12.32">
        <description>
          <narrative>Multicomponent -&gt; Program management -&gt; Grant management</narrative>
        </description>
      </budget-item>
      <budget-item code="c9e8bc4a-398e-4c4b-afbb-cf98965f552e" percentage="1.67">
        <description>
          <narrative>RSSH -&gt; RSSH: Health management information systems and M&amp;E -&gt; Analysis, evaluations, reviews and transparency</narrative>
        </description>
      </budget-item>
      <budget-item code="7d2483ee-e340-40e2-8f81-88b761c385aa" percentage="0.16">
        <description>
          <narrative>RSSH -&gt; RSSH: Health management information systems and M&amp;E -&gt; Routine reporting</narrative>
        </description>
      </budget-item>
      <budget-item code="5c6d2150-43bf-412f-a249-05dbaa402867" percentage="0.86">
        <description>
          <narrative>RSSH -&gt; RSSH: Health products management systems -&gt; Procurement capacity</narrative>
        </description>
      </budget-item>
      <budget-item code="45f58950-e70b-425c-a83d-28115a57a936" percentage="0.18">
        <description>
          <narrative>RSSH -&gt; RSSH: Health products management systems -&gt; Regulatory/quality assurance support</narrative>
        </description>
      </budget-item>
      <budget-item code="4078713e-8351-4887-be1a-1617bf48ccd5" percentage="1.05">
        <description>
          <narrative>RSSH -&gt; RSSH: Health sector governance and planning -&gt; National health sector strategies and financing</narrative>
        </description>
      </budget-item>
      <budget-item code="0651e028-d13e-4937-8777-a97183a5b108" percentage="2.75">
        <description>
          <narrative>RSSH -&gt; RSSH: Laboratory systems -&gt; Laboratory supply chain systems</narrative>
        </description>
      </budget-item>
      <budget-item code="30f85a5d-1110-4276-932f-a742fc65c90f" percentage="10.47">
        <description>
          <narrative>Tuberculosis -&gt; MDR-TB -&gt; Case detection and diagnosis (MDR-TB)</narrative>
        </description>
      </budget-item>
      <budget-item code="452ec704-0b92-43c1-9cac-6649d925fde1" percentage="0.56">
        <description>
          <narrative>Tuberculosis -&gt; MDR-TB -&gt; Collaborative activities with other programs and sectors (MDR-TB)</narrative>
        </description>
      </budget-item>
      <budget-item code="9a89bb7c-0497-4574-b9d1-dd46b1823c81" percentage="1.2">
        <description>
          <narrative>Tuberculosis -&gt; MDR-TB -&gt; Engaging all care providers (MDR-TB)</narrative>
        </description>
      </budget-item>
      <budget-item code="8194063f-1bf8-4be2-9ebd-2823d5ac44a3" percentage="42.05">
        <description>
          <narrative>Tuberculosis -&gt; MDR-TB -&gt; Treatment (MDR-TB)</narrative>
        </description>
      </budget-item>
      <budget-item code="75ab2142-781a-4a2a-b8e0-50e6a129924b" percentage="0.54">
        <description>
          <narrative>Tuberculosis -&gt; Removing human rights and gender related barriers to TB services -&gt; Community mobilization and advocacy (TB)</narrative>
        </description>
      </budget-item>
      <budget-item code="95aeb1ae-4531-4aec-8557-537759098b9c" percentage="0.12">
        <description>
          <narrative>Tuberculosis -&gt; Removing human rights and gender related barriers to TB services -&gt; Legal literacy ("Know Your Rights")</narrative>
        </description>
      </budget-item>
      <budget-item code="b108d9bd-d341-43a6-a473-1be4efabc458" percentage="0.65">
        <description>
          <narrative>Tuberculosis -&gt; Removing human rights and gender related barriers to TB services -&gt; Stigma and discrimination reduction (TB)</narrative>
        </description>
      </budget-item>
      <budget-item code="a93b0a8f-4b2d-4b43-806e-06b2f2240144" percentage="3.75">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Case detection and diagnosis (TB care and prevention)</narrative>
        </description>
      </budget-item>
      <budget-item code="e5d69248-af9e-44de-a99d-c2557c675f55" percentage="6.11">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Engaging all care providers (TB care and prevention)</narrative>
        </description>
      </budget-item>
      <budget-item code="3d30473b-46e8-4203-ad93-10040d8517cb" percentage="9.67">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Key populations (TB care and prevention) - Others</narrative>
        </description>
      </budget-item>
      <budget-item code="87435fc1-d92b-4039-b203-96061e6e85be" percentage="2.18">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Key populations (TB care and prevention) - Prisoners</narrative>
        </description>
      </budget-item>
      <budget-item code="2b47e4dd-6430-4bc5-829c-127bb93a72a8" percentage="0.63">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Treatment (TB care and prevention)</narrative>
        </description>
      </budget-item>
      <budget-item code="f9ff8a94-1fc1-4acf-863f-a191df107ee9" percentage="1.33">
        <description>
          <narrative>Tuberculosis -&gt; TB/HIV -&gt; Engaging all care providers (TB/HIV)</narrative>
        </description>
      </budget-item>
      <budget-item code="2146ce4f-9254-4a2a-8be8-e14734ab53dc" percentage="1.36">
        <description>
          <narrative>Tuberculosis -&gt; TB/HIV -&gt; TB/HIV - Collaborative interventions</narrative>
        </description>
      </budget-item>
      <budget-item code="d5851297-913c-4ce3-a373-c0915334727a" percentage="0.01">
        <description>
          <narrative>Tuberculosis -&gt; TB/HIV -&gt; TB/HIV - Prevention</narrative>
        </description>
      </budget-item>
    </country-budget-items>
    <collaboration-type code="1" />
    <default-flow-type code="10" />
    <default-finance-type code="110" />
    <default-aid-type code="C01" vocabulary="1" />
    <default-tied-status code="5" />
    <budget type="2" status="2">
      <period-start iso-date="2021-01-01" />
      <period-end iso-date="2021-12-31" />
      <value currency="USD" value-date="2021-01-01">37323897.48</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2022-01-01" />
      <period-end iso-date="2022-12-31" />
      <value currency="USD" value-date="2022-01-01">58637843.02</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2023-01-01" />
      <period-end iso-date="2023-12-31" />
      <value currency="USD" value-date="2023-01-01">73005530.70</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2024-01-01" />
      <period-end iso-date="2024-12-31" />
      <value currency="USD" value-date="2024-01-01">17983840.45</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2025-01-01" />
      <period-end iso-date="2025-12-31" />
      <value currency="USD" value-date="2025-01-01">4240953.42</value>
    </budget>
    <capital-spend percentage="16.49" />
    <transaction ref="e570daed-1340-4868-a56b-65c0c19c7254">
      <transaction-type code="2" />
      <transaction-date iso-date="2020-12-16" />
      <value currency="USD" value-date="2020-12-16">67281202.96</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="0a72ab37-f4b2-4307-b2d3-e5266904b625">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-12-22" />
      <value currency="USD" value-date="2020-12-22">8922352.30</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP03 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="4286bf3e-a9b7-4174-a22c-54c0564b3e21">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-02-12" />
      <value currency="USD" value-date="2021-02-12">1575412.80</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="4ffed38f-5764-4432-af8a-3089f114f190">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-03-05" />
      <value currency="USD" value-date="2021-03-05">166358.99</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="64368d7e-be24-4695-8f67-ad3e555d7219">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-04-09" />
      <value currency="USD" value-date="2021-04-09">95549.84</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="223456c6-56e9-4728-8d7b-a6231feaab0e">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-05-07" />
      <value currency="USD" value-date="2021-05-07">11346876.15</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP03 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="97b2eeb7-22d3-4b65-afe1-905a7b0e1656">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-07-07" />
      <value currency="USD" value-date="2021-07-07">119009.00</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="aaab8a78-a369-401b-a94e-0cfac5907f75">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-07-07" />
      <value currency="USD" value-date="2021-07-07">50000.00</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="db409cc7-8362-409c-9470-76aba5d81dcc">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-07-15" />
      <value currency="USD" value-date="2021-07-15">81600.00</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP03 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="db681d89-b3a8-4dc7-be14-3ff11f66d991">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-07-15" />
      <value currency="USD" value-date="2021-07-15">37409.00</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP03 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="f526ecf9-0114-4a9f-8901-8d1557013e69">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-08-04" />
      <value currency="USD" value-date="2021-08-04">45533.37</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="33f9881b-80df-4b7f-b958-04141e6a83b9">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-08-05" />
      <value currency="USD" value-date="2021-08-05">9639066.00</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP03 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="d07cf24d-e78b-45c3-bc08-b83157dcdcd6">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-08-05" />
      <value currency="USD" value-date="2021-08-05">4081338.36</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP03 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="c1af1747-eded-4179-b920-7901ccfbea20">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-08-11" />
      <value currency="USD" value-date="2021-08-11">8507985.94</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="4d681903-8484-4ce3-80d8-63f2498079f5">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-09-21" />
      <value currency="USD" value-date="2021-09-21">8507985.94</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP03 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="d3522e05-3ae1-48ec-85c7-9d1b3095d98a">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-10-08" />
      <value currency="USD" value-date="2021-10-08">-8626994.94</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="80733d48-aeb6-4069-923f-ea6f55354cf6">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-10-08" />
      <value currency="USD" value-date="2021-10-08">8626994.94</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="3a81ef11-ca44-404c-a950-2136de51506d">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-10-08" />
      <value currency="USD" value-date="2021-10-08">-45533.37</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="6c2690af-a552-4c34-b5de-6df925347539">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-10-08" />
      <value currency="USD" value-date="2021-10-08">-8626994.94</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="0544d59c-6841-49a1-a661-7ab189542bdc">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-10-08" />
      <value currency="USD" value-date="2021-10-08">8626994.94</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="6faf4961-5eba-48b3-ab75-eb8a0d6ea4e0">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-10-08" />
      <value currency="USD" value-date="2021-10-08">45533.37</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="3becd0e8-d31d-4aa1-a135-e46e018a7a81">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-10-19" />
      <value currency="USD" value-date="2021-10-19">8507985.94</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP03 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="3d89dafc-df12-469a-9d49-4e9bc8dc9be9">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-10-19" />
      <value currency="USD" value-date="2021-10-19">81600.00</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP03 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="54f92380-4136-4156-8e25-7b073621c02b">
      <transaction-type code="7" />
      <transaction-date iso-date="2021-10-19" />
      <value currency="USD" value-date="2021-10-19">8626994.94</value>
      <description>
        <narrative>Funds returned to the Global Fund from PHL-T-PBSPP03 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="75c01336-105f-4f14-b7b2-4ace744a4315">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-10-19" />
      <value currency="USD" value-date="2021-10-19">37409.00</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP03 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="d22843b9-02cb-4312-92c6-a986d6c20433">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-10-19" />
      <value currency="USD" value-date="2021-10-19">1019372.31</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="f7851226-019e-44cc-8f3a-ca462b6caa73">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-10-21" />
      <value currency="USD" value-date="2021-10-21">2475143.85</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="a2aa3ac5-fd7e-4125-82df-9ba9ae988dea">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-11-04" />
      <value currency="USD" value-date="2021-11-04">8205113.94</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP03 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="ed5ad7f3-6b0d-44d3-a877-62016f78ebac">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-11-04" />
      <value currency="USD" value-date="2021-11-04">1653688.02</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP03 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="05de58bc-a72f-4fee-9ba8-00424dcbea0c">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-11-20" />
      <value currency="USD" value-date="2021-11-20">867553.91</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="095094f0-e7e1-4e8f-ab2c-8a16db967f7a">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-11-20" />
      <value currency="USD" value-date="2021-11-20">-1019372.31</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="a179cac6-d6a0-4347-9b2f-bb46212c6a29">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-11-22" />
      <value currency="USD" value-date="2021-11-22">28856.13</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP03 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="2fcd52c4-2beb-40d8-a225-69c7838bb81a">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-12-03" />
      <value currency="USD" value-date="2021-12-03">10854.66</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="f26a70b9-087f-498c-822c-089f5fddb1af">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-12-03" />
      <value currency="USD" value-date="2021-12-03">-10854.66</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="66d92d3e-134b-4907-a95b-6288298e121b">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-12-04" />
      <value currency="USD" value-date="2021-12-04">-867553.91</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="ba6abf74-094a-4f1d-b67e-9f55dd6662b0">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-12-04" />
      <value currency="USD" value-date="2021-12-04">1057694.71</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="687a4767-9e92-4662-b782-04fb61dcb5bb">
      <transaction-type code="7" />
      <transaction-date iso-date="2021-12-08" />
      <value currency="USD" value-date="2021-12-08">10854.66</value>
      <description>
        <narrative>Funds returned to the Global Fund from PHL-T-PBSPP03 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="38a36b15-ffa3-4600-86ad-1c129abb3bd0">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-12-14" />
      <value currency="USD" value-date="2021-12-14">-16677.24</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="406fe08a-df6a-462d-b744-bf57bffd5df9">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-12-14" />
      <value currency="USD" value-date="2021-12-14">651299.62</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="bac042b8-f40e-4275-905d-b80bc057966e">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-01-12" />
      <value currency="USD" value-date="2022-01-12">5767.75</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP03 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="5e3e967e-7254-4447-aac8-52f723c30e84">
      <transaction-type code="7" />
      <transaction-date iso-date="2022-01-20" />
      <value currency="USD" value-date="2022-01-20">7635.90</value>
      <description>
        <narrative>Funds returned to the Global Fund from PHL-T-PBSPP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="ff5cb919-81e9-4748-bee4-30d261edc65f">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-01-25" />
      <value currency="USD" value-date="2022-01-25">-7635.90</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="88e80e38-2ddc-48d1-9da4-625e045f500c">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-01-29" />
      <value currency="USD" value-date="2022-01-29">-10854.66</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="7233c747-95f0-41fe-9dd1-529d6d2cb121">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-02-02" />
      <value currency="USD" value-date="2022-02-02">88769.28</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP03 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="0b4db668-ac4f-488f-9795-cd4d247b49b0">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-02-25" />
      <value currency="USD" value-date="2022-02-25">100000.00</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="7957e33e-ce51-4185-a1a9-d026d9f268e0">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-02-25" />
      <value currency="USD" value-date="2022-02-25">-50000.00</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="9a8aaaee-f20c-4fb1-83bd-f262481eb39b">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-03-09" />
      <value currency="USD" value-date="2022-03-09">51483.97</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="deafcb67-875c-4242-bf48-f658f631e3de">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-03-09" />
      <value currency="USD" value-date="2022-03-09">-51483.97</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="4a869c16-04aa-46a8-ac66-ba67bc06b0d5">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-03-14" />
      <value currency="USD" value-date="2022-03-14">13996.25</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP03 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="b6b1e54d-c3ab-4718-82a0-7ec4cd5cb356">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-03-14" />
      <value currency="USD" value-date="2022-03-14">50000.00</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="69d1208d-47e0-4789-8275-b8c653b2cf97">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-03-24" />
      <value currency="USD" value-date="2022-03-24">16180904.98</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP03 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="f9689828-6c2b-4de4-b09d-22caa1bdf1e8">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-03-25" />
      <value currency="USD" value-date="2022-03-25">243394.12</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP03 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="a8a4c093-57eb-4815-9049-32954ae4016b">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-03-26" />
      <value currency="USD" value-date="2022-03-26">-542766.34</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="ba66ba0b-2291-49a5-af52-45f1e3b662b0">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-03-26" />
      <value currency="USD" value-date="2022-03-26">531856.85</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="c9a33d41-f17f-4e71-9ac7-95fcbe3e1372">
      <transaction-type code="7" />
      <transaction-date iso-date="2022-03-29" />
      <value currency="USD" value-date="2022-03-29">51483.97</value>
      <description>
        <narrative>Funds returned to the Global Fund from PHL-T-PBSPP03 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="a85b985d-b5da-44d3-9187-9737e7312b57">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-04-20" />
      <value currency="USD" value-date="2022-04-20">332297.00</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP03 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="dc685f62-75bb-4a45-8fb2-4a2771ce44d6">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-04-24" />
      <value currency="USD" value-date="2022-04-24">-51483.97</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="56783b13-c919-4d71-ad9b-6d2cd16287f1">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-04-28" />
      <value currency="USD" value-date="2022-04-28">106170.78</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="9106be70-0cf8-449f-a722-24fcd721270b">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-05-12" />
      <value currency="USD" value-date="2022-05-12">-2833226.95</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="98fdd9bc-de8f-4608-a830-f20660032144">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-05-12" />
      <value currency="USD" value-date="2022-05-12">11391551.31</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="99887cae-0470-4c92-9ac8-e32863bcc40f">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-05-18" />
      <value currency="USD" value-date="2022-05-18">158259.68</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP03 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="d02593e3-6e14-49e0-b810-78f4803ee387">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-05-19" />
      <value currency="USD" value-date="2022-05-19">7095584.31</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="15f05fe2-5a7c-483d-8bee-ad27148fb266">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-05-25" />
      <value currency="USD" value-date="2022-05-25">119634.72</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP03 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="0c15d04e-6556-46f2-8f46-d36dc184cb8b">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-05-31" />
      <value currency="USD" value-date="2022-05-31">127411.07</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="33830b0c-5bfb-4b8f-951f-94efc6b70057">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-05-31" />
      <value currency="USD" value-date="2022-05-31">-199559.85</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="1bf6c64f-ae91-4d96-be6a-a89663670f81">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-06-16" />
      <value currency="USD" value-date="2022-06-16">32520.04</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP03 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="76b4ad99-5b1e-490e-9d1b-1d7188ce3a0b">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-06-18" />
      <value currency="USD" value-date="2022-06-18">4651132.28</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="94d5d0a9-5c54-4578-b849-bddaace63dfc">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-06-18" />
      <value currency="USD" value-date="2022-06-18">-536406.19</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="add25503-be67-449b-8ae9-14f199a9b3b2">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-06-22" />
      <value currency="USD" value-date="2022-06-22">12061808.99</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="ea3560d4-51a4-4e31-9f52-437c19d5e50c">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-06-22" />
      <value currency="USD" value-date="2022-06-22">-4295967.00</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="0b8daef2-c9b9-4937-b3e4-4dd699a288f5">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-06-27" />
      <value currency="USD" value-date="2022-06-27">3355360.63</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP03 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="062a7aaf-e4ed-489c-890b-906b6a18cede">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-08-04" />
      <value currency="USD" value-date="2022-08-04">2185985.01</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP03 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="c3cb7e74-0000-4b77-b5c6-9c7e5a8e0c00">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-08-04" />
      <value currency="USD" value-date="2022-08-04">129368.48</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP03 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="3dbae79c-38bb-4656-be17-f47453d824fb">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-08-11" />
      <value currency="USD" value-date="2022-08-11">2346264.53</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="4adf7349-907e-42d5-8563-7a6a369a4497">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-08-11" />
      <value currency="USD" value-date="2022-08-11">-2335778.79</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="f5f00004-50be-4fb8-8f86-d88b5e57087f">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-08-11" />
      <value currency="USD" value-date="2022-08-11">-10485.74</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="b46f1fea-da9c-4d15-9e70-f9fddc5b83ba">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-08-22" />
      <value currency="USD" value-date="2022-08-22">31017.00</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP03 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="f37d576d-4087-4d43-8484-b87966a78a9d">
      <transaction-type code="7" />
      <transaction-date iso-date="2022-08-22" />
      <value currency="USD" value-date="2022-08-22">10485.74</value>
      <description>
        <narrative>Funds returned to the Global Fund from PHL-T-PBSPP03 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="5b6d006e-ebca-4faa-babf-dba481085454">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-09-06" />
      <value currency="USD" value-date="2022-09-06">2297314.98</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="5ba1a4a3-b9da-4ef8-82bb-b03506ab1ad4">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-09-06" />
      <value currency="USD" value-date="2022-09-06">-2315247.53</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="d6ddfea5-1c4b-4852-8c58-c66eff51d204">
      <transaction-type code="7" />
      <transaction-date iso-date="2022-10-01" />
      <value currency="USD" value-date="2022-10-01">9293.86</value>
      <description>
        <narrative>Funds returned to the Global Fund from PHL-T-PBSPP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="2701461e-aff4-44aa-8471-aa6cbb34247b">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-10-19" />
      <value currency="USD" value-date="2022-10-19">-9293.86</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="46df63cf-77fe-4b06-9981-dde4c6c9f6d8">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-10-27" />
      <value currency="USD" value-date="2022-10-27">43451096.00</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="a361f8c8-70c8-468c-b59a-9f60b238b018">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-10-27" />
      <value currency="USD" value-date="2022-10-27">-8706448.36</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="4e75dcd4-0dc8-4944-9ffa-d3e4f6d57bd7">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-11-01" />
      <value currency="USD" value-date="2022-11-01">347700.03</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="c08aaa1c-1c88-431b-a7f4-9e1a27ec702a">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-11-14" />
      <value currency="USD" value-date="2022-11-14">89807.79</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="e49cb8b1-2fff-4bbc-9227-0bc83bdd90ff">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-11-14" />
      <value currency="USD" value-date="2022-11-14">-94891.03</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="1bff2072-cb89-4c04-b33b-58884125b570">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-11-16" />
      <value currency="USD" value-date="2022-11-16">770901.79</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="3598b630-2dd2-47fe-ba9e-bea399514fb1">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-11-16" />
      <value currency="USD" value-date="2022-11-16">-89807.79</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="d1a0e300-501a-44f4-b6fa-59b6974b1f1e">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-11-24" />
      <value currency="USD" value-date="2022-11-24">9483.94</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP03 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="bc88672b-60c9-4404-97a3-ccae7c79f3e1">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-11-28" />
      <value currency="USD" value-date="2022-11-28">13950606.12</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP03 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="d8fa94bf-b836-4a29-9d60-96b787d19d75">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-11-28" />
      <value currency="USD" value-date="2022-11-28">2418033.53</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP03 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="a030400c-0a7f-4174-994f-f38f76ed157a">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-12-20" />
      <value currency="USD" value-date="2022-12-20">4500000.00</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP03 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="52413ff4-25e0-4697-b6f4-0118d384a705">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-01-10" />
      <value currency="USD" value-date="2023-01-10">11978.86</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP03 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="c4cad441-84fc-49fb-b412-bc29132870fc">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-01-10" />
      <value currency="USD" value-date="2023-01-10">144775.44</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP03 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="b45eef42-92f8-4828-9002-b56fc4f76dba">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-01-12" />
      <value currency="USD" value-date="2023-01-12">1808329.87</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP03 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="0ee4206b-590a-4f4d-b571-6f07309137d1">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-01-24" />
      <value currency="USD" value-date="2023-01-24">4553639.12</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="5e5c4c43-07c4-4202-8eb0-1b21d35ed782">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-02-01" />
      <value currency="USD" value-date="2023-02-01">1701.19</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP03 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="3708efcc-dda9-473f-9e39-e8feef69e20a">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-02-02" />
      <value currency="USD" value-date="2023-02-02">11180890.00</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP03 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="0013c935-b977-4116-ab90-63f915326a52">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-02-03" />
      <value currency="USD" value-date="2023-02-03">2369905.32</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="b9120ed5-2e51-4329-bf00-323230f43df4">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-02-03" />
      <value currency="USD" value-date="2023-02-03">-2369905.32</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="5b09dcf3-d9d8-420e-b0ea-b2eef7839a6e">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-02-09" />
      <value currency="USD" value-date="2023-02-09">873.37</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP03 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="624b5d38-a386-432e-abdc-cb7e3f788539">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-02-09" />
      <value currency="USD" value-date="2023-02-09">-49322.55</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="6b67d057-bf0c-49ab-ab31-c9e5022d0a3f">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-02-09" />
      <value currency="USD" value-date="2023-02-09">-2369905.32</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="b0fdf678-ba02-4094-af24-854a16fbb933">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-02-09" />
      <value currency="USD" value-date="2023-02-09">2419227.87</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="7cdfa04b-2190-4a6e-810c-9c299b2c17ae">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-02-10" />
      <value currency="USD" value-date="2023-02-10">26.18</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="cabdac3d-61ba-4b51-83f1-eef56b2006ba">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-02-10" />
      <value currency="USD" value-date="2023-02-10">-2419227.87</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="53a1780b-fc1e-45e1-b44b-ac85e011cd5e">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-03-09" />
      <value currency="USD" value-date="2023-03-09">368573.90</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="bc1e9e21-523e-4e75-96b3-6ea1aa3f4196">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-03-09" />
      <value currency="USD" value-date="2023-03-09">524339.70</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="be48311a-3b65-4840-9e13-a462923d7efb">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-03-09" />
      <value currency="USD" value-date="2023-03-09">-488985.11</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="e6dcb18e-6767-4be5-9b0a-e2999dc569f6">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-03-09" />
      <value currency="USD" value-date="2023-03-09">-602088.99</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="ca91dbb1-0380-4181-8ae1-9cb787a5b1ea">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-03-21" />
      <value currency="USD" value-date="2023-03-21">50000.00</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="d3da6630-75f6-49f3-bae3-e91bcdcc7b8e">
      <transaction-type code="7" />
      <transaction-date iso-date="2023-04-11" />
      <value currency="USD" value-date="2023-04-11">49322.55</value>
      <description>
        <narrative>Funds returned to the Global Fund from PHL-T-PBSPP03 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="af7cf5ee-5c91-4040-a417-938acb20dbe2">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-05-09" />
      <value currency="USD" value-date="2023-05-09">1132098.63</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="c2ceb5bb-4c18-4c27-aefe-c41644611141">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-05-09" />
      <value currency="USD" value-date="2023-05-09">-524339.70</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="f6e99cdc-6cd1-47fa-aaaf-dc310f05c985">
      <transaction-type code="7" />
      <transaction-date iso-date="2023-06-01" />
      <value currency="USD" value-date="2023-06-01">1689.44</value>
      <description>
        <narrative>Funds returned to the Global Fund from PHL-T-PBSPP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="0e09c38f-9728-46ae-8271-40af3ad31205">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-06-06" />
      <value currency="USD" value-date="2023-06-06">-6500227.20</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="c06230d0-0fc9-4859-944a-55e60b2ed65a">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-06-06" />
      <value currency="USD" value-date="2023-06-06">36241003.41</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="65670057-0a90-41b9-8647-f0e1e374f00a">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-06-08" />
      <value currency="USD" value-date="2023-06-08">9498868.00</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP03 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="420efe8e-d90d-436a-a0f3-a71116083dc9">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-06-15" />
      <value currency="USD" value-date="2023-06-15">10100.68</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="18e5b82f-f2d6-4893-9c2b-99cee86a1f6b">
      <transaction-type code="7" />
      <transaction-date iso-date="2023-06-27" />
      <value currency="USD" value-date="2023-06-27">2369905.32</value>
      <description>
        <narrative>Funds returned to the Global Fund from PHL-T-PBSPP03 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="615907bc-d029-47d0-bb5d-31658e2fc3f3">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-06-29" />
      <value currency="USD" value-date="2023-06-29">1218552.44</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="352341f8-3834-477f-9972-139b1d91a528">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-06-30" />
      <value currency="USD" value-date="2023-06-30">-1689.44</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="c918f6cc-6d98-417d-9a77-97a037ae4e4f">
      <transaction-type code="7" />
      <transaction-date iso-date="2023-07-01" />
      <value currency="USD" value-date="2023-07-01">26249.71</value>
      <description>
        <narrative>Funds returned to the Global Fund from PHL-T-PBSPP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="4572355a-e36e-434f-b542-19e537dacf4a">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-07-04" />
      <value currency="USD" value-date="2023-07-04">26.16</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP03 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="16af6e94-1358-4bf0-995c-eb518e634589">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-07-12" />
      <value currency="USD" value-date="2023-07-12">-26249.71</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="451fdfba-335d-42db-ae10-5591e1ee40d2">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-07-20" />
      <value currency="USD" value-date="2023-07-20">353594.80</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP03 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="1038634d-db0d-4d3f-9c9d-d77155eb1fc9">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-07-23" />
      <value currency="USD" value-date="2023-07-23">50000.00</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="a5da05c1-acd4-47f0-94d2-44a759c359ef">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-08-10" />
      <value currency="USD" value-date="2023-08-10">5804176.90</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP03 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="c0bd92a8-bf97-46bb-845c-982c330767eb">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-08-10" />
      <value currency="USD" value-date="2023-08-10">13629486.64</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP03 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="21539de3-3691-42d0-83d3-dc3eb8a79d0f">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-08-24" />
      <value currency="USD" value-date="2023-08-24">1692.62</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP03 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="efe6962b-8747-44a7-8a90-8742ac05684c">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-09-05" />
      <value currency="USD" value-date="2023-09-05">23943.71</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP03 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="fd0a6144-79cf-4ba7-b1d2-6da5bc94009f">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-09-05" />
      <value currency="USD" value-date="2023-09-05">289381.62</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP03 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="26a1a92b-35e8-4a68-9c2c-b0b9b5e7f53d">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-09-14" />
      <value currency="USD" value-date="2023-09-14">-463485.88</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="903446f9-4e5c-4a8f-8e06-3ed83de4d6a7">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-09-14" />
      <value currency="USD" value-date="2023-09-14">-289381.62</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="ed543699-a987-46d1-87ed-2fa009e9e55a">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-09-14" />
      <value currency="USD" value-date="2023-09-14">752867.50</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="5d097fd0-673f-4642-bc8e-a833ad48507f">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-09-20" />
      <value currency="USD" value-date="2023-09-20">289381.61</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP03 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="6506f351-eded-4fd7-9ee7-1ea25434f120">
      <transaction-type code="7" />
      <transaction-date iso-date="2023-09-20" />
      <value currency="USD" value-date="2023-09-20">289381.62</value>
      <description>
        <narrative>Funds returned to the Global Fund from PHL-T-PBSPP03 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="fc00e246-a068-4910-8a7a-d34dc09d3a7a">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-09-26" />
      <value currency="USD" value-date="2023-09-26">-0.02</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="2f064e6e-4c80-489f-be62-734fb3c13c98">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-10-03" />
      <value currency="USD" value-date="2023-10-03">-463485.89</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="920ed8f0-d0c2-49b7-8742-a8be6a00fb59">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-10-03" />
      <value currency="USD" value-date="2023-10-03">265730.49</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="04a28e17-040b-4830-8f7d-a6b92b9cacec">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-10-05" />
      <value currency="USD" value-date="2023-10-05">21522.00</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP03 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="a8364083-8a90-40b1-8308-e6724ebbf1a0">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-11-01" />
      <value currency="USD" value-date="2023-11-01">3182387.12</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="ab542d28-59e5-421f-b898-9bd3564839cf">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-11-01" />
      <value currency="USD" value-date="2023-11-01">-368573.90</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="29d6bdd9-9f4d-4834-83a8-5b4cdc0f4338">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-11-08" />
      <value currency="USD" value-date="2023-11-08">-244208.49</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="9c5d6e11-e827-4dc8-b167-0c5d044d8147">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-11-08" />
      <value currency="USD" value-date="2023-11-08">384722.49</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="07fcfb65-dbd7-4ec6-8cae-bc32050bec14">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-11-16" />
      <value currency="USD" value-date="2023-11-16">1148002.87</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP03 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="273564a0-8654-42bc-94b3-d4fa4a52a6ff">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-11-16" />
      <value currency="USD" value-date="2023-11-16">2389083.45</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP03 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="1e1d8e58-105e-4e8b-aed8-e887649c4562">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-11-21" />
      <value currency="USD" value-date="2023-11-21">9857.88</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP03 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="5d446d22-4d45-414c-b5e1-0abea6d83a71">
      <transaction-type code="7" />
      <transaction-date iso-date="2023-11-29" />
      <value currency="USD" value-date="2023-11-29">21281.97</value>
      <description>
        <narrative>Funds returned to the Global Fund from PHL-T-PBSPP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="3a81dbb6-abb0-437f-b224-0dd765bf9f6f">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-11-30" />
      <value currency="USD" value-date="2023-11-30">-21281.97</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="c5a0f9f6-0ccf-4c71-b049-3faefbd55c50">
      <transaction-type code="7" />
      <transaction-date iso-date="2023-12-01" />
      <value currency="USD" value-date="2023-12-01">606.79</value>
      <description>
        <narrative>Funds returned to the Global Fund from PHL-T-PBSPP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="38876635-c900-4d9b-a85e-ba34dd0970cb">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-12-03" />
      <value currency="USD" value-date="2023-12-03">-374864.61</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="a8e241f5-1cc5-486e-8a5f-4d68ec493754">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-12-03" />
      <value currency="USD" value-date="2023-12-03">339977.88</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="7e7676ee-0b28-4f54-805a-b513c6b249d4">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-12-12" />
      <value currency="USD" value-date="2023-12-12">-339977.88</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="b58fd60e-9862-473e-8296-8327417c2ca6">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-12-12" />
      <value currency="USD" value-date="2023-12-12">290001.63</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="00cca8ba-2f17-48b8-9de7-657b3bc9fa63">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-12-19" />
      <value currency="USD" value-date="2023-12-19">48230.27</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP03 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="bdf88438-934b-4d6b-9180-9ecd8e129bae">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-12-19" />
      <value currency="USD" value-date="2023-12-19">3990.62</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP03 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="2eedb295-8315-4c64-b8fe-46da5658e12b">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-12-22" />
      <value currency="USD" value-date="2023-12-22">-606.79</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="4e9f2a09-2f95-4074-8990-766a630857a5">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-01-09" />
      <value currency="USD" value-date="2024-01-09">9670.88</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP03 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="cc0d9799-1d83-409c-b524-feab6b470145">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-01-19" />
      <value currency="USD" value-date="2024-01-19">3186152.88</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="ce2a28e5-16a0-4ce4-b809-e1b09a22198c">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-01-19" />
      <value currency="USD" value-date="2024-01-19">-3182387.12</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="3b159876-41d8-4e29-9f69-78a606da238d">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-01-29" />
      <value currency="USD" value-date="2024-01-29">50000.00</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="421f5480-0844-459d-a134-db29c58f8a5c">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-03-02" />
      <value currency="USD" value-date="2024-03-02">3124727.88</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="6d0f480c-37a2-46b7-84e4-adc58cfbcf96">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-03-02" />
      <value currency="USD" value-date="2024-03-02">-3186152.88</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="1a62da43-8750-4307-8eed-6e92b8efc8d7">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-03-21" />
      <value currency="USD" value-date="2024-03-21">694478.44</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP03 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="4050ce10-d0a4-4381-ad52-5bf9394e8455">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-03-23" />
      <value currency="USD" value-date="2024-03-23">-2542732.43</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="d6fe6cfa-0f1b-4a36-8fd6-873f04a9f580">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-03-23" />
      <value currency="USD" value-date="2024-03-23">21752093.00</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="9f82423c-38aa-4d3f-956d-40acc0197325">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-04-02" />
      <value currency="USD" value-date="2024-04-02">6699458.00</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP03 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="04f5bbc1-2446-432b-9246-ef077da07343">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-04-13" />
      <value currency="USD" value-date="2024-04-13">243284.79</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="ddea034b-ed3f-461c-93ba-565278a98a84">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-04-13" />
      <value currency="USD" value-date="2024-04-13">-228109.86</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="0551c871-e186-4725-9a1d-0afb06405dcf">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-04-16" />
      <value currency="USD" value-date="2024-04-16">72615.57</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP03 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="a3273d6b-0ada-43a9-83ee-01435ae03512">
      <transaction-type code="7" />
      <transaction-date iso-date="2024-07-01" />
      <value currency="USD" value-date="2024-07-01">143.27</value>
      <description>
        <narrative>Funds returned to the Global Fund from PHL-T-PBSPP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="c9f259f0-ba06-4ca8-9b23-8c55198f8818">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-07-04" />
      <value currency="USD" value-date="2024-07-04">-143.27</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="42323bc6-d3d2-4084-a303-575d29a91095">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-07-30" />
      <value currency="USD" value-date="2024-07-30">8652.00</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP03 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="b183238a-7241-4b3b-950a-34f87d10c12a">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-08-17" />
      <value currency="USD" value-date="2024-08-17">2418738.80</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="e150ba21-b6a6-418b-a691-bd0edfcd892f">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-08-17" />
      <value currency="USD" value-date="2024-08-17">-2421597.44</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="3e2f2de0-23bb-42f2-a02e-327c18a42d39">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-09-24" />
      <value currency="USD" value-date="2024-09-24">1922236.79</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP03 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="45bdfe4f-b5f6-4ac1-8615-ec9eb90997d0">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-09-28" />
      <value currency="USD" value-date="2024-09-28">172440.32</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="8736bd55-b611-425e-8633-ef2977d2b71b">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-09-28" />
      <value currency="USD" value-date="2024-09-28">-170669.22</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="cb9a80d3-8fc5-48fe-8a91-bb15674241c3">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-09-28" />
      <value currency="USD" value-date="2024-09-28">-1771.10</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="aab6e56c-7935-49a7-b104-2ce883e7dd9b">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-09-30" />
      <value currency="USD" value-date="2024-09-30">-39690.23</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="ecf08c06-4c54-4118-8900-de67163d49a1">
      <transaction-type code="7" />
      <transaction-date iso-date="2024-10-01" />
      <value currency="USD" value-date="2024-10-01">39690.23</value>
      <description>
        <narrative>Funds returned to the Global Fund from PHL-T-PBSPP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="110970a4-a1f3-4fa9-9142-ca0d189cdd15">
      <transaction-type code="7" />
      <transaction-date iso-date="2024-10-04" />
      <value currency="USD" value-date="2024-10-04">1771.10</value>
      <description>
        <narrative>Funds returned to the Global Fund from PHL-T-PBSPP03 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="23431a66-a6ba-413e-aad4-01b246e0af0a">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-11-07" />
      <value currency="USD" value-date="2024-11-07">-172440.32</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="a16cb113-beb0-4080-aa47-cc4eea4cfe00">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-11-07" />
      <value currency="USD" value-date="2024-11-07">268780.76</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="8d32b964-cf7e-437d-988b-645548c8360f">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-01-28" />
      <value currency="USD" value-date="2025-01-28">14079012.00</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="b5253952-a681-463a-8274-948d17ac73ab">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-01-28" />
      <value currency="USD" value-date="2025-01-28">-15052635.00</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="7d55fce0-c025-4a34-ac8d-cb997ec02ecb">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-01-30" />
      <value currency="USD" value-date="2025-01-30">4625942.00</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP03 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="1b3e1753-d10c-4a30-acc4-a11a11fa2a02">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-02-08" />
      <value currency="USD" value-date="2025-02-08">-70844.47</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="ca81be0b-1f90-4d32-9cf3-2c613cb5658a">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-02-08" />
      <value currency="USD" value-date="2025-02-08">-268780.76</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="f0f8262e-006c-4421-813a-1304d5291d8e">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-02-08" />
      <value currency="USD" value-date="2025-02-08">339625.23</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="84b98f12-6338-49db-a78b-c66cbac3f893">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-02-13" />
      <value currency="USD" value-date="2025-02-13">119014.69</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP03 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="9ef789af-727d-4b53-8ca9-1e990cdef3f0">
      <transaction-type code="7" />
      <transaction-date iso-date="2025-02-13" />
      <value currency="USD" value-date="2025-02-13">70844.47</value>
      <description>
        <narrative>Funds returned to the Global Fund from PHL-T-PBSPP03 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="8a540945-be2b-4d8c-8aab-fa379598ee0d">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-06-27" />
      <value currency="USD" value-date="2025-06-27">-3662477.00</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="fe672821-93ff-4104-aab9-394575d02751">
      <transaction-type code="7" />
      <transaction-date iso-date="2025-06-30" />
      <value currency="USD" value-date="2025-06-30">3662477.00</value>
      <description>
        <narrative>Funds returned to the Global Fund from PHL-T-PBSPP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="14a47d42-00c8-4b8f-8ac8-224ba8fd522a">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-10-22" />
      <value currency="USD" value-date="2025-10-22">-496502.01</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="fe997642-6e5e-43a3-adaa-d97d976fe670">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-10-22" />
      <value currency="USD" value-date="2025-10-22">521149.91</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="56536217-efd5-42fa-b2ff-e6b960929b2f">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-11-11" />
      <value currency="USD" value-date="2025-11-11">3844505.78</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP03 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="5bed09b0-a3c1-4784-85e8-1b8c6225d402">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-12-12" />
      <value currency="USD" value-date="2025-12-12">206867.19</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="e77de375-ed23-46bf-818f-ef5cb4ac69bb">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-12-12" />
      <value currency="USD" value-date="2025-12-12">-521149.91</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="8a8c6fb9-3103-48d5-a799-00222d31c4f1">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-12-16" />
      <value currency="USD" value-date="2025-12-16">50789.30</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP03 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="9e4e027c-f6cc-44e6-9f0f-044921c737b3">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-12-16" />
      <value currency="USD" value-date="2025-12-16">-220610.54</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="aca0c53e-c86e-47bf-a253-d25807a6ce54">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-12-16" />
      <value currency="USD" value-date="2025-12-16">247629.14</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="dc70fd71-87a6-4fd2-a95b-f4d7d68999ed">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-12-16" />
      <value currency="USD" value-date="2025-12-16">-27018.60</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="0310abe1-0cd9-475b-bbf7-e59dba7e31ec">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-12-17" />
      <value currency="USD" value-date="2025-12-17">247629.14</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="f0ed4286-4900-409b-9620-d6efebbc6e8d">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-12-17" />
      <value currency="USD" value-date="2025-12-17">-247629.14</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="8872571e-85f0-4aae-93f2-516e4613321b">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-12-23" />
      <value currency="USD" value-date="2025-12-23">220610.54</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="8889fd12-2f2f-44f7-b4a2-5e34889e4925">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-12-23" />
      <value currency="USD" value-date="2025-12-23">-247629.14</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="0176dfb1-ef6a-417e-a043-db9564d1364f">
      <transaction-type code="7" />
      <transaction-date iso-date="2026-01-13" />
      <value currency="USD" value-date="2026-01-13">27018.60</value>
      <description>
        <narrative>Funds returned to the Global Fund from PHL-T-PBSPP03 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="216c0778-657f-4ed7-8318-3f6036cf68e2">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-01-20" />
      <value currency="USD" value-date="2026-01-20">7294.86</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP03 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="b1229379-8674-4a75-b682-c6adabfdd779">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-01-20" />
      <value currency="USD" value-date="2026-01-20">20691.42</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP03 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="001aa21b-c35d-4836-9d27-b752a3b104cf">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-02-24" />
      <value currency="USD" value-date="2026-02-24">95211.75</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP03 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="29d61bc7-581f-4b38-a33d-82bea9d5b6a5">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-03-06" />
      <value currency="USD" value-date="2026-03-06">145750.65</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="6cfb69d0-489c-48a4-9a0b-61432c1d0202">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-03-06" />
      <value currency="USD" value-date="2026-03-06">-128091.61</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="bb116997-0079-4562-b3b4-8684d18941ce">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-03-06" />
      <value currency="USD" value-date="2026-03-06">-17659.04</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="5409ba4a-2a30-47ae-a4d0-1fcc52f031a6">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-03-07" />
      <value currency="USD" value-date="2026-03-07">-145750.65</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="bdc2ee05-9ab0-4a95-9026-4dbe9ad0e0f3">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-03-07" />
      <value currency="USD" value-date="2026-03-07">122748.10</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="e1ff1413-46d4-4727-af58-5cf2ea738cfa">
      <transaction-type code="7" />
      <transaction-date iso-date="2026-03-13" />
      <value currency="USD" value-date="2026-03-13">17659.04</value>
      <description>
        <narrative>Funds returned to the Global Fund from PHL-T-PBSPP03 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="f3e20095-deda-4d7e-ad7c-6a863b5cf67c">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-04-21" />
      <value currency="USD" value-date="2026-04-21">24398.00</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP03 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="60207ee3-9e46-4717-88b6-4a8b3d2e70db">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-04-25" />
      <value currency="USD" value-date="2026-04-25">-101000.79</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="74488e96-3a55-497f-bfad-86e21d1e82ff">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-04-25" />
      <value currency="USD" value-date="2026-04-25">101595.85</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="c363c988-391e-4b80-9e00-5071b14074c3">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-04-25" />
      <value currency="USD" value-date="2026-04-25">-595.06</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="1d132e3b-a957-4b98-9fb7-92fa14eb42f6">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-05-03" />
      <value currency="USD" value-date="2026-05-03">91178.60</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="50c73229-42fe-41e5-9c99-06baacd018ac">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-05-03" />
      <value currency="USD" value-date="2026-05-03">-122748.10</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="a59dbfb6-74fa-4ed1-ba48-cb8365d3a2ac">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-05-05" />
      <value currency="USD" value-date="2026-05-05">9000.00</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP03 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="fd8a7d9a-5f16-4fcf-9654-cdb2e8743af7">
      <transaction-type code="7" />
      <transaction-date iso-date="2026-05-05" />
      <value currency="USD" value-date="2026-05-05">595.06</value>
      <description>
        <narrative>Funds returned to the Global Fund from PHL-T-PBSPP03 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="868ffd22-9ded-48c3-bb94-3eb8048cd898">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-06-03" />
      <value currency="USD" value-date="2026-06-03">81727.85</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="d82f3f8f-6d25-4e2d-bd18-395db573340f">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-06-03" />
      <value currency="USD" value-date="2026-06-03">-91178.60</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="f52d2afe-a1e5-4aac-8237-9949f274b145">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-06-16" />
      <value currency="USD" value-date="2026-06-16">13222.50</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP03 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="043c46b1-42f1-4d1f-9db9-4df796040ebd">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-06-20" />
      <value currency="USD" value-date="2026-06-20">-79373.35</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="394a3c82-6d1a-4ce8-b811-8ee226bbf2e6">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-06-20" />
      <value currency="USD" value-date="2026-06-20">74373.36</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="27a1a14c-99aa-41c9-a557-fff6619be1ae">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-07-01" />
      <value currency="USD" value-date="2026-07-01">1648.00</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP03 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="1dc310fd-e6ec-4e8c-aa14-3d7440778cd3">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-07-11" />
      <value currency="USD" value-date="2026-07-11">-48304.35</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="c8611753-24c6-40f8-a09e-25826ec5064e">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-07-11" />
      <value currency="USD" value-date="2026-07-11">41712.35</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="6613a407-9041-43f3-ba10-72331f026e5f">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-07-14" />
      <value currency="USD" value-date="2026-07-14">31775.50</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP03 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="1d292f3d-8c7a-4c22-b94e-033c6d18314c">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-08-04" />
      <value currency="USD" value-date="2026-08-04">37582.15</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="9030eb29-f58f-404b-8e74-7cdcceb6ad85">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-08-04" />
      <value currency="USD" value-date="2026-08-04">-41712.35</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="595a9a1a-dc57-44fb-8698-011d5e323d89">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-08-29" />
      <value currency="USD" value-date="2026-08-29">5608565.22</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="ea7dfdef-d54b-405f-a1d6-8b298c395c61">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-08-29" />
      <value currency="USD" value-date="2026-08-29">-5608564.22</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="7cb4ed07-2f86-4b63-833f-4da4190a3ea0">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-09-20" />
      <value currency="USD" value-date="2026-09-20">-37582.15</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="PHL-T-PBSPP03-EXP-20211231">
      <transaction-type code="4" />
      <transaction-date iso-date="2021-12-31" />
      <value currency="USD" value-date="2021-12-31">37080352.59</value>
      <description>
        <narrative>Expenditure reported by Philippine Business for Social Progress, Inc. for PHL-T-PBSPP03, Jan 2021 to Dec 2021.</narrative>
      </description>
      <provider-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </provider-org>
    </transaction>
    <transaction ref="PHL-T-PBSPP03-EXP-20221231">
      <transaction-type code="4" />
      <transaction-date iso-date="2022-12-31" />
      <value currency="USD" value-date="2022-12-31">59071348.83</value>
      <description>
        <narrative>Expenditure reported by Philippine Business for Social Progress, Inc. for PHL-T-PBSPP03, Jan 2022 to Dec 2022.</narrative>
      </description>
      <provider-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </provider-org>
    </transaction>
    <transaction ref="PHL-T-PBSPP03-EXP-20231231">
      <transaction-type code="4" />
      <transaction-date iso-date="2023-12-31" />
      <value currency="USD" value-date="2023-12-31">62827858.77</value>
      <description>
        <narrative>Expenditure reported by Philippine Business for Social Progress, Inc. for PHL-T-PBSPP03, Jan 2023 to Dec 2023.</narrative>
      </description>
      <provider-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </provider-org>
    </transaction>
    <transaction ref="PHL-T-PBSPP03-EXP-20240630">
      <transaction-type code="4" />
      <transaction-date iso-date="2024-06-30" />
      <value currency="USD" value-date="2024-06-30">-3932275.27</value>
      <description>
        <narrative>Expenditure reported by Philippine Business for Social Progress, Inc. for PHL-T-PBSPP03, Jan 2024 to Jun 2024.</narrative>
      </description>
      <provider-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </provider-org>
    </transaction>
    <transaction ref="PHL-T-PBSPP03-EXP-20241231">
      <transaction-type code="4" />
      <transaction-date iso-date="2024-12-31" />
      <value currency="USD" value-date="2024-12-31">5414730.44</value>
      <description>
        <narrative>Expenditure reported by Philippine Business for Social Progress, Inc. for PHL-T-PBSPP03, Jul 2024 to Dec 2024.</narrative>
      </description>
      <provider-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </provider-org>
    </transaction>
    <transaction ref="PHL-T-PBSPP03-EXP-20250630">
      <transaction-type code="4" />
      <transaction-date iso-date="2025-06-30" />
      <value currency="USD" value-date="2025-06-30">7860767.47</value>
      <description>
        <narrative>Expenditure reported by Philippine Business for Social Progress, Inc. for PHL-T-PBSPP03, Jan 2025 to Jun 2025.</narrative>
      </description>
      <provider-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </provider-org>
    </transaction>
    <transaction ref="PHL-T-PBSPP03-EXP-20251231">
      <transaction-type code="4" />
      <transaction-date iso-date="2025-12-31" />
      <value currency="USD" value-date="2025-12-31">14022038.46</value>
      <description>
        <narrative>Expenditure reported by Philippine Business for Social Progress, Inc. for PHL-T-PBSPP03, Jan 2025 to Dec 2025.</narrative>
      </description>
      <provider-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </provider-org>
    </transaction>
    <document-link url="https://data.theglobalfund.org/grant/PHL-T-PBSP" format="text/html">
      <title>
        <narrative>Grant page on the data explorer of the Global Fund.</narrative>
      </title>
      <description>
        <narrative>An overview of a grant over its lifetime.</narrative>
      </description>
      <category code="A12" />
      <category code="A01" />
      <category code="A02" />
      <category code="A05" />
      <category code="A07" />
      <category code="A08" />
      <language code="en" />
      <document-date iso-date="2026-11-09" />
    </document-link>
    <document-link url="https://www.theglobalfund.org/media/13342/core_grantregulationsversiontwo_regulations_en.pdf" format="application/pdf">
      <title>
        <narrative>Grant terms and conditions.</narrative>
      </title>
      <description>
        <narrative>General terms and conditions which apply to Global Fund grants.</narrative>
      </description>
      <category code="A04" />
      <language code="en" />
    </document-link>
    <document-link url="https://docs.theglobalfund.org/files/Applications/Funding Requests/PHL/2020/Tuberculosis/en/PHL-T_FundingRequest_1_en.zip" format="application/zip">
      <title>
        <narrative>2020 - Funding Request - Window 1 - Tuberculosis - Philippines - English</narrative>
      </title>
      <description>
        <narrative>Funding Request of funding request FR688-PHL-T.</narrative>
      </description>
      <category code="A01" />
      <category code="A02" />
      <category code="A08" />
      <language code="en" />
      <document-date iso-date="2020-03-23" />
    </document-link>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of PSA plants installed with Global Fund investments and functional</narrative>
      </title>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Number of PSA plants installed with Global Fund investments and functional</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2023" iso-date="2023-12-31">
          <comment>
            <narrative>Numerator: 0; Denominator: 0.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 1; Denominator: 1; Percentage: 100%.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of districts reporting events (per national guidelines)</narrative>
      </title>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of districts reporting events (per national guidelines)</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="61.44">
          <comment>
            <narrative>Numerator: 1004; Denominator: 1634.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target value="70.01">
            <comment>
              <narrative>Numerator: 1144; Denominator: 1634.</narrative>
            </comment>
          </target>
          <actual value="25.19">
            <comment>
              <narrative>Numerator: 433; Denominator: 1719.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target value="79.99">
            <comment>
              <narrative>Numerator: 1307; Denominator: 1634.</narrative>
            </comment>
          </target>
          <actual value="25.19">
            <comment>
              <narrative>Numerator: 433; Denominator: 1719.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of reporting units which digitally enter and submit data at the reporting unit level using the electronic information system</narrative>
      </title>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of reporting units which digitally enter and submit data at the reporting unit level using the electronic information system</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2023" iso-date="2023-12-31" value="84.08">
          <comment>
            <narrative>Numerator: 3438; Denominator: 4089.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target value="85.01">
            <comment>
              <narrative>Numerator: 3476; Denominator: 4089.</narrative>
            </comment>
          </target>
          <actual value="25.52">
            <comment>
              <narrative>Numerator: 554; Denominator: 2171.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target value="90">
            <comment>
              <narrative>Numerator: 3680; Denominator: 4089.</narrative>
            </comment>
          </target>
          <actual value="25.52">
            <comment>
              <narrative>Numerator: 554; Denominator: 2171.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of TB cases with RR-TB and/or MDR-TB notified</narrative>
      </title>
      <description>
        <narrative>Module: MDR-TB.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of TB cases with RR-TB and/or MDR-TB notified</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2018" iso-date="2018-12-31" value="6681" />
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-12-31" />
          <target value="9288" />
          <actual value="6447" />
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-06-30" />
          <target value="4644" />
          <actual value="3177" />
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2021-12-31" />
          <target value="4644" />
          <actual value="3270" />
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-12-31" />
          <target value="10655" />
          <actual value="8207" />
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-06-30" />
          <target value="5327" />
          <actual value="4108" />
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2022-12-31" />
          <target value="5328" />
          <actual value="4099" />
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-06-30" />
          <target value="5856" />
          <actual value="4179" />
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target value="11713" />
          <actual value="8540" />
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2023-12-31" />
          <target value="5857" />
          <actual value="4361" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of cases with RR-TB and/or MDR-TB that began second-line treatment</narrative>
      </title>
      <description>
        <narrative>Module: MDR-TB.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of cases with RR-TB and/or MDR-TB that began second-line treatment</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2018" iso-date="2018-12-31" value="6284" />
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-12-31" />
          <target value="8360" />
          <actual value="6081" />
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-06-30" />
          <target value="4180" />
          <actual value="3038" />
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2021-12-31" />
          <target value="4180" />
          <actual value="3043" />
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-12-31" />
          <target value="10123" />
          <actual value="8235" />
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-06-30" />
          <target value="5061" />
          <actual value="3931" />
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2022-12-31" />
          <target value="5062" />
          <actual value="4304" />
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target value="11127" />
          <actual value="8345" />
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-06-30" />
          <target value="5563" />
          <actual value="4229" />
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2023-12-31" />
          <target value="5564" />
          <actual value="4116" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of TB patients with DST result for at least Rifampicin among the total number of notified (new and retreatment) cases in the same year</narrative>
      </title>
      <description>
        <narrative>Module: MDR-TB.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of TB patients with DST result for at least Rifampicin among the total number of notified (new and retreatment) cases in the same year</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2018" iso-date="2018-12-31" value="40.43">
          <comment>
            <narrative>Numerator: 133514; Denominator: 330216.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-06-30" />
          <target value="70">
            <comment>
              <narrative>Numerator: 164711; Denominator: 235302.</narrative>
            </comment>
          </target>
          <actual value="87.1">
            <comment>
              <narrative>Numerator: 87365; Denominator: 100288.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-12-31" />
          <target value="70">
            <comment>
              <narrative>Numerator: 329422; Denominator: 470604.</narrative>
            </comment>
          </target>
          <actual value="86.3">
            <comment>
              <narrative>Numerator: 201486; Denominator: 233527.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2021-12-31" />
          <target value="70">
            <comment>
              <narrative>Numerator: 164711; Denominator: 235302.</narrative>
            </comment>
          </target>
          <actual value="85.7">
            <comment>
              <narrative>Numerator: 114121; Denominator: 133239.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-12-31" />
          <target value="80">
            <comment>
              <narrative>Numerator: 394660; Denominator: 493326.</narrative>
            </comment>
          </target>
          <actual value="79.8">
            <comment>
              <narrative>Numerator: 335483; Denominator: 420364.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-06-30" />
          <target value="80">
            <comment>
              <narrative>Numerator: 197330; Denominator: 246663.</narrative>
            </comment>
          </target>
          <actual value="86.5">
            <comment>
              <narrative>Numerator: 148286; Denominator: 171361.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2022-12-31" />
          <target value="80">
            <comment>
              <narrative>Numerator: 197330; Denominator: 246663.</narrative>
            </comment>
          </target>
          <actual value="75.2">
            <comment>
              <narrative>Numerator: 187197; Denominator: 249003.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-06-30" />
          <target value="90">
            <comment>
              <narrative>Numerator: 228289; Denominator: 253654.</narrative>
            </comment>
          </target>
          <actual value="83.1">
            <comment>
              <narrative>Numerator: 179525; Denominator: 216150.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target value="90">
            <comment>
              <narrative>Numerator: 456578; Denominator: 507308.</narrative>
            </comment>
          </target>
          <actual value="85.9">
            <comment>
              <narrative>Numerator: 370580; Denominator: 431199.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2023-12-31" />
          <target value="90">
            <comment>
              <narrative>Numerator: 228289; Denominator: 253654.</narrative>
            </comment>
          </target>
          <actual value="88.8">
            <comment>
              <narrative>Numerator: 191055; Denominator: 215049.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of confirmed RR/MDR-TB cases tested for resistance to second-line drugs</narrative>
      </title>
      <description>
        <narrative>Module: MDR-TB.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of confirmed RR/MDR-TB cases tested for resistance to second-line drugs</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2018" iso-date="2018-12-31" value="92.71">
          <comment>
            <narrative>Numerator: 5826; Denominator: 6284.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-06-30" />
          <target value="90">
            <comment>
              <narrative>Numerator: 4180; Denominator: 4644.</narrative>
            </comment>
          </target>
          <actual value="94.6">
            <comment>
              <narrative>Numerator: 3007; Denominator: 3177.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-12-31" />
          <target value="90">
            <comment>
              <narrative>Numerator: 8360; Denominator: 9288.</narrative>
            </comment>
          </target>
          <actual value="92.8">
            <comment>
              <narrative>Numerator: 5985; Denominator: 6447.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2021-12-31" />
          <target value="90">
            <comment>
              <narrative>Numerator: 4180; Denominator: 4644.</narrative>
            </comment>
          </target>
          <actual value="91.1">
            <comment>
              <narrative>Numerator: 2978; Denominator: 3270.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-06-30" />
          <target value="95.01">
            <comment>
              <narrative>Numerator: 5061; Denominator: 5327.</narrative>
            </comment>
          </target>
          <actual value="94.8">
            <comment>
              <narrative>Numerator: 3893; Denominator: 4108.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-12-31" />
          <target value="95">
            <comment>
              <narrative>Numerator: 10123; Denominator: 10654.</narrative>
            </comment>
          </target>
          <actual value="98.9">
            <comment>
              <narrative>Numerator: 8115; Denominator: 8207.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2022-12-31" />
          <target value="95.03">
            <comment>
              <narrative>Numerator: 5062; Denominator: 5327.</narrative>
            </comment>
          </target>
          <actual value="103">
            <comment>
              <narrative>Numerator: 4222; Denominator: 4099.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-06-30" />
          <target value="95">
            <comment>
              <narrative>Numerator: 5563; Denominator: 5856.</narrative>
            </comment>
          </target>
          <actual value="98.5">
            <comment>
              <narrative>Numerator: 4114; Denominator: 4178.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target value="95">
            <comment>
              <narrative>Numerator: 11126; Denominator: 11712.</narrative>
            </comment>
          </target>
          <actual value="95.4">
            <comment>
              <narrative>Numerator: 8150; Denominator: 8539.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2023-12-31" />
          <target value="95">
            <comment>
              <narrative>Numerator: 5563; Denominator: 5856.</narrative>
            </comment>
          </target>
          <actual value="92.5">
            <comment>
              <narrative>Numerator: 4036; Denominator: 4361.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Timeliness of facility reporting: Percentage of submitted facility monthly reports (for the reporting period) that are received on time per the national guidelines</narrative>
      </title>
      <description>
        <narrative>Module: RSSH: Health management information systems and M&amp;E.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Timeliness of facility reporting: Percentage of submitted facility monthly reports (for the reporting period) that are received on time per the national guidelines</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2018" iso-date="2018-12-31" value="99.45">
          <comment>
            <narrative>Numerator: 3085; Denominator: 3130.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-06-30" />
          <target value="99">
            <comment>
              <narrative>Numerator: 3071; Denominator: 3102.</narrative>
            </comment>
          </target>
          <actual value="63.7">
            <comment>
              <narrative>Numerator: 2161; Denominator: 3394.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-12-31" />
          <target value="99">
            <comment>
              <narrative>Numerator: 6142; Denominator: 6204.</narrative>
            </comment>
          </target>
          <actual value="72.1">
            <comment>
              <narrative>Numerator: 4825; Denominator: 6691.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2021-12-31" />
          <target value="99">
            <comment>
              <narrative>Numerator: 3071; Denominator: 3102.</narrative>
            </comment>
          </target>
          <actual value="80.8">
            <comment>
              <narrative>Numerator: 2664; Denominator: 3297.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 6204; Denominator: 6204.</narrative>
            </comment>
          </target>
          <actual value="95.8">
            <comment>
              <narrative>Numerator: 6189; Denominator: 6463.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-06-30" />
          <target value="100">
            <comment>
              <narrative>Numerator: 3102; Denominator: 3102.</narrative>
            </comment>
          </target>
          <actual value="91.7">
            <comment>
              <narrative>Numerator: 3026; Denominator: 3300.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2022-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 3102; Denominator: 3102.</narrative>
            </comment>
          </target>
          <actual value="100">
            <comment>
              <narrative>Numerator: 3163; Denominator: 3163.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 6204; Denominator: 6204.</narrative>
            </comment>
          </target>
          <actual value="100">
            <comment>
              <narrative>Numerator: 6343; Denominator: 6343.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-06-30" />
          <target value="100">
            <comment>
              <narrative>Numerator: 3102; Denominator: 3102.</narrative>
            </comment>
          </target>
          <actual value="100">
            <comment>
              <narrative>Numerator: 3180; Denominator: 3180.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2023-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 3102; Denominator: 3102.</narrative>
            </comment>
          </target>
          <actual value="100">
            <comment>
              <narrative>Numerator: 3163; Denominator: 3163.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of TB cases (all forms) notified among key affected populations/ high risk groups (other than prisoners)</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of TB cases (all forms) notified among key affected populations/ high risk groups (other than prisoners)</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2018" iso-date="2018-12-31" value="4526" />
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-12-31" />
          <target value="18456" />
          <actual value="12721" />
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-06-30" />
          <target value="6728" />
          <actual value="3364" />
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2021-12-31" />
          <target value="11728" />
          <actual value="9357" />
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-06-30" />
          <target value="11228" />
          <actual value="16301" />
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-12-31" />
          <target value="22456" />
          <actual value="40594" />
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2022-12-31" />
          <target value="11228" />
          <actual value="24293" />
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target value="26456" />
          <actual value="49156" />
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-06-30" />
          <target value="13228" />
          <actual value="23945" />
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2023-12-31" />
          <target value="13228" />
          <actual value="25211" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of TB cases (all forms) notified among prisoners</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of TB cases (all forms) notified among prisoners</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2018" iso-date="2018-12-31" value="3676" />
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-06-30" />
          <target value="2700" />
          <actual value="2291" />
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-12-31" />
          <target value="5400" />
          <actual value="4930" />
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2021-12-31" />
          <target value="2700" />
          <actual value="2639" />
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-12-31" />
          <target value="5130" />
          <actual value="4717" />
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-06-30" />
          <target value="2565" />
          <actual value="2313" />
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2022-12-31" />
          <target value="2565" />
          <actual value="2404" />
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-06-30" />
          <target value="2437" />
          <actual value="2439" />
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target value="4874" />
          <actual value="5422" />
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2023-12-31" />
          <target value="2437" />
          <actual value="2983" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of notified TB cases (all forms) contributed by non-national TB program providers - private/non-governmental facilities</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of notified TB cases (all forms) contributed by non-national TB program providers - private/non-governmental facilities</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2018" iso-date="2018-12-31" value="26032" />
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-12-31" />
          <target value="75751" />
          <actual value="65221" />
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-06-30" />
          <target value="18938" />
          <actual value="19490" />
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2021-12-31" />
          <target value="56813" />
          <actual value="45731" />
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-12-31" />
          <target value="106760" />
          <actual value="122732" />
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-06-30" />
          <target value="51655" />
          <actual value="54925" />
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2022-12-31" />
          <target value="55105" />
          <actual value="67807" />
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-06-30" />
          <target value="60248" />
          <actual value="74054" />
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target value="120496" />
          <actual value="144501" />
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2023-12-31" />
          <target value="60248" />
          <actual value="70447" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2018" iso-date="2018-12-31" value="371668" />
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-06-30" />
          <target value="235302" />
          <actual value="98730" />
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-12-31" />
          <target value="470604" />
          <actual value="268245" />
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2021-12-31" />
          <target value="235302" />
          <actual value="169515" />
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-06-30" />
          <target value="246663" />
          <actual value="199665" />
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-12-31" />
          <target value="493326" />
          <actual value="444582" />
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2022-12-31" />
          <target value="246663" />
          <actual value="244917" />
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target value="507308" />
          <actual value="593581" />
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-06-30" />
          <target value="253654" />
          <actual value="288139" />
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2023-12-31" />
          <target value="253654" />
          <actual value="305442" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of people in contact with TB patients who began preventive therapy</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of people in contact with TB patients who began preventive therapy</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2018" iso-date="2018-12-31" value="5939" />
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-12-31" />
          <target value="9228" />
          <actual value="3801" />
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-06-30" />
          <target value="4614" />
          <actual value="937" />
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2021-12-31" />
          <target value="4614" />
          <actual value="2864" />
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-12-31" />
          <target value="16168" />
          <actual value="18742" />
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-06-30" />
          <target value="8084" />
          <actual value="5548" />
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2022-12-31" />
          <target value="8084" />
          <actual value="13194" />
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target value="25926" />
          <actual value="35114" />
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-06-30" />
          <target value="12963" />
          <actual value="16886" />
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2023-12-31" />
          <target value="12963" />
          <actual value="18228" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Treatment success rate- all forms: Percentage of TB cases, all forms, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB cases registered for treatment during a specified period, new and relapse cases</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Treatment success rate- all forms: Percentage of TB cases, all forms, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB cases registered for treatment during a specified period, new and relapse cases</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2018" iso-date="2018-12-31" value="91">
          <comment>
            <narrative>Numerator: 287489; Denominator: 315923.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-06-30" />
          <target value="90">
            <comment>
              <narrative>Numerator: 205502; Denominator: 228336.</narrative>
            </comment>
          </target>
          <actual value="91.4">
            <comment>
              <narrative>Numerator: 82465; Denominator: 90187.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-12-31" />
          <target value="90">
            <comment>
              <narrative>Numerator: 411004; Denominator: 456672.</narrative>
            </comment>
          </target>
          <actual value="88.8">
            <comment>
              <narrative>Numerator: 169418; Denominator: 190793.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2021-12-31" />
          <target value="90">
            <comment>
              <narrative>Numerator: 205502; Denominator: 228336.</narrative>
            </comment>
          </target>
          <actual value="86.4">
            <comment>
              <narrative>Numerator: 86953; Denominator: 100606.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-12-31" />
          <target value="90">
            <comment>
              <narrative>Numerator: 423544; Denominator: 470604.</narrative>
            </comment>
          </target>
          <actual value="83.3">
            <comment>
              <narrative>Numerator: 229490; Denominator: 275603.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-06-30" />
          <target value="90">
            <comment>
              <narrative>Numerator: 211772; Denominator: 235302.</narrative>
            </comment>
          </target>
          <actual value="89.1">
            <comment>
              <narrative>Numerator: 106789; Denominator: 119789.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2022-12-31" />
          <target value="90">
            <comment>
              <narrative>Numerator: 211772; Denominator: 235302.</narrative>
            </comment>
          </target>
          <actual value="78.7">
            <comment>
              <narrative>Numerator: 122701; Denominator: 155814.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target value="90">
            <comment>
              <narrative>Numerator: 443994; Denominator: 493326.</narrative>
            </comment>
          </target>
          <actual value="76.9">
            <comment>
              <narrative>Numerator: 397730; Denominator: 517339.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-06-30" />
          <target value="90">
            <comment>
              <narrative>Numerator: 221997; Denominator: 246663.</narrative>
            </comment>
          </target>
          <actual value="79.3">
            <comment>
              <narrative>Numerator: 174633; Denominator: 220305.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2023-12-31" />
          <target value="90">
            <comment>
              <narrative>Numerator: 221997; Denominator: 246663.</narrative>
            </comment>
          </target>
          <actual value="75.1">
            <comment>
              <narrative>Numerator: 223097; Denominator: 297034.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of HIV-positive new and relapse TB patients on ART during TB treatment</narrative>
      </title>
      <description>
        <narrative>Module: TB/HIV.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of HIV-positive new and relapse TB patients on ART during TB treatment</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2018" iso-date="2018-12-31" value="95.78">
          <comment>
            <narrative>Numerator: 1134; Denominator: 1184.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 2982; Denominator: 2982.</narrative>
            </comment>
          </target>
          <actual value="96.9">
            <comment>
              <narrative>Numerator: 1326; Denominator: 1368.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-06-30" />
          <target value="100">
            <comment>
              <narrative>Numerator: 1491; Denominator: 1491.</narrative>
            </comment>
          </target>
          <actual value="97.2">
            <comment>
              <narrative>Numerator: 700; Denominator: 720.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2021-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 1491; Denominator: 1491.</narrative>
            </comment>
          </target>
          <actual value="96.6">
            <comment>
              <narrative>Numerator: 626; Denominator: 648.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 3908; Denominator: 3908.</narrative>
            </comment>
          </target>
          <actual value="98.2">
            <comment>
              <narrative>Numerator: 1967; Denominator: 2003.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-06-30" />
          <target value="100">
            <comment>
              <narrative>Numerator: 1954; Denominator: 1954.</narrative>
            </comment>
          </target>
          <actual value="97.7">
            <comment>
              <narrative>Numerator: 795; Denominator: 814.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2022-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 1954; Denominator: 1954.</narrative>
            </comment>
          </target>
          <actual value="98.6">
            <comment>
              <narrative>Numerator: 1172; Denominator: 1189.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-06-30" />
          <target value="100">
            <comment>
              <narrative>Numerator: 2110; Denominator: 2110.</narrative>
            </comment>
          </target>
          <actual value="98.7">
            <comment>
              <narrative>Numerator: 1253; Denominator: 1270.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 4220; Denominator: 4220.</narrative>
            </comment>
          </target>
          <actual value="98.8">
            <comment>
              <narrative>Numerator: 2484; Denominator: 2514.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2023-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 2110; Denominator: 2110.</narrative>
            </comment>
          </target>
          <actual value="99">
            <comment>
              <narrative>Numerator: 1231; Denominator: 1244.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of PLHIV on ART who initiated TB preventive therapy among those eligible during the reporting period</narrative>
      </title>
      <description>
        <narrative>Module: TB/HIV.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of PLHIV on ART who initiated TB preventive therapy among those eligible during the reporting period</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2018" iso-date="2018-12-31" value="52" />
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-06-30" />
          <target value="70">
            <comment>
              <narrative>Numerator: 2601; Denominator: 3715.</narrative>
            </comment>
          </target>
          <actual value="63.9">
            <comment>
              <narrative>Numerator: 2161; Denominator: 3381.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-12-31" />
          <target value="70">
            <comment>
              <narrative>Numerator: 5202; Denominator: 7430.</narrative>
            </comment>
          </target>
          <actual value="65.6">
            <comment>
              <narrative>Numerator: 4989; Denominator: 7601.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2021-12-31" />
          <target value="70">
            <comment>
              <narrative>Numerator: 2601; Denominator: 3715.</narrative>
            </comment>
          </target>
          <actual value="67">
            <comment>
              <narrative>Numerator: 2828; Denominator: 4220.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-12-31" />
          <target value="75">
            <comment>
              <narrative>Numerator: 8362; Denominator: 11150.</narrative>
            </comment>
          </target>
          <actual value="70.5">
            <comment>
              <narrative>Numerator: 6903; Denominator: 9793.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-06-30" />
          <target value="75">
            <comment>
              <narrative>Numerator: 4181; Denominator: 5575.</narrative>
            </comment>
          </target>
          <actual value="66.9">
            <comment>
              <narrative>Numerator: 3213; Denominator: 4803.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2022-12-31" />
          <target value="75">
            <comment>
              <narrative>Numerator: 4181; Denominator: 5575.</narrative>
            </comment>
          </target>
          <actual value="73.9">
            <comment>
              <narrative>Numerator: 3690; Denominator: 4990.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-06-30" />
          <target value="80.01">
            <comment>
              <narrative>Numerator: 5243; Denominator: 6553.</narrative>
            </comment>
          </target>
          <actual value="75.1">
            <comment>
              <narrative>Numerator: 4109; Denominator: 5471.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target value="80">
            <comment>
              <narrative>Numerator: 10486; Denominator: 13106.</narrative>
            </comment>
          </target>
          <actual value="76.1">
            <comment>
              <narrative>Numerator: 8070; Denominator: 10611.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2023-12-31" />
          <target value="80.01">
            <comment>
              <narrative>Numerator: 5243; Denominator: 6553.</narrative>
            </comment>
          </target>
          <actual value="77.1">
            <comment>
              <narrative>Numerator: 3961; Denominator: 5140.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of registered new and relapse TB patients with documented HIV status</narrative>
      </title>
      <description>
        <narrative>Module: TB/HIV.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of registered new and relapse TB patients with documented HIV status</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2018" iso-date="2018-12-31" value="27">
          <comment>
            <narrative>Numerator: 100350.36; Denominator: 371668.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-12-31" />
          <target value="54">
            <comment>
              <narrative>Numerator: 178904; Denominator: 331306.</narrative>
            </comment>
          </target>
          <actual value="47.1">
            <comment>
              <narrative>Numerator: 102830; Denominator: 218124.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-06-30" />
          <target value="54">
            <comment>
              <narrative>Numerator: 89452; Denominator: 165653.</narrative>
            </comment>
          </target>
          <actual value="45.8">
            <comment>
              <narrative>Numerator: 48639; Denominator: 106266.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2021-12-31" />
          <target value="54">
            <comment>
              <narrative>Numerator: 89452; Denominator: 165653.</narrative>
            </comment>
          </target>
          <actual value="48.4">
            <comment>
              <narrative>Numerator: 54191; Denominator: 111858.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-12-31" />
          <target value="72">
            <comment>
              <narrative>Numerator: 234428; Denominator: 325594.</narrative>
            </comment>
          </target>
          <actual value="72">
            <comment>
              <narrative>Numerator: 236108; Denominator: 328086.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-06-30" />
          <target value="72">
            <comment>
              <narrative>Numerator: 117214; Denominator: 162797.</narrative>
            </comment>
          </target>
          <actual value="61.6">
            <comment>
              <narrative>Numerator: 83875; Denominator: 136132.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2022-12-31" />
          <target value="72">
            <comment>
              <narrative>Numerator: 117214; Denominator: 162797.</narrative>
            </comment>
          </target>
          <actual value="79.3">
            <comment>
              <narrative>Numerator: 152233; Denominator: 191954.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-06-30" />
          <target value="90">
            <comment>
              <narrative>Numerator: 140626; Denominator: 156251.</narrative>
            </comment>
          </target>
          <actual value="90.3">
            <comment>
              <narrative>Numerator: 176662; Denominator: 195699.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target value="90">
            <comment>
              <narrative>Numerator: 281252; Denominator: 312502.</narrative>
            </comment>
          </target>
          <actual value="92.3">
            <comment>
              <narrative>Numerator: 365306; Denominator: 395804.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2023-12-31" />
          <target value="90">
            <comment>
              <narrative>Numerator: 140626; Denominator: 156251.</narrative>
            </comment>
          </target>
          <actual value="94.3">
            <comment>
              <narrative>Numerator: 188644; Denominator: 200105.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
  </iati-activity>
  <iati-activity last-updated-datetime="2026-11-09T09:21:46+00:00" xml:lang="en" default-currency="USD" humanitarian="0" hierarchy="1">
    <iati-identifier>47045-PHL-T-PBSP-4</iati-identifier>
    <reporting-org ref="47045" type="30">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </reporting-org>
    <title>
      <narrative>Advancing Client-centered Care and Expanding Sustainable Services for TB (ACCESS TB) Project - Philippines (01-Jan-2024-31-Dec-2026)</narrative>
    </title>
    <description type="1">
      <narrative>Philippines, Tuberculosis, Philippine Business for Social Progress, Inc.</narrative>
    </description>
    <description type="2">
      <narrative>Goals: Decrease TB deaths by 50% from 54 in 2021 to 27 in 2026; Reduce TB catastrophic cost from 42% in 2017 to 0% in 2026; Achieve 90% patient satisfaction for TB services received. Objectives: Achieve 88% treatment success rate for all forms TB by 2026; Achieve 79% treatment coverage for all forms of TB by 2026.</narrative>
    </description>
    <participating-org ref="47045" type="30" role="1" crs-channel-code="47045">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </participating-org>
    <participating-org type="24" role="2" crs-channel-code="23000">
      <narrative>Philippine Business for Social Progress, Inc.</narrative>
    </participating-org>
    <participating-org type="24" role="4" crs-channel-code="23000">
      <narrative>Philippine Business for Social Progress, Inc.</narrative>
    </participating-org>
    <other-identifier ref="PHL-T-PBSPP04" type="A1">
      <owner-org ref="47045">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </owner-org>
    </other-identifier>
    <activity-status code="2" />
    <activity-date type="1" iso-date="2024-01-01" />
    <activity-date type="2" iso-date="2024-01-01" />
    <activity-date type="3" iso-date="2026-12-31" />
    <contact-info type="1">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Communications</narrative>
      </department>
      <telephone>+41 58 791 1700</telephone>
      <email>website@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <contact-info type="2">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Grant Management Division</narrative>
      </department>
      <person-name>
        <narrative>xxxx xxxx</narrative>
      </person-name>
      <job-title>
        <narrative>Fund Portfolio Manager</narrative>
      </job-title>
      <telephone>+41 58 791 1700</telephone>
      <email>xxxx</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <activity-scope code="4" />
    <recipient-country code="PH" percentage="100">
      <narrative>Philippines</narrative>
    </recipient-country>
    <sector vocabulary="1" code="12263" percentage="79.95">
      <narrative>Tuberculosis</narrative>
    </sector>
    <sector vocabulary="1" code="12110" percentage="20.05">
      <narrative>Multicomponent, RSSH</narrative>
    </sector>
    <tag vocabulary="2" code="3">
      <narrative>Ensure healthy lives and promote well-being for all at all ages</narrative>
    </tag>
    <tag vocabulary="3" code="3.3">
      <narrative>End the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases, and combat hepatitis, water-borne diseases and other communicable diseases</narrative>
    </tag>
    <tag vocabulary="3" code="3.8">
      <narrative>Achieve universal health coverage</narrative>
    </tag>
    <country-budget-items vocabulary="4">
      <budget-item code="43337786-bfab-487f-b388-9fbe8808948d" percentage="11.65">
        <description>
          <narrative>Multicomponent -&gt; Program management -&gt; Grant management</narrative>
        </description>
      </budget-item>
      <budget-item code="80d429dc-894d-4f0c-99cc-2403b8f1f5fe" percentage="0.02">
        <description>
          <narrative>RSSH -&gt; RSSH/PP: Human resources for health (HRH) and quality of care -&gt; RSSH/PP: HRH planning, management and governance including for community health workers (CHWs)</narrative>
        </description>
      </budget-item>
      <budget-item code="a964bfef-7776-4f8c-bf11-c2f904336a18" percentage="3.03">
        <description>
          <narrative>RSSH -&gt; RSSH/PP: Laboratory systems (including national and peripheral) -&gt; RSSH/PP: Specimen referral and transport system</narrative>
        </description>
      </budget-item>
      <budget-item code="7dbf6454-4357-4937-89a1-9a1c7f0174fa" percentage="1.08">
        <description>
          <narrative>RSSH -&gt; RSSH: Community systems strengthening -&gt; Community engagement, linkages and coordination</narrative>
        </description>
      </budget-item>
      <budget-item code="8c042996-0cb7-4540-ad17-483cf18ec784" percentage="0.29">
        <description>
          <narrative>RSSH -&gt; RSSH: Community systems strengthening -&gt; Community-led monitoring</narrative>
        </description>
      </budget-item>
      <budget-item code="12d82614-1fc1-4696-b954-b899115b31d9" percentage="0.01">
        <description>
          <narrative>RSSH -&gt; RSSH: Community systems strengthening -&gt; Community-led research and advocacy</narrative>
        </description>
      </budget-item>
      <budget-item code="4f5c256c-b6d1-40ea-9bd7-f061f042bc98" percentage="0.06">
        <description>
          <narrative>RSSH -&gt; RSSH: Health financing systems -&gt; Health financing strategies and planning</narrative>
        </description>
      </budget-item>
      <budget-item code="78165abf-6e6d-46ad-b445-d380c1037123" percentage="0.08">
        <description>
          <narrative>RSSH -&gt; RSSH: Health products management systems -&gt; Policy, strategy, governance</narrative>
        </description>
      </budget-item>
      <budget-item code="31d3a0e8-e9f1-4c88-b1b7-ce75b4e952eb" percentage="0.66">
        <description>
          <narrative>RSSH -&gt; RSSH: Health products management systems -&gt; Storage and distribution capacity, design &amp; operations</narrative>
        </description>
      </budget-item>
      <budget-item code="0e90e07b-37cc-4294-9a44-c1afd707a824" percentage="0.32">
        <description>
          <narrative>RSSH -&gt; RSSH: Health sector planning and governance for integrated people-centered services -&gt; Integration/coordination across disease programs and at the service delivery level</narrative>
        </description>
      </budget-item>
      <budget-item code="69e672f0-6d26-46e7-8e97-fcb0b6526cb4" percentage="0.58">
        <description>
          <narrative>RSSH -&gt; RSSH: Health sector planning and governance for integrated people-centered services -&gt; National health sector strategy, policy &amp; regulations</narrative>
        </description>
      </budget-item>
      <budget-item code="42e7a4b3-fa75-4c16-8a4d-110492b156f4" percentage="1.76">
        <description>
          <narrative>RSSH -&gt; RSSH: Monitoring and evaluation systems -&gt; Routine reporting</narrative>
        </description>
      </budget-item>
      <budget-item code="1a5ab4c7-9695-4567-adb4-0a3768fa01ee" percentage="0.51">
        <description>
          <narrative>RSSH -&gt; RSSH: Monitoring and evaluation systems -&gt; Surveys</narrative>
        </description>
      </budget-item>
      <budget-item code="95211519-fdf1-4ae4-964d-27e8afa798cf" percentage="0.47">
        <description>
          <narrative>Tuberculosis -&gt; Collaboration with other providers and sectors -&gt; Community-based TB/DR-TB care</narrative>
        </description>
      </budget-item>
      <budget-item code="1da38701-f878-40c8-aeaf-621a89991324" percentage="8.19">
        <description>
          <narrative>Tuberculosis -&gt; Collaboration with other providers and sectors -&gt; Private provider engagement in TB/DR-TB care</narrative>
        </description>
      </budget-item>
      <budget-item code="ea39b4f6-cd94-4310-b181-394f794f9144" percentage="6.77">
        <description>
          <narrative>Tuberculosis -&gt; Drug-resistant (DR)-TB diagnosis, treatment and care -&gt; DR-TB diagnosis/drug susceptibility testing (DST)</narrative>
        </description>
      </budget-item>
      <budget-item code="5b20da70-c625-405c-858b-6de52626ae46" percentage="26.07">
        <description>
          <narrative>Tuberculosis -&gt; Drug-resistant (DR)-TB diagnosis, treatment and care -&gt; DR-TB treatment, care and support</narrative>
        </description>
      </budget-item>
      <budget-item code="03989069-d574-46fc-9fad-200e03cde744" percentage="0.31">
        <description>
          <narrative>Tuberculosis -&gt; Key and vulnerable populations (KVP) - TB/DR-TB -&gt; KVP - Others</narrative>
        </description>
      </budget-item>
      <budget-item code="99e62de4-459a-4fc3-a5da-f5297d23736d" percentage="2.91">
        <description>
          <narrative>Tuberculosis -&gt; Key and vulnerable populations (KVP) - TB/DR-TB -&gt; KVP - People in prisons/jails/detention centers</narrative>
        </description>
      </budget-item>
      <budget-item code="8d2f8312-6339-4e40-9c64-84e09bb628b3" percentage="25.35">
        <description>
          <narrative>Tuberculosis -&gt; Key and vulnerable populations (KVP) - TB/DR-TB -&gt; KVP - Urban poor/slum dwellers</narrative>
        </description>
      </budget-item>
      <budget-item code="23608000-3108-4c67-92d0-b1a31eb68b3f" percentage="0">
        <description>
          <narrative>Tuberculosis -&gt; Removing human rights and gender related barriers to TB services -&gt; Eliminating TB-related stigma and discrimination</narrative>
        </description>
      </budget-item>
      <budget-item code="a690df09-3265-4854-a83c-e358df086817" percentage="0">
        <description>
          <narrative>Tuberculosis -&gt; Removing human rights and gender related barriers to TB services -&gt; Ensuring people-centered and rights-based law enforcement practices</narrative>
        </description>
      </budget-item>
      <budget-item code="4cd951bf-504b-4a56-bbf4-1300accaaa5d" percentage="0.08">
        <description>
          <narrative>Tuberculosis -&gt; Removing human rights and gender related barriers to TB services -&gt; Increasing access to justice (TB)</narrative>
        </description>
      </budget-item>
      <budget-item code="2f74d6d7-267e-4393-87f1-d47588e1025c" percentage="0">
        <description>
          <narrative>Tuberculosis -&gt; Removing human rights and gender related barriers to TB services -&gt; Monitoring and reforming policies, regulations and laws</narrative>
        </description>
      </budget-item>
      <budget-item code="003bd5ec-d813-43cd-9bae-ec060870a2c4" percentage="4.87">
        <description>
          <narrative>Tuberculosis -&gt; TB diagnosis, treatment and care -&gt; TB treatment, care and support</narrative>
        </description>
      </budget-item>
      <budget-item code="897b3d08-9a6f-4d26-89e2-f762e49dad11" percentage="2.66">
        <description>
          <narrative>Tuberculosis -&gt; TB/DR-TB Prevention -&gt; Preventive treatment</narrative>
        </description>
      </budget-item>
      <budget-item code="8f363382-1b81-4d2d-a396-2be1435016f2" percentage="1.64">
        <description>
          <narrative>Tuberculosis -&gt; TB/HIV -&gt; TB/HIV - Collaborative interventions</narrative>
        </description>
      </budget-item>
      <budget-item code="602586f6-9a77-484c-bf39-acc8a3151170" percentage="0.25">
        <description>
          <narrative>Tuberculosis -&gt; TB/HIV -&gt; TB/HIV - Prevention</narrative>
        </description>
      </budget-item>
      <budget-item code="7c7a7505-bdfe-4146-976c-78a03ca0d545" percentage="0.38">
        <description>
          <narrative>Tuberculosis -&gt; TB/HIV -&gt; TB/HIV - Screening, testing and diagnosis</narrative>
        </description>
      </budget-item>
    </country-budget-items>
    <collaboration-type code="1" />
    <default-flow-type code="10" />
    <default-finance-type code="110" />
    <default-aid-type code="C01" vocabulary="1" />
    <default-tied-status code="5" />
    <budget type="2" status="2">
      <period-start iso-date="2024-01-01" />
      <period-end iso-date="2024-12-31" />
      <value currency="USD" value-date="2024-01-01">38724512.92</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2025-01-01" />
      <period-end iso-date="2025-12-31" />
      <value currency="USD" value-date="2025-01-01">46310998.93</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2026-01-01" />
      <period-end iso-date="2026-12-31" />
      <value currency="USD" value-date="2026-01-01">35032542.63</value>
    </budget>
    <capital-spend percentage="3.19" />
    <transaction ref="cfc574d7-1044-4cfc-b253-b21e19785980">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-11-24" />
      <value currency="USD" value-date="2023-11-24">63796257.87</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="ec6ad978-05e7-4624-b145-40af9c858eee">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-11-28" />
      <value currency="USD" value-date="2023-11-28">2969671.36</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP04 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="c4aed19d-2418-4da8-96f7-b6243d64ba0a">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-12-07" />
      <value currency="USD" value-date="2023-12-07">11528792.60</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP04 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="507ec2a5-04b5-4b26-9b6b-b6b303974179">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-02-22" />
      <value currency="USD" value-date="2024-02-22">31923.43</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP04 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="e6600711-d653-4ba1-bd84-4a3abf405600">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-05-08" />
      <value currency="USD" value-date="2024-05-08">6523535.41</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP04 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="a2614c38-f37b-4128-b483-79592a1d5098">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-07-23" />
      <value currency="USD" value-date="2024-07-23">6497686.95</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP04 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="498c0882-a229-4411-a7c2-50f83ad00221">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-08-06" />
      <value currency="USD" value-date="2024-08-06">5815245.51</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP04 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="3d7ca4a8-75d5-45d7-be16-afe79e14d997">
      <transaction-type code="7" />
      <transaction-date iso-date="2024-09-01" />
      <value currency="USD" value-date="2024-09-01">5428.33</value>
      <description>
        <narrative>Funds returned to the Global Fund from PHL-T-PBSPP04 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="d4419f64-19d6-4e7d-a0ed-465050a9829e">
      <transaction-type code="7" />
      <transaction-date iso-date="2024-09-01" />
      <value currency="USD" value-date="2024-09-01">4394.78</value>
      <description>
        <narrative>Funds returned to the Global Fund from PHL-T-PBSPP04 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="e84fff5d-d66a-4213-9d6f-85a933879df5">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-09-21" />
      <value currency="USD" value-date="2024-09-21">70208.35</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="900d575c-8055-4828-8154-91449febd88d">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-09-24" />
      <value currency="USD" value-date="2024-09-24">-5428.33</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="f9f14b68-dde2-4ff6-86b6-9b8f51c6ab8f">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-09-26" />
      <value currency="USD" value-date="2024-09-26">6157001.68</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP04 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="f4e8d016-4a43-44c4-af5d-5abb4eabe15c">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-09-27" />
      <value currency="USD" value-date="2024-09-27">-4394.78</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="7859c2e2-249c-4be0-8957-3aaea1c41139">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-10-01" />
      <value currency="USD" value-date="2024-10-01">388157.49</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="ceebeaca-00cf-458b-8ae6-e4f27cfdc0d2">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-10-01" />
      <value currency="USD" value-date="2024-10-01">-70208.35</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="8e2688ed-25eb-4609-a09e-b287ebdbf6c0">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-10-17" />
      <value currency="USD" value-date="2024-10-17">126942.49</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP04 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="0a1e7eb8-e15a-4d3c-a383-0a4df1ab144f">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-11-28" />
      <value currency="USD" value-date="2024-11-28">9233884.71</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP04 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="7899f3e4-de0b-4009-aadf-cb519609fd27">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-02-04" />
      <value currency="USD" value-date="2025-02-04">1697.36</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP04 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="93f077c0-b832-45b2-9acd-022f0771e0b2">
      <transaction-type code="7" />
      <transaction-date iso-date="2025-03-01" />
      <value currency="USD" value-date="2025-03-01">75956.96</value>
      <description>
        <narrative>Funds returned to the Global Fund from PHL-T-PBSPP04 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="4f46f51b-5041-4ec6-83a6-cd466664cd1a">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-03-04" />
      <value currency="USD" value-date="2025-03-04">2512401.26</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP04 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="40ff6bdd-91f1-4973-9b4e-8413c4a58fe5">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-03-18" />
      <value currency="USD" value-date="2025-03-18">8295185.88</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP04 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="75ae438c-8078-4b9f-a09c-a1aa4b623d5e">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-03-20" />
      <value currency="USD" value-date="2025-03-20">9137.01</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP04 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="1e1e29b0-1a90-4df9-a604-92bc80badfa1">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-03-26" />
      <value currency="USD" value-date="2025-03-26">-75956.96</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="b9674eb9-c595-4739-9c3e-975ea8f257f9">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-04-01" />
      <value currency="USD" value-date="2025-04-01">10130.53</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP04 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="a13ecbb9-271f-4a6e-bb43-0dba00974b39">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-05-28" />
      <value currency="USD" value-date="2025-05-28">-89.07</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="a5145ce7-2320-4c62-9b14-deab78e29d68">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-05-28" />
      <value currency="USD" value-date="2025-05-28">240339.17</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="afe21bde-f79b-4598-bfb5-4b73e1709820">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-05-28" />
      <value currency="USD" value-date="2025-05-28">-240250.10</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="fd13bc10-b5d1-4218-a446-24b0ac423aac">
      <transaction-type code="7" />
      <transaction-date iso-date="2025-06-01" />
      <value currency="USD" value-date="2025-06-01">1540.78</value>
      <description>
        <narrative>Funds returned to the Global Fund from PHL-T-PBSPP04 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="7bcfe320-687a-4fec-8689-546096fbfeed">
      <transaction-type code="7" />
      <transaction-date iso-date="2025-06-05" />
      <value currency="USD" value-date="2025-06-05">89.07</value>
      <description>
        <narrative>Funds returned to the Global Fund from PHL-T-PBSPP04 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="ed2dbb36-a286-489c-8c25-e4fe4045726b">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-06-06" />
      <value currency="USD" value-date="2025-06-06">-1540.78</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="40163c1f-b745-42e4-9ef6-66ff460613ce">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-06-27" />
      <value currency="USD" value-date="2025-06-27">3662477.00</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="7191cb90-905e-4b29-afbd-5010b317533a">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-06-30" />
      <value currency="USD" value-date="2025-06-30">3662477.00</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP04 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="d8370936-5582-4181-aa32-40cbdf0284ef">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-07-01" />
      <value currency="USD" value-date="2025-07-01">126276.13</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP04 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="dce95e9a-9dba-4b16-85a8-60bce083ef88">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-07-01" />
      <value currency="USD" value-date="2025-07-01">1576.26</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP04 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="8973c26f-d126-4997-9ae5-b344de26fc01">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-07-01" />
      <value currency="USD" value-date="2025-07-01">23743565.00</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="8d3425ee-703c-4952-b432-6adea65b7700">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-07-01" />
      <value currency="USD" value-date="2025-07-01">-4230929.08</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="1a24c8f3-01b3-429d-8c98-717a9752557f">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-07-14" />
      <value currency="USD" value-date="2025-07-14">61456.90</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="269b22d8-2ff7-4b22-a9bc-a311a3ef478c">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-07-14" />
      <value currency="USD" value-date="2025-07-14">-112486.78</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="fe211d94-0930-4e14-9be0-6410d525d8a7">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-07-22" />
      <value currency="USD" value-date="2025-07-22">7410557.00</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP04 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="8735cce1-5de8-45c4-a47c-94380964bd01">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-08-16" />
      <value currency="USD" value-date="2025-08-16">-61456.90</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="afbe47fb-fa18-4ba3-ab71-2e6e77ecbcaa">
      <transaction-type code="7" />
      <transaction-date iso-date="2025-09-01" />
      <value currency="USD" value-date="2025-09-01">127479.79</value>
      <description>
        <narrative>Funds returned to the Global Fund from PHL-T-PBSPP04 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="1ac44518-a722-4f5e-8dc9-4e79fa256688">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-09-10" />
      <value currency="USD" value-date="2025-09-10">-127479.79</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="aef21ae0-dc54-4d0c-96bf-4e0273c67089">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-09-23" />
      <value currency="USD" value-date="2025-09-23">474063.74</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP04 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="40b3e962-3b4f-4a13-886f-a29371d86783">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-10-01" />
      <value currency="USD" value-date="2025-10-01">8173799.98</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP04 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="b03d6ac5-6360-4ea6-98ad-055c49a7156a">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-10-21" />
      <value currency="USD" value-date="2025-10-21">7791.45</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP04 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="7bdcbb9e-d3e4-478f-9637-3efdfacb01f2">
      <transaction-type code="7" />
      <transaction-date iso-date="2025-12-10" />
      <value currency="USD" value-date="2025-12-10">250085.05</value>
      <description>
        <narrative>Funds returned to the Global Fund from PHL-T-PBSPP04 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="7fd9ba40-fae4-46b0-a89c-d96eeab73fe1">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-12-18" />
      <value currency="USD" value-date="2025-12-18">-250085.05</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="1b3fbb74-9878-4743-a741-e46be54254c1">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-12-19" />
      <value currency="USD" value-date="2025-12-19">27018.60</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="4c75aec2-dc6b-492c-a99a-d2f63e9c9e20">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-01-13" />
      <value currency="USD" value-date="2026-01-13">17292.97</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP04 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="ebea7abc-c303-41be-9c56-9eefa7bf4155">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-01-13" />
      <value currency="USD" value-date="2026-01-13">9725.63</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP04 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="c07374d6-6108-4682-9f89-f54364a40492">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-01-27" />
      <value currency="USD" value-date="2026-01-27">11850.06</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="52c110b1-488c-4e7d-a51e-dd49ba98752a">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-01-29" />
      <value currency="USD" value-date="2026-01-29">-7677352.83</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="5c680a1e-81ed-4c26-88ff-b0cbfa6da54c">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-01-29" />
      <value currency="USD" value-date="2026-01-29">35885673.10</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="34e573e4-74e0-4a19-a668-8980a06181b7">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-02-03" />
      <value currency="USD" value-date="2026-02-03">8741075.82</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP04 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="bd6c4e7f-8987-4807-b4fb-3954c483623b">
      <transaction-type code="7" />
      <transaction-date iso-date="2026-03-01" />
      <value currency="USD" value-date="2026-03-01">167723.74</value>
      <description>
        <narrative>Funds returned to the Global Fund from PHL-T-PBSPP04 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="a301ca13-1966-444b-990d-c952cb84715b">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-03-12" />
      <value currency="USD" value-date="2026-03-12">-167723.74</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="fba8ca2f-a744-4da1-b08d-3ed5965d3e94">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-04-08" />
      <value currency="USD" value-date="2026-04-08">611600.00</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="e00fa2cd-6b7c-41bd-ae48-702cf36ee74c">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-04-21" />
      <value currency="USD" value-date="2026-04-21">2768982.03</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP04 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="69f12f48-a729-49c0-b4a7-3169056127b2">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-04-28" />
      <value currency="USD" value-date="2026-04-28">17813.03</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="7306bd95-8712-4341-8315-470c2f206afe">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-04-28" />
      <value currency="USD" value-date="2026-04-28">-11850.06</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="eaec7f49-35f9-428b-90ae-6482fb41c458">
      <transaction-type code="7" />
      <transaction-date iso-date="2026-06-01" />
      <value currency="USD" value-date="2026-06-01">102273.37</value>
      <description>
        <narrative>Funds returned to the Global Fund from PHL-T-PBSPP04 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="ace9085e-9ea8-4c03-950c-0addeca12436">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-06-03" />
      <value currency="USD" value-date="2026-06-03">1581572.34</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP04 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="cfa74c74-e66b-4ec3-b9a2-88d9814dd35d">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-06-03" />
      <value currency="USD" value-date="2026-06-03">1000000.00</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP04 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="4b7d0a94-cbc5-40ca-9cac-6bbf1b8fd2ff">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-06-04" />
      <value currency="USD" value-date="2026-06-04">-17813.03</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="cda3031d-ad84-4973-adda-ffbffa5650fb">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-06-04" />
      <value currency="USD" value-date="2026-06-04">311560.87</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="8eb148d8-fc40-4628-aba2-a73180da4c30">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-06-08" />
      <value currency="USD" value-date="2026-06-08">-102273.37</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="078b45d5-f632-400a-885a-14748463c043">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-06-09" />
      <value currency="USD" value-date="2026-06-09">7500000.00</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP04 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="7145ff67-4998-4dc3-8d1a-141d80a1d4ea">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-07-01" />
      <value currency="USD" value-date="2026-07-01">52867.79</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP04 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="b18f2a09-a188-4f13-ae08-1ce2cd1e677e">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-07-14" />
      <value currency="USD" value-date="2026-07-14">109619.04</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP04 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="0fc0c5e6-2306-45e1-b2e6-ed572e7ff3af">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-07-15" />
      <value currency="USD" value-date="2026-07-15">195978.86</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="3c899842-b5bc-4f8a-bfaf-1062a01dd25f">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-07-15" />
      <value currency="USD" value-date="2026-07-15">-201941.83</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="cd4adc1e-f805-48bc-b41a-804d22d98c56">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-07-28" />
      <value currency="USD" value-date="2026-07-28">109619.03</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP04 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="8a95c0c6-55cd-42d1-abbf-ea976a1edf6d">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-08-04" />
      <value currency="USD" value-date="2026-08-04">7850000.00</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP04 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="4819db99-f73f-42de-a1bc-4833b415f029">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-08-04" />
      <value currency="USD" value-date="2026-08-04">-611600.00</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="9534c970-0b14-473a-a09a-0585520911c8">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-08-04" />
      <value currency="USD" value-date="2026-08-04">618189.44</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="ea6ca658-efb9-4a1d-a527-fae7fdde5b60">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-08-11" />
      <value currency="USD" value-date="2026-08-11">52997.88</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP04 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="49bbc260-8914-4df5-b110-967c1a09f1b6">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-08-14" />
      <value currency="USD" value-date="2026-08-14">-618189.44</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="c08fd4bc-461b-4cb9-a2e1-3dcccea0e99b">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-08-14" />
      <value currency="USD" value-date="2026-08-14">1880676.90</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="58d12212-42f6-474e-aef7-bbd7c802cd89">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-08-25" />
      <value currency="USD" value-date="2026-08-25">227700.00</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP04 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="2908a5f5-8a6e-4a54-a26e-ec36387525db">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-08-27" />
      <value currency="USD" value-date="2026-08-27">-86359.83</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="b9109d67-161a-4d89-a67f-bb8b8300f0a6">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-08-27" />
      <value currency="USD" value-date="2026-08-27">94559.83</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="b987abfd-0616-4e03-bef2-cea1de8e80c0">
      <transaction-type code="7" />
      <transaction-date iso-date="2026-09-01" />
      <value currency="USD" value-date="2026-09-01">765.19</value>
      <description>
        <narrative>Funds returned to the Global Fund from PHL-T-PBSPP04 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="280d2961-7eb9-4c67-b3fb-72014bb43b5a">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-09-09" />
      <value currency="USD" value-date="2026-09-09">-765.19</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="8bc48783-2372-4933-b224-d4badaac6d61">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-09-29" />
      <value currency="USD" value-date="2026-09-29">1000000.00</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP04 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="0e741074-a3fc-4ce5-9b8e-853e07026f13">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-10-06" />
      <value currency="USD" value-date="2026-10-06">1284.29</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP04 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="05b5fe53-f544-464c-a348-2de7f46a2893">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-10-08" />
      <value currency="USD" value-date="2026-10-08">-109619.04</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="aa531bbc-3124-4d86-ac6e-cdfd2693e8e1">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-10-08" />
      <value currency="USD" value-date="2026-10-08">202894.58</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="ba3f0116-cdd5-4a16-8c78-1dcd25fc95f7">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-10-08" />
      <value currency="USD" value-date="2026-10-08">-93275.54</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="0eec9d09-3fd6-4d9f-8c62-8871c52dc45b">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-10-09" />
      <value currency="USD" value-date="2026-10-09">-202894.58</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="5eb88689-050d-4aaf-b89e-7e7ea66fde11">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-10-09" />
      <value currency="USD" value-date="2026-10-09">-109619.03</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="e85e9fb8-4afd-4570-b9d5-3596dd88c746">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-10-09" />
      <value currency="USD" value-date="2026-10-09">312513.61</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="aa3b06a1-b738-4ea4-8f4c-99294c075e4b">
      <transaction-type code="7" />
      <transaction-date iso-date="2026-10-14" />
      <value currency="USD" value-date="2026-10-14">109619.04</value>
      <description>
        <narrative>Funds returned to the Global Fund from PHL-T-PBSPP04 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="c0e63582-4c76-4ff6-8f62-cb62551e8ece">
      <transaction-type code="7" />
      <transaction-date iso-date="2026-10-14" />
      <value currency="USD" value-date="2026-10-14">109619.03</value>
      <description>
        <narrative>Funds returned to the Global Fund from PHL-T-PBSPP04 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="06a9afdf-def4-474c-a507-9bbf21c1e7b1">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-10-15" />
      <value currency="USD" value-date="2026-10-15">96747.45</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP04 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="e8f4fb15-3698-440c-8ae3-9585a24e24a5">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-10-15" />
      <value currency="USD" value-date="2026-10-15">96747.45</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP04 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="62e9747b-f62d-4807-a591-da23d996cc51">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-11-04" />
      <value currency="USD" value-date="2026-11-04">-312513.61</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="77a141b1-8b27-4d81-b300-c9bcba06a0b6">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-11-04" />
      <value currency="USD" value-date="2026-11-04">213544.96</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="PHL-T-PBSPP04-EXP-20241231">
      <transaction-type code="4" />
      <transaction-date iso-date="2024-12-31" />
      <value currency="USD" value-date="2024-12-31">37876038.95</value>
      <description>
        <narrative>Expenditure reported by Philippine Business for Social Progress, Inc. for PHL-T-PBSPP04, Jan 2024 to Dec 2024.</narrative>
      </description>
      <provider-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </provider-org>
    </transaction>
    <transaction ref="PHL-T-PBSPP04-EXP-20251231">
      <transaction-type code="4" />
      <transaction-date iso-date="2025-12-31" />
      <value currency="USD" value-date="2025-12-31">36763457.46</value>
      <description>
        <narrative>Expenditure reported by Philippine Business for Social Progress, Inc. for PHL-T-PBSPP04, Jan 2025 to Dec 2025.</narrative>
      </description>
      <provider-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </provider-org>
    </transaction>
    <document-link url="https://data.theglobalfund.org/grant/PHL-T-PBSP" format="text/html">
      <title>
        <narrative>Grant page on the data explorer of the Global Fund.</narrative>
      </title>
      <description>
        <narrative>An overview of a grant over its lifetime.</narrative>
      </description>
      <category code="A12" />
      <category code="A01" />
      <category code="A02" />
      <category code="A05" />
      <category code="A07" />
      <category code="A08" />
      <language code="en" />
      <document-date iso-date="2026-11-09" />
    </document-link>
    <document-link url="https://www.theglobalfund.org/media/13342/core_grantregulationsversiontwo_regulations_en.pdf" format="application/pdf">
      <title>
        <narrative>Grant terms and conditions.</narrative>
      </title>
      <description>
        <narrative>General terms and conditions which apply to Global Fund grants.</narrative>
      </description>
      <category code="A04" />
      <language code="en" />
    </document-link>
    <document-link url="https://docs.theglobalfund.org/files/Applications/Funding Requests/PHL/2023/Tuberculosis/en/PHL-T_FundingRequest_1_en.zip" format="application/zip">
      <title>
        <narrative>2023 - Funding Request - Window 1 - Tuberculosis - Philippines - English</narrative>
      </title>
      <description>
        <narrative>Funding Request of funding request FR1547-PHL-T.</narrative>
      </description>
      <category code="A01" />
      <category code="A02" />
      <category code="A08" />
      <language code="en" />
      <document-date iso-date="2023-03-30" />
    </document-link>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Treatment Success Rate in private sector: Percentage of TB patients (all forms) bacteriologically confirmed plus clinically diagnosed, successfully treated in the private sector</narrative>
      </title>
      <description>
        <narrative>Module: Collaboration with other providers and sectors.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Treatment Success Rate in private sector: Percentage of TB patients (all forms) bacteriologically confirmed plus clinically diagnosed, successfully treated in the private sector</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="22.94">
          <comment>
            <narrative>Numerator: 12935; Denominator: 56377.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target value="65" />
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target value="65" />
          <actual value="54.41">
            <comment>
              <narrative>Numerator: 80674; Denominator: 148273.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target value="65" />
          <actual value="60.52">
            <comment>
              <narrative>Numerator: 42568; Denominator: 70334.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target value="70" />
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="70" />
          <actual value="71.49">
            <comment>
              <narrative>Numerator: 101243; Denominator: 141625.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target value="70" />
          <actual value="74.55">
            <comment>
              <narrative>Numerator: 51294; Denominator: 68801.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target value="80" />
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target value="80" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of people with confirmed RR-TB and/or MDR-TB notified</narrative>
      </title>
      <description>
        <narrative>Module: Drug-resistant (DR)-TB diagnosis, treatment and care.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of people with confirmed RR-TB and/or MDR-TB notified</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="8235" />
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target value="5018" />
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target value="10036" />
          <actual value="8903" />
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target value="5018" />
          <actual value="3669" />
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target value="5887" />
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="11773" />
          <actual value="8374" />
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target value="5886" />
          <actual value="3953" />
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target value="6397.5" />
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target value="6397" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of RR/MDR-TB patients with DST results for Fluoroquinolone among the total number of notified RR/MDR-TB patients during the reporting period</narrative>
      </title>
      <description>
        <narrative>Module: Drug-resistant (DR)-TB diagnosis, treatment and care.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of RR/MDR-TB patients with DST results for Fluoroquinolone among the total number of notified RR/MDR-TB patients during the reporting period</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="98.59">
          <comment>
            <narrative>Numerator: 8119; Denominator: 8235.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target value="100" />
          <actual value="88.7">
            <comment>
              <narrative>Numerator: 6867; Denominator: 7742.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target value="100" />
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target value="100" />
          <actual value="93.82">
            <comment>
              <narrative>Numerator: 3337; Denominator: 3557.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target value="100" />
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="100" />
          <actual value="76.5">
            <comment>
              <narrative>Numerator: 6406; Denominator: 8374.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target value="100" />
          <actual value="67.34">
            <comment>
              <narrative>Numerator: 2783; Denominator: 4133.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target value="100" />
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target value="100" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of people with confirmed RR-TB and/or MDR-TB that began second-line treatment</narrative>
      </title>
      <description>
        <narrative>Module: Drug-resistant (DR)-TB diagnosis, treatment and care.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Percentage of people with confirmed RR-TB and/or MDR-TB that began second-line treatment</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31">
          <comment>
            <narrative>Numerator: 7850; Denominator: 8235; Percentage: 95.32%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 4259; Denominator: 4304; Percentage: 98.95%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 4259; Denominator: 4304; Percentage: 98.95%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 45; Denominator: 4304; Percentage: 1.05%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 45; Denominator: 4304; Percentage: 1.05%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 1317; Denominator: 4304; Percentage: 30.6%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 1317; Denominator: 4304; Percentage: 30.6%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Treatment regimen" value="Longer individualized" />
          <comment>
            <narrative>Numerator: 1663; Denominator: 4304; Percentage: 38.64%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Treatment regimen" value="Longer individualized" />
          <comment>
            <narrative>Numerator: 1663; Denominator: 4304; Percentage: 38.64%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 2987; Denominator: 4304; Percentage: 69.4%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 2987; Denominator: 4304; Percentage: 69.4%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Treatment regimen" value="Shorter 6-9 month" />
          <comment>
            <narrative>Numerator: 2641; Denominator: 4304; Percentage: 61.36%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Treatment regimen" value="Shorter 6-9 month" />
          <comment>
            <narrative>Numerator: 2641; Denominator: 4304; Percentage: 61.36%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target>
            <comment>
              <narrative>Percentage: 100%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Percentage: 100%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 7742; Denominator: 8903; Percentage: 86.96%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Percentage: 100%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 3557; Denominator: 3669; Percentage: 96.95%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 7616; Denominator: 8758; Percentage: 86.96%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 126; Denominator: 145; Percentage: 86.9%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 2289.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Treatment regimen" value="Longer individualized" />
            <comment>
              <narrative>Numerator: 1044.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 5453.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Treatment regimen" value="Shorter 6-9 month" />
            <comment>
              <narrative>Numerator: 6608.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Percentage: 100%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 7952; Denominator: 8374; Percentage: 94.96%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target>
            <comment>
              <narrative>Percentage: 100%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Percentage: 100%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 3711; Denominator: 3953; Percentage: 93.88%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 7826; Denominator: 8242; Percentage: 94.95%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 126; Denominator: 132; Percentage: 95.45%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 2403; Denominator: 2517; Percentage: 95.47%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Treatment regimen" value="Longer individualized" />
            <comment>
              <narrative>Numerator: 990.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 5549; Denominator: 5857; Percentage: 94.74%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Treatment regimen" value="Shorter 6-9 month" />
            <comment>
              <narrative>Numerator: 6775.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target>
            <comment>
              <narrative>Percentage: 100%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target>
            <comment>
              <narrative>Percentage: 100%.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Treatment success rate of RR-TB and/or MDR-TB: Percentage of patients with RR and/or MDR-TB successfully treated</narrative>
      </title>
      <description>
        <narrative>Module: Drug-resistant (DR)-TB diagnosis, treatment and care.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Treatment success rate of RR-TB and/or MDR-TB: Percentage of patients with RR and/or MDR-TB successfully treated</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31" value="73.5">
          <comment>
            <narrative>Numerator: 4146; Denominator: 5641.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target value="75" />
          <actual value="78.19">
            <comment>
              <narrative>Numerator: 3980; Denominator: 5090.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target value="75" />
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target value="75" />
          <actual value="79.8">
            <comment>
              <narrative>Numerator: 2086; Denominator: 2614.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target value="80" />
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="80" />
          <actual value="69.35">
            <comment>
              <narrative>Numerator: 3075; Denominator: 4434.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target value="80" />
          <actual value="66.93">
            <comment>
              <narrative>Numerator: 1435; Denominator: 2144.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target value="85" />
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target value="85" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of people with TB (all forms) notified among key affected populations/high risk groups (other than prisoners); *includes only those with new and relapse</narrative>
      </title>
      <description>
        <narrative>Module: Key and vulnerable populations (KVP) - TB/DR-TB.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of people with TB (all forms) notified among key affected populations/high risk groups (other than prisoners); *includes only those with new and relapse</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="31689" />
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target value="44158" />
          <actual value="55571" />
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target value="20186" />
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target value="23972" />
          <actual value="28569" />
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target value="26550" />
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="53100" />
          <actual value="71498" />
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target value="26550" />
          <actual value="34450" />
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target value="29444" />
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target value="29444" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of people with TB (all forms) notified among prisoners; *includes only those with new and relapse TB</narrative>
      </title>
      <description>
        <narrative>Module: Key and vulnerable populations (KVP) - TB/DR-TB.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of people with TB (all forms) notified among prisoners; *includes only those with new and relapse TB</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="4186" />
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target value="2500" />
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target value="5000" />
          <actual value="6099" />
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target value="2500" />
          <actual value="3443" />
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="4600" />
          <actual value="7211" />
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target value="2300" />
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target value="2300" />
          <actual value="3455" />
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target value="2000" />
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target value="2000" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of reporting units which digitally enter and submit data at the reporting unit level using the electronic information system</narrative>
      </title>
      <description>
        <narrative>Module: RSSH: Monitoring and evaluation systems.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of reporting units which digitally enter and submit data at the reporting unit level using the electronic information system</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative - other.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="100">
          <comment>
            <narrative>Numerator: 3297; Denominator: 3297.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target value="100" />
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target value="100" />
          <actual value="89.09">
            <comment>
              <narrative>Numerator: 3472; Denominator: 3897.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target value="100" />
          <actual value="89.09">
            <comment>
              <narrative>Numerator: 3472; Denominator: 3897.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="100" />
          <actual value="93.43">
            <comment>
              <narrative>Numerator: 7350; Denominator: 7867.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target value="100" />
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target value="100" />
          <actual value="93.43">
            <comment>
              <narrative>Numerator: 7350; Denominator: 7867.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target value="100" />
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target value="100" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of patients with of all forms of TB notified (i.e., bacteriologically confirmed + clinically diagnosed); *includes only those with new and relapse TB</narrative>
      </title>
      <description>
        <narrative>Module: TB diagnosis, treatment and care.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Number of patients with of all forms of TB notified (i.e., bacteriologically confirmed + clinically diagnosed); *includes only those with new and relapse TB</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31">
          <comment>
            <narrative>Numerator: 476754.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 242265; Denominator: 263033; Percentage: 92.1%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 242265; Denominator: 263033; Percentage: 92.1%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 20768; Denominator: 263033; Percentage: 7.9%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 20768; Denominator: 263033; Percentage: 7.9%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Type of TB" value="Bacteriologically confirmed" />
          <comment>
            <narrative>Numerator: 116085; Denominator: 263033; Percentage: 44.13%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Type of TB" value="Bacteriologically confirmed" />
          <comment>
            <narrative>Numerator: 116085; Denominator: 263033; Percentage: 44.13%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 94776; Denominator: 263033; Percentage: 36.03%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 94776; Denominator: 263033; Percentage: 36.03%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 168257; Denominator: 263033; Percentage: 63.97%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 168257; Denominator: 263033; Percentage: 63.97%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="HIV status" value="Negative" />
          <comment>
            <narrative>Numerator: 137575; Denominator: 263033; Percentage: 52.3%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="HIV status" value="Negative" />
          <comment>
            <narrative>Numerator: 137575; Denominator: 263033; Percentage: 52.3%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="HIV status" value="Positive" />
          <comment>
            <narrative>Numerator: 952; Denominator: 263033; Percentage: 0.36%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="HIV status" value="Positive" />
          <comment>
            <narrative>Numerator: 952; Denominator: 263033; Percentage: 0.36%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="HIV status" value="Unknown" />
          <comment>
            <narrative>Numerator: 63045; Denominator: 263033; Percentage: 23.97%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="HIV status" value="Unknown" />
          <comment>
            <narrative>Numerator: 63045; Denominator: 263033; Percentage: 23.97%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 560719.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 563335.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 280359.5.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 280359.5.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 276435.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 513791.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 49503.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Type of TB" value="Bacteriologically confirmed" />
            <comment>
              <narrative>Numerator: 250479.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 205003.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 358332.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV status" value="Negative" />
            <comment>
              <narrative>Numerator: 177477.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV status" value="Positive" />
            <comment>
              <narrative>Numerator: 2556.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV status" value="Unknown" />
            <comment>
              <narrative>Numerator: 241313.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 598012.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 558403.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 299006.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 299006.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 275580.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 522371.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 36031.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Type of TB" value="Bacteriologically confirmed" />
            <comment>
              <narrative>Numerator: 256566.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 99707.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 175872.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV status" value="Negative" />
            <comment>
              <narrative>Numerator: 360675.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV status" value="Positive" />
            <comment>
              <narrative>Numerator: 2505.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV status" value="Unknown" />
            <comment>
              <narrative>Numerator: 195223.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 297855.5.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 297855.5.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of new and relapse TB patients tested using WHO recommended rapid diagnostic tests at the time of diagnosis</narrative>
      </title>
      <description>
        <narrative>Module: TB diagnosis, treatment and care.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of new and relapse TB patients tested using WHO recommended rapid diagnostic tests at the time of diagnosis</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="70.74">
          <comment>
            <narrative>Numerator: 337262; Denominator: 476754.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target value="75" />
          <actual value="74.25">
            <comment>
              <narrative>Numerator: 418261; Denominator: 563335.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target value="75" />
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target value="75" />
          <actual value="75.64">
            <comment>
              <narrative>Numerator: 209094; Denominator: 276435.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target value="78" />
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="78" />
          <actual value="87.42">
            <comment>
              <narrative>Numerator: 488154; Denominator: 558403.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target value="78" />
          <actual value="89.14">
            <comment>
              <narrative>Numerator: 245651; Denominator: 275580.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target value="80" />
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target value="80" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of notified patients with all forms of TB (i.e., bacteriologically confirmed + clinically diagnosed) contributed by non-national TB program providers- private/non-governmental facilities; *includes only those with new and relapse TB</narrative>
      </title>
      <description>
        <narrative>Module: TB diagnosis, treatment and care.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of notified patients with all forms of TB (i.e., bacteriologically confirmed + clinically diagnosed) contributed by non-national TB program providers- private/non-governmental facilities; *includes only those with new and relapse TB</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="20.82">
          <comment>
            <narrative>Numerator: 99240; Denominator: 476754.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target value="25" />
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target value="25" />
          <actual value="24.92">
            <comment>
              <narrative>Numerator: 140404; Denominator: 563335.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target value="25" />
          <actual value="24.58">
            <comment>
              <narrative>Numerator: 67956; Denominator: 276435.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target value="26" />
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="26" />
          <actual value="23.68">
            <comment>
              <narrative>Numerator: 132238; Denominator: 558403.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target value="26" />
          <actual value="23.23">
            <comment>
              <narrative>Numerator: 64028; Denominator: 275580.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target value="27" />
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target value="27" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Treatment success rate- all forms: Percentage of patients with all forms of TB, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB patients notified during a specified period; *includes only those with new and relapse TB</narrative>
      </title>
      <description>
        <narrative>Module: TB diagnosis, treatment and care.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Treatment success rate- all forms: Percentage of patients with all forms of TB, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB patients notified during a specified period; *includes only those with new and relapse TB</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2021" iso-date="2021-12-31" value="76.25">
          <comment>
            <narrative>Numerator: 206635; Denominator: 270987.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31" value="75.64">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 118729; Denominator: 156965.11.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31" value="75.64">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 118729; Denominator: 156965.11.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31" value="63.8">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 8590; Denominator: 13463.89.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31" value="63.8">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 8590; Denominator: 13463.89.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31" value="69.76">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 42837; Denominator: 61405.57.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31" value="69.76">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 42837; Denominator: 61405.57.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31" value="77.49">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 84482; Denominator: 109023.43.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31" value="77.49">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 84482; Denominator: 109023.43.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31" value="63.38">
          <dimension name="HIV status" value="Negative" />
          <comment>
            <narrative>Numerator: 56494; Denominator: 89134.37.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31" value="63.38">
          <dimension name="HIV status" value="Negative" />
          <comment>
            <narrative>Numerator: 56494; Denominator: 89134.37.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31" value="87.2">
          <dimension name="HIV status" value="Positive" />
          <comment>
            <narrative>Numerator: 535; Denominator: 613.54.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31" value="87.2">
          <dimension name="HIV status" value="Positive" />
          <comment>
            <narrative>Numerator: 535; Denominator: 613.54.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31" value="76.11">
          <dimension name="HIV status" value="Unknown" />
          <comment>
            <narrative>Numerator: 61405; Denominator: 80681.09.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31" value="76.11">
          <dimension name="HIV status" value="Unknown" />
          <comment>
            <narrative>Numerator: 61405; Denominator: 80681.09.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target value="84" />
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target value="84" />
          <actual value="85.19">
            <comment>
              <narrative>Numerator: 475629; Denominator: 558319.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target value="84" />
          <actual value="84.92">
            <comment>
              <narrative>Numerator: 237692; Denominator: 279886.</narrative>
            </comment>
          </actual>
          <actual value="45.29">
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 215415; Denominator: 475629.</narrative>
            </comment>
          </actual>
          <actual value="4.68">
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 22256; Denominator: 475629.</narrative>
            </comment>
          </actual>
          <actual value="18.44">
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 87711; Denominator: 475629.</narrative>
            </comment>
          </actual>
          <actual value="31.53">
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 149960; Denominator: 475629.</narrative>
            </comment>
          </actual>
          <actual value="0.09">
            <dimension name="HIV status" value="Negative" />
            <comment>
              <narrative>Numerator: 447; Denominator: 475629.</narrative>
            </comment>
          </actual>
          <actual value="0.23">
            <dimension name="HIV status" value="Positive" />
            <comment>
              <narrative>Numerator: 1112; Denominator: 475629.</narrative>
            </comment>
          </actual>
          <actual value="41.27">
            <dimension name="HIV status" value="Unknown" />
            <comment>
              <narrative>Numerator: 196271; Denominator: 475629.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target value="85" />
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="85" />
          <actual value="88.11">
            <comment>
              <narrative>Numerator: 493035; Denominator: 559562.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target value="85" />
          <actual value="88.06">
            <comment>
              <narrative>Numerator: 243690; Denominator: 276739.</narrative>
            </comment>
          </actual>
          <actual value="87.33">
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 447348; Denominator: 512231.</narrative>
            </comment>
          </actual>
          <actual value="92.54">
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 45673; Denominator: 49355.</narrative>
            </comment>
          </actual>
          <actual value="87.88">
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 180090; Denominator: 204919.</narrative>
            </comment>
          </actual>
          <actual value="87.74">
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 312931; Denominator: 356667.</narrative>
            </comment>
          </actual>
          <actual value="93.74">
            <dimension name="HIV status" value="Negative" />
            <comment>
              <narrative>Numerator: 339426; Denominator: 362090.</narrative>
            </comment>
          </actual>
          <actual value="86.2">
            <dimension name="HIV status" value="Positive" />
            <comment>
              <narrative>Numerator: 2418; Denominator: 2805.</narrative>
            </comment>
          </actual>
          <actual value="77.29">
            <dimension name="HIV status" value="Unknown" />
            <comment>
              <narrative>Numerator: 151191; Denominator: 195604.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target value="90" />
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target value="90" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of people in contact with TB patients who began preventive therapy</narrative>
      </title>
      <description>
        <narrative>Module: TB/DR-TB Prevention.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Number of people in contact with TB patients who began preventive therapy</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31">
          <comment>
            <narrative>Numerator: 30492.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 11164; Denominator: 19721; Percentage: 56.61%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 11164; Denominator: 19721; Percentage: 56.61%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="5-14" />
          <comment>
            <narrative>Numerator: 4465; Denominator: 19721; Percentage: 22.64%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="5-14" />
          <comment>
            <narrative>Numerator: 4465; Denominator: 19721; Percentage: 22.64%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="&lt;5" />
          <comment>
            <narrative>Numerator: 4092; Denominator: 19721; Percentage: 20.75%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="&lt;5" />
          <comment>
            <narrative>Numerator: 4092; Denominator: 19721; Percentage: 20.75%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 106609.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 90157.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 53304.5.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 53304.5.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 50505.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 53949.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="5-14" />
            <comment>
              <narrative>Numerator: 16854.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;5" />
            <comment>
              <narrative>Numerator: 12655.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 183299.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 131044.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 91649.5.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 91649.5.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 72205.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 94114.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="5-14" />
            <comment>
              <narrative>Numerator: 23096.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;5" />
            <comment>
              <narrative>Numerator: 13834.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 146726.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 146726.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of HIV-positive new and relapse TB patients on ART during TB treatment</narrative>
      </title>
      <description>
        <narrative>Module: TB/HIV.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Percentage of HIV-positive new and relapse TB patients on ART during TB treatment</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31">
          <comment>
            <narrative>Numerator: 1969; Denominator: 2001; Percentage: 98.4%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 3684; Denominator: 3690; Percentage: 99.84%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 3684; Denominator: 3690; Percentage: 99.84%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="5-14" />
          <comment>
            <narrative>Numerator: 6; Denominator: 3690; Percentage: 0.16%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="5-14" />
          <comment>
            <narrative>Numerator: 6; Denominator: 3690; Percentage: 0.16%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="&lt;5" />
          <comment>
            <narrative>Numerator: 0; Denominator: 3690; Percentage: 0%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="&lt;5" />
          <comment>
            <narrative>Numerator: 0; Denominator: 3690; Percentage: 0%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 115; Denominator: 3690; Percentage: 3.12%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 115; Denominator: 3690; Percentage: 3.12%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 3575; Denominator: 3690; Percentage: 96.88%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 3575; Denominator: 3690; Percentage: 96.88%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Percentage: 95%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 2790; Denominator: 2806; Percentage: 99.43%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target>
            <comment>
              <narrative>Percentage: 95%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Percentage: 95%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1451; Denominator: 1465; Percentage: 99.04%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 2790; Denominator: 2790; Percentage: 100%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="5-14" />
            <comment>
              <narrative>Numerator: 0; Denominator: 2790.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;5" />
            <comment>
              <narrative>Numerator: 0; Denominator: 2790.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 149; Denominator: 2790; Percentage: 5.34%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 2641; Denominator: 2790; Percentage: 94.66%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target>
            <comment>
              <narrative>Percentage: 95%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Percentage: 95%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 2731; Denominator: 2780; Percentage: 98.24%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Percentage: 95%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1383; Denominator: 1411; Percentage: 98.02%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 2720; Denominator: 2768; Percentage: 98.27%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="5-14" />
            <comment>
              <narrative>Numerator: 4; Denominator: 4; Percentage: 100%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;5" />
            <comment>
              <narrative>Numerator: 7; Denominator: 8; Percentage: 87.5%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 165; Denominator: 169; Percentage: 97.63%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target>
            <comment>
              <narrative>Percentage: 95%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target>
            <comment>
              <narrative>Percentage: 95%.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of people living with HIV currently enrolled on antiretroviral therapy who started TB preventive treatment (TPT) during the reporting period</narrative>
      </title>
      <description>
        <narrative>Module: TB/HIV.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of people living with HIV currently enrolled on antiretroviral therapy who started TB preventive treatment (TPT) during the reporting period</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative - special.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="7.97">
          <comment>
            <narrative>Numerator: 6699; Denominator: 84086.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target value="85">
            <comment>
              <narrative>Numerator: 85809; Denominator: 100418.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target value="81.8">
            <comment>
              <narrative>Numerator: 92273; Denominator: 112814.</narrative>
            </comment>
          </target>
          <actual value="88.61">
            <comment>
              <narrative>Numerator: 80506; Denominator: 90854.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target value="5.73">
            <comment>
              <narrative>Numerator: 6464; Denominator: 112814.</narrative>
            </comment>
          </target>
          <actual value="7.73">
            <comment>
              <narrative>Numerator: 7026; Denominator: 90854.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target value="6.73">
            <comment>
              <narrative>Numerator: 10561; Denominator: 156820.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="13.5">
            <comment>
              <narrative>Numerator: 21122; Denominator: 156820.</narrative>
            </comment>
          </target>
          <actual value="12.89">
            <comment>
              <narrative>Numerator: 12974; Denominator: 100671.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target value="6.73">
            <comment>
              <narrative>Numerator: 10561; Denominator: 156820.</narrative>
            </comment>
          </target>
          <actual value="6.72">
            <comment>
              <narrative>Numerator: 6761; Denominator: 100671.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target value="6.03">
            <comment>
              <narrative>Numerator: 12378; Denominator: 205360.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target value="6.03">
            <comment>
              <narrative>Numerator: 12378; Denominator: 205360.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of registered new and relapse TB patients with documented HIV status</narrative>
      </title>
      <description>
        <narrative>Module: TB/HIV.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of registered new and relapse TB patients with documented HIV status</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="71.95">
          <comment>
            <narrative>Numerator: 236152; Denominator: 328201.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target value="80" />
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target value="80" />
          <actual value="64.65">
            <comment>
              <narrative>Numerator: 364183; Denominator: 563335.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target value="80" />
          <actual value="49.6">
            <comment>
              <narrative>Numerator: 185941; Denominator: 374915.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="54.7" />
          <actual value="66.71">
            <comment>
              <narrative>Numerator: 372500; Denominator: 558403.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target value="85" />
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target value="54.72" />
          <actual value="69.55">
            <comment>
              <narrative>Numerator: 191656; Denominator: 275580.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target value="56.5" />
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target value="56.5" />
        </period>
      </indicator>
    </result>
  </iati-activity>
</iati-activities>